Iontophoretic drug delivery to the nail by Dutet, Julie
 1 
IONTOPHORETIC DRUG DELIVERY TO THE NAIL 
 
 
 
JULIE DUTET 
 
A thesis submitted for the degree of Doctor of Philosophy 
 
University of Bath 
Department of Pharmacy and Pharmacology 
November 2008 
 
COPYRIGHT 
Attention is drawn to the fact that copyright of this thesis rests with its author. A  
copy of this thesis has been supplied on condition that anyone who consults it is 
understood to recognise that its copyright rests with the author and they must  
not copy it or use material from it except as permitted by law or with the consent  
of the author. 
 
This thesis may be not be consulted, photocopied or lent  
to other libraries without the permission of the author 
for 3 years from the date of acceptance of the thesis. 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 2 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 3 
TABLE OF CONTENTS 
 
Acknowledgements ..........................................................................................................5 
Abstract ............................................................................................................................7 
List of abbreviations ........................................................................................................9 
Chapter 1: INTRODUCTION.......................................................................................11 
Nail structure and properties ....................................................................................12 
1. Structure and growth ........................................................................................12 
2. Composition and mechanical properties ...........................................................13 
3. Permeability properties ....................................................................................14 
Onychomycosis and psoriasis ....................................................................................15 
1. Onychomycosis.................................................................................................15 
2. Psoriasis...........................................................................................................21 
Drug formulations for transungual delivery .............................................................22 
1. Formulations prolonging the contact of drugs with the nail surface: ................23 
2. Formulations interacting with the nail structure:..............................................25 
Principles of iontophoresis.........................................................................................26 
Application of iontophoresis to the human nail plate ...............................................29 
Chapter 2: Visualisation of ungual penetration by laser scanning confocal 
microscopy. .................................................................................................................31 
Overview.....................................................................................................................31 
Introduction ...............................................................................................................32 
Materials and methods...............................................................................................35 
1. Materials ..........................................................................................................35 
2. Nails.................................................................................................................35 
3. Nile Blue Chloride experiments ........................................................................35 
4. Sodium Fluorescein experiments ......................................................................36 
5. Iontophoretic set up ..........................................................................................36 
6. Passive experiments..........................................................................................37 
7. Binding study....................................................................................................37 
8. Confocal microscopy analysis ..........................................................................38 
9. HPLC analysis .................................................................................................40 
10.  Data analysis and statistics ...............................................................................41 
Results and discussion................................................................................................41 
1. NBC experiments ..............................................................................................42 
2. SF dorsal penetration experiments....................................................................49 
3. SF ventral and intermediate layer penetration experiment ...............................56 
4. Comparison between SF and NBC penetration .................................................64 
5. SF binding study...............................................................................................64 
6. Pathways of passive and iontophoretic transungual permeation ......................69 
Conclusions of Chapter 2 ...........................................................................................74 
Chapter 3: Transungual iontophoresis of mannitol: The electroosmotic contribution 
to transungual iontophoretic transport.........................................................................75 
Overview.....................................................................................................................75 
Introduction ...............................................................................................................76 
Materials and methods...............................................................................................79 
1. Materials ..........................................................................................................79 
2. Nails.................................................................................................................80 
3. Mannitol iontophoresis.....................................................................................80 
4. Mannitol quantification ....................................................................................82 
5. Mannitol binding study .....................................................................................83 
6. Data analysis and statistics ..............................................................................83 
Results and discussion................................................................................................84 
1. Mannitol electroosmotic transport ....................................................................84 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 4 
2. Mannitol binding ..............................................................................................98 
Conclusions of Chapter 3 ...........................................................................................99 
Chapter 4: Transungual iontophoresis of lithium and sodium: Electromigration and 
transport numbers. ......................................................................................................101 
Overview...................................................................................................................101 
Introduction .............................................................................................................102 
Materials and Methods ............................................................................................104 
1. Materials ........................................................................................................104 
2. Nails...............................................................................................................105 
3. Sodium and lithium iontophoresis...................................................................105 
4. Cation quantification......................................................................................106 
5. Data analysis and statistics ............................................................................107 
Results and discussion..............................................................................................107 
1. Sodium and lithium iontophoresis...................................................................107 
2. Effect of cation mobility and concentration ratio on cationic transport numbers...
 .......................................................................................................................118 
3. Effect of cation molar fraction on cationic transport number .........................121 
4. Total cationic transport number (Σ tC+= tNa+ + tLi+) .......................................123 
Conclusions of Chapter 4 .........................................................................................125 
Chapter 5: In vivo transungual iontophoresis: Effect of current application on ion 
transport and on transonychial water loss..................................................................127 
Overview...................................................................................................................127 
Introduction .............................................................................................................128 
Materials and methods.............................................................................................130 
1. Materials ........................................................................................................130 
2. Volunteers ......................................................................................................130 
3. Methods..........................................................................................................131 
4. Data analysis and statisticss ...........................................................................137 
Results and discussion..............................................................................................138 
Conclusions of Chapter 5 .........................................................................................156 
GENERAL DISCUSSION AND PERSPECTIVES ...................................................157 
General discussion .......................................................................................................157 
Perspectives ..................................................................................................................160 
GENERAL CONCLUSIONS ......................................................................................163 
REFERENCES ............................................................................................................165 
APPENDICES..............................................................................................................179 
Appendix 1: Confocal microscopy images ..............................................................181 
NBC.Passive .........................................................................................................183 
NBC.0.1.................................................................................................................193 
NBC.0.4.................................................................................................................203 
SF.Passive .............................................................................................................217 
SF.0.1 ....................................................................................................................225 
SF.0.4 ....................................................................................................................241 
SF.V.Passive .........................................................................................................252 
SF.V.0.1.................................................................................................................261 
SF.I.0.1..................................................................................................................279 
SF Binding Study .................................................................................................293 
Appendix 2: Mannitol recovered in the nails ..........................................................298 
Appendix 3: Ethical forms for nail collection .........................................................302 
 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 5 
Acknowledgements 
 
I would like to thank my supervisor Dr Begoña Delgado-Charro for her guidance and 
support throughout my doctoral studies. 
 
I gratefully acknowledge Dr Michael Cork and Dr Stephen Moss for accepting to evaluate 
this work. 
 
I thank Adrian Rogers for his technical help to use the Laser Scanning Confocal 
Microscope. 
 
I thank all the volunteers for their participation in the experiments and for their patience. 
 
I would like to thank my friends and colleagues, past and present, for their moral and 
technical support. I would like to especially thank Sarah Cordery for her invaluable moral 
and technical support. 
 
I acknowledge the University of Bath for its financial support. 
 
Finally, I would like to thank my family for their constant moral support. 
 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 6 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 7 
Abstract 
 
Basic information about nail behaviour, under passive and especially iontophoretic 
condition, lacks in the literature. Thus, this thesis aims to fill gaps in the nail understanding 
by studying the potential and feasibility of the application of iontophoresis to human nail.  
The iontophoretic and passive delivery of Sodium Fluorescein (SF) and Nile Blue Chloride 
(NBC) were studied, in vitro, in order to determine their pathways as well as their depth 
and uniformity of penetration into the nail.  
The permselective properties of the nail were investigated by characterizing the 
contribution of electroosmosis, using mannitol as a marker, and by studying the flux of two 
inorganic cations, sodium and lithium, during in vitro experiments. 
Finally, the feasibility of transungual iontophoresis and the extraction of sodium and 
chloride ions from the body through the nail plate were performed on a group of human 
volunteers. 
Iontophoresis led the fluorescent markers slightly deeper into the nail plate than passive 
diffusion. The delivery of the bianion and of the cation was not different. Both compounds 
mainly penetrated the nail via the transcellular pathway. 
Electroosmosis resulted only in a slight enhancement of the mannitol fluxes compared to 
passive diffusion and the fluxes presented high variability, especially at pH 7.4 and when 
the current was applied in the anode-to-cathode direction. 
The delivery of the two inorganic cations was significantly higher at pH 7.0 than at pH 4.0 
and supported that nails hold a negative charge at physiological pH. 
Ions were easily extractable through the nail plate during in vivo iontophoresis and all 
volunteers’ feedbacks supported iontophoresis as an acceptable technique. 
This thesis demonstrated the feasibility and potential of in vivo transungual iontophoresis. 
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Chapter 1:      
 INTRODUCTION  
 
Nails represent a small part of the body but have the structure of a very efficient barrier. 
Nails are made up of layers of dead, flattened, overlapping keratinised cells which form a 
0.2–0.6 mm hard structure (Walters et al., 1983 b; Murdan, 2002; Hao et al., 2008).  
Two main diseases affect the nail unit: onychomycosis and psoriasis. Treatments of these 
two diseases usually lead to poor patient compliance. Indeed, due to the lack of penetration 
of topically applied drugs into the nails, long term systemic treatments resulting in side 
effects or painful injections in the nail folds are the usual alternatives.  
Iontophoresis consists in the application of a small electrical current and has proven to 
efficiently enhance drug delivery in various fields such as transdermal application (Kalia et 
al., 2004), orthopaedics (Day et al., 2005), ophthalmology (Eljarrat-Binstock et al., 2005) 
or dentistry (Singal et al., 2005). 
Recent publications investigating the in vitro application of iontophoresis to human nail 
plate demonstrated an interesting potential for drug delivery (Murthy et al, 2007 a and b, 
Hao et al., 2008 a, b and c). 
The aim of this chapter is 1) to describe the structure and properties of the human nail, 2) 
to present the main diseases that can affect nails, onychomycosis and psoriasis, and their 
treatments, 3) the formulations developed for transungual delivery, 4) to introduce the 
principles of iontophoresis and 5) to describe the application of iontophoresis to the nail 
and its potential. 
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Nail structure and properties 
1. Structure and growth 
 
The nail plate is constituted of “hard” hair-type (80%) and “soft” skin-type (20%) keratins  
(Lynch et al., 1986; De Berker et al., 2000). Sulfur and nitrogen are the most important 
elements in nail composition. Lipids (mainly cholesterol) represent 0.1 to 1 % of the nail 
composition and small quantities of potassium, calcium, magnesium, sodium, copper, zinc 
and iron can be found (Walters et al., 1983a; Debruyne et al., 2001). Water is the main 
plasticiser in the nail and nail water content is usually 18-20 % but can be as high as 25 % 
for excised nail exposed to 100 % RH (Gunt et al., 2007a). 
In the past, the terms used to describe the structure of the nail were not shared by all 
authors which led to the use either of similar words to indicate different areas or of 
different words for similar area. This misunderstanding was partly due to a disagreement 
on the existence/absence of a ventral layer and thus, of an area in the nail matrix to produce 
it. Now, as authors agree on the existence of this layer, the situation is simpler.  
Fig. 1 shows a lateral view and the different parts where the nail formation takes place. 
 
 
Fig. 1: Lateral view of a nail. Reproduced from Jiaravuthisan et al. (2007)  
 
The proximal and lateral nail folds are the skin parts holding in place the nail plate. The 
eponychium is the thin cuticle sealing off the space between the proximal nail fold and the 
nail plate and the hyponychium is the skin under the free edge of the nail plate. 
Keratinocytes are present in the nail matrix and differentiate to produce the nail plate cells, 
the onychocytes (Lowry et al., 1999). The nail matrix is subdivided in the dorsal, 
intermediate and ventral matrix. The ventral matrix, at the level of the lunula, connects 
with the nail bed. There is no granular layer in the epithelium of the matrix or in the nail 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 13 
bed. This means that, unlike skin keratinisation, nail keratinisation occurs without the 
formation of keratohyalin. 
By a process of parakeratosis, the dorsal layer originates from the dorsal matrix, the 
intermediate layer from the intermediate matrix and the ventral layer from the ventral 
matrix (Reardon et al., 1999). Parakeratosis is defined as the flattening of the cells 
associated with a reduction in size and the persistence of the nuclei.  
Some authors (Lewis, 1954; Reardon et al., 1999) suggested that the walls of the lateral 
nail folds and the ventral proximal nail fold could participate in the formation of the 
intermediate and dorsal layers, respectively.  
It is thought that the nail bed participates all along the nail growth to an increase in 
thickness (Johnson et al., 1993). However, no increase in the number of nail cells has been 
observed and it has been suggested that the shape of the cells could become altered as the 
nail grows resulting in a reduction of the number of cells but as well in an increase in 
thickness (De Berker et al., 2007). 
The growth of the nail is the consequence of the pressure of the expanding cells. As Fig. 1 
shows, the nail plate follows an angled growth: newly formed cells delimit an almost 
horizontal band which, with the nail growth, will be pushed towards a vertical position (De 
Berker et al., 2007). 
The average growth rate is 3 mm per month for healthy fingernails and 1 mm per month 
for toenails (Murdan, 2002; Geyer et al., 2004). 
 
2. Composition and mechanical properties 
 
The orientation of the keratin fibres and contents in calcium, phospholipids, disulphide 
bounds (S-S), sulfydryl groups (S-H) and acid phosphatase activity are specific to each 
layer (Table 1).  
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Table 1: Comparison of the nail layers composition and orientation of the keratin fibres 
 Dorsal Intermediate Ventral 
Calciuma High Low High 
Phospholipidsa  High Low High 
Disulphide boundsa Low High High 
Sulfhydryl groupsa High Low High 
Acid Phosphatase 
activitya 
Low High High 
Keratin fibres 
orientation to the 
growth axisb 
60% perpendicular 
40% parallel 
All perpendicular Similar to dorsal 
adata from Jarrett et al. (1966).  bdata from Farren et al. (2004) 
 
In terms of mechanical behaviour, the dorsal and ventral layers, by their keratin fibres 
orientation, are isotropic whereas the intermediate layer is anisotropic. Despite this 
“sandwich” structure, the nail mechanical properties are governed by the isotropic 
intermediate layer. This means that when a cut happens in the nail plate, it propagates 
perpendicularly to the growth axis in accordance with the keratin fibres orientation in the 
intermediate layer (Farren et al., 2004). It is to note that this property allows the protection 
of the finger: indeed, if the cut propagated parallel to the growth axis it would reach the 
sensitive nail bed and might cause damage to the finger. 
All the keratins fibres are held together by disulfide bounds (S-S). These bounds are the 
usual target of penetration enhancers such as N-acetyl-L-cysteine (drug formulations for 
nail delivery are addressed in a section below).  
 
3. Permeability properties 
 
The effects of the vehicle, the lipophilicity, the ionisation and the MW on nail drug 
permeation have been subject to controversy.  
It is accepted by several authors that the aqueous or lipophilic nature of vehicles do not 
change the drug permeation rate (Walters et al., 1985a; Mertin et al., 1997a). However, 
Walters et al. (1983b, 1985a) asserted the existence of a lipophilic pathway determining 
the nail penetration of homologous n-alcanols whereas Mertin et al. (1997b) and 
Kobayashi et al. (2004) respectively used homologous nicotinic acid esters of increasing 
carbonated chain length (and increasing octanol/water partition coefficient) and 
homologous p-hydroxybenzoic acid esters and proved that no lipophilic pathway existed. 
The former authors (Mertin et al., 1997b; Kobayashi et al., 2004) also showed that the 
partition coefficient of the molecule had little importance upon drug permeation. 
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The same authors disagreed as well on the effect of ionisation on drug permeation: Walters 
et al. (1985b) studied the effect of the pH on the nail permeation of miconazole and did not 
find any whereas Mertin et al. (1997b) and Kobayashi et al. (2004) both found that ionised 
molecules penetrated the nail plate less efficiently than their respective neutral form. 
The MW cut-off of the membrane, probably partly because of the previously cited 
controversy, is not well determined: Kobayashi et al. (2004) were not able to measure any 
permeation rate for compounds presenting MW above 240 whereas Mertin et al. (1997c) 
studied the permeation of several antimycotics with MW ranging from 151.2 to 956.1, 
Walters et al. (1985b) studied the permeation of miconazole which has a MW of 416.1 and 
Gunt et al. (2007b) studied the permeation of ketoconazole which has a MW of 531.4 
showing that compounds having a MW above 400 Da were still able to penetrate the nail 
plate. Despite the fact that no clear value of a MW cut-off was found, an inverse 
relationship between the log of the permeability coefficient and the MW has been 
established (Mertin et al., 1997c; Kobayashi et al., 2004) which suggests that the 
permeability coefficient decreases when the MW increases. 
 
Onychomycosis and psoriasis 
1. Onychomycosis 
 
Onychomycosis affects 3 to 10 % of the European population (Murdan, 2002) and 
approximately 18 % of the world population (Repka et al., 2002). It is more likely to affect 
1) toenails than fingernails (4:1) and 2) elderly, immunosuppressed or diabetics patients 
rather than healthy “young” people (Lowry et al., 1999; Roberts, 1999; Murdan, 2002; 
Repka et al., 2002). 
90 to 95% of toenail onychomycosis are due to dermatophytes (mainly Trichophyton 
rubrum, Trychophyton mentagrophytes), 5 to 10% are due to yeasts or moulds (mainly 
Candida Albicans or Aspergillus Versicolor). Fingernail onychomycosis are caused by the 
same microorganisms as toenail affections but 50 % are due to dermatophytes (mainly T. 
rubrum and T. mentagrophytes) and the other 50 % are due to yeasts or moulds (Roberts, 
1999; Murdan, 2002; Repka et al., 2002; Lever, 2005). 
Dermatophytes are eukaryotic and form multicellular tubes called hyphae which, when 
they intertwine, form mycelia. Their reproduction is asexual and the arthrospores are 
formed by hyphal segmentation (Lever, 2005). 
Yeasts are single-celled usually rounded fungi. The association of the cells can form 
pseudo-hyphae (Candida sp) and mycelia. They reproduce by budding forming 
blastospores (Lever, 2005). 
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Onychomycosis is classified in four clinical types (Lever, 2005): 
• DLSO: distal and lateral subungual onychomycosis is the most common form and 
is usually due to T. rubrum. 
• SWO: superficial white onychomycosis which is primarily caused by T. 
mentagrophytes and frequently affects HIV patients. 
• PSO: proximal subungual onychomycosis which is typically caused by T. rubrum 
but is rare in the general population. 
• Candida infections: there is no nail plate invasion (Unlike dermatophytes, Candida 
sp do not “feed” on keratin) and yeasts are seen along the undersurface of the nail 
plate. 
Two types of treatment can be used to treat onychomycosis: avulsion treatments or drug 
based treatments. The drug based treatments will be more highlighted as usually avulsion 
treatments are not well accepted by patients and drugs active against dermatophytes will be 
privileged. 
 
a) Avulsion treatments 
Two kinds of avulsion treatments can be found in the literature (Lowry et al., 1999; 
Murdan, 2002): 1) surgical avulsion consists in the removal of the infected nails. This is a 
very traumatic operation which is now kept as a last resort. 2) chemical avulsion consists in 
the application, under occlusive dressings, of a formulation containing around 40 % of urea 
during 5 to 10 days. This formulation softens the nail plate and provokes its separation 
from the nail bed. The application of a topical antifungal is usually coupled with this 
treatment in order to ensure the growth of healthy nails. 
 
b) Drug based treatments 
Drug treatments can be systemic or topical. Oral treatments are based on two “old” 
molecules, namely griseofulvin and ketoconazole, and three “new” molecules; 
itraconazole, terbinafine and fluconazole. Main topical treatments involve nail lacquers 
containing amorolfine or ciclopirox. 
Terbinafine (allylamine), azoles and amorolfine (morpholine) are inhibitors of enzymes in 
the biosynthesis of ergosterol (Fig. 2). Ergosterol is the equivalent of mammalian 
cholesterol in the fungus cell membrane and therefore, inhibiting enzymes in its 
biosynthesis results in an increased permeability of the fungus membrane and may provoke 
the cell death. 
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Fig. 2: Simplified biosynthesis of ergosterol and sites of action of allylamine, azole and morpholine 
antifungals. Modified from Gupta et al., 2003a 
 
Oral treatments: 
• Griseofulvin is derived from Penicillium griseofulvum. It was the standard 
treatment of onychomycosis until the development of azoles and allylamines. It is 
fungistatic and its spectrum is limited to dermatophytes (Develoux, 2001). It 
inhibits the formation of intracellular microtubules, disrupts the mitotic spindle and 
thus, prevents cell division of the fungus (Gupta et al., 2003a). Treatments must be 
pursued until complete cure (12 months or more) and relapses are common (Lowry 
et al., 1999). It is roughly well tolerated (digestive side-effects) but teratogenic and 
potentially carcinogenic effects were shown in animals (Develoux, 2001). 
• Ketoconazole is fungistatic, generally well tolerated and keratophilic. A rare side 
effect, a drug-induced hepatitis, imposes short term treatment and close monitoring 
of the liver function and thus, leads to its very limited use (De Doncker, 1999; 
Debruyne et al., 2001). The usual dose is 200 to 400 mg daily. 
• Itraconazole is fungistatic. It can be taken continuously, 200 mg daily for 3 months, 
or be taken in pulse therapy based on the administration of 200 mg twice daily 
during 7 days with subsequent courses repeated after 21-day intervals. The 
treatment takes 2 courses for fingernails and 3 courses for toenails (BNF 56).  
• Terbinafine is fungicidal and well-tolerated with usually only gastro-intestinal 
disturbances and cutaneous reactions. Roberts (1999) gathered clinical studies of 
these molecules and determined that terbinafine was the most cost-effectiveness 
and the most efficient drug with a cure rate of 70 to 80%. However, this conclusion 
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has to be taken cautiously as this author received fundings from Novartis Pharma 
(Lamisil®, Terbinafine), Janssen Pharmaceuticals (Sporanox®, Itraconazole) and 
Pfizer (Diflucan®, Fluconazole). 
• Fluconazole is used at a posology of 150-300 mg weekly until complete cure 
(Gupta et al., 2003a) but this application is not licensed in UK. 
 
The description of the possible drug interactions of these oral treatments have been 
addressed by Katz et al. (2003) and can be of two kinds: 
1) Pharmacodynamic:  
a) itraconazole is thought to have a negative inotropic effect and thus association 
with other drugs presenting the same effect such as calcium channel blockers 
(eg. nifedipine or verapamil) or its administration to patients presenting already 
heart failure is not recommended.  
b) All antifungal drugs present a risk of hepatotoxicity. Therefore administration to 
patients presenting already a liver dysfunction or concomitant administration 
with drugs extensively processed by the liver are not recommended. 
2)  Pharmacokinetic:  
a) the gastro-intestinal absorption and bioavailability of some antifungals such as 
griseofulvin, ketoconazole and itraconazole (capsules) is highly dependent on 
the gastric pH or meals composition. Thus, drugs able to modify the gastric pH 
such as divalent cationic antiacids or proton pump inhibitors have to be 
administered carefully.  
b) Itraconazole and ketoconazole are inhibitors of the P-glycoprotein which is a 
membrane transporter found on the apical surface of enterocytes in the small 
intestine and in the secretory cells of the renal tubules. Its inhibition can cause 
increased gastro-intestinal absorption or decreased renal excretion and may 
result in an increased bioavailability of substances depending on this transporter 
(digoxin).  
c) Ketoconazole, itraconazole and fluconazole (dose > 200 mg/d) are inhibitors of 
the CYP3A4, fluconazole inhibits the CYP2C9 as well and terbinafine inhibits 
CYP2D6. All these enzymes are part of the cytochrome P-450 which is 
involved in the biotransformation/metabolisation of numerous drugs. Therefore, 
depending on the therapeutic window of the drugs involved, side effects may 
result from this inhibition by increasing the level of un-metabolised drugs in the 
blood flow.  
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d) ketoconazole, itraconazole and, to a partial extent, fluconazole are substrate of 
CYP3A4. Thus, CYP3A4 inducers such as rifampicin, or carbamazepin may be 
responsible for a bioavailability decrease and, potentially, for a failure of the 
antifungal treatment. 
 
Topical treatments: 
Amorolfine and ciclopirox are used topically and therefore cause only local side effects (eg 
irritation or rash). 
• Amorolfine is a fungicidal drug of the morpholine class. It must be applied one or 
two times weekly. The treatment last 6 months for fingernail and 9 to 12 months for 
toenails (BNF 56). It has two sites of actions in the ergosterol biosynthetic 
pathway: it inhibits the ∆14-reductase and the ∆7-8-isomerase (Gupta et al., 
2003b). 
• Ciclopirox is a hydroxypyridone derivative. It is fungicidal and must be applied 
once daily. It has at least three mechanisms of action. The main one relates to its 
high affinity for trivalent cations such as Fe3+ and Al3+. These ions are involved in 
mitochondrial electrotransport processes to produce energy and thus, by blocking 
these transports, ciclopirox provokes a lack of energy production and subsequently 
the cell death. The second is related to a strong decrease of catalase and peroxidase 
activity responsible for the degradation of toxic peroxides creating an accumulation 
of the toxic compounds in the cell. Finally the third mechanism is responsible for a 
decrease in the nutrient uptake creating an intracellular depletion of essential 
aminoacids which reduces the synthesis of proteins and nucleic acids (Gupta et al., 
2003b).  
 
The posology, MIC, plasma and nail concentrations of drugs used for onychomycosis 
systemic and topical treatments are presented in Table 2. 
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Table 2: Antifungal drugs used to treat onychomycosis. Appl. means application and MIC is the minimum 
inhibitory concentration.  
Molecule Dose a, MIC (ng/g) b 
Plasma 
concentration 
(mg/L)c 
Nail concentrationc  
Griseofulvin 500 mg to 1 g/d 94 – 6000  1.39   
Ketoconazole 200 to 400 mg/d 94 – 12000  5.5 – 6.5   
Itraconazole 
200 mg/d 
400 mg/d during 
one week repeated 
after 21-day 
interval 
11 – 1500  0.272  
600 – 900 ng/g  
 
 
 
 
Terbinafine 250 mg/d 2 – 750  0.03 – 1.39  250 – 1000 ng/g  
Fluconazole 150 mg/week 750 – 48000  0.3 – 2.7 
8.5 – 9.5 µg/g 
(peak)  
Amorolfine 1 – 2 appl./week 300   3.9 – 24.6 mg/g  
Ciclopirox 1 appl./d 11 – 94   5.91±2.42 mg/g  
a doses from BNF except fluconazole from Gupta et al. (2003a) 
b
 MIC from Perea et al. (2001) (griseofulvin and fluconazole) and Gupta et al. (2003c) (Ciclopirox, 
terbinafine, itraconazole and ketoconazole) concern T. mentagrophytes and T. rubrum. Amorolfine MIC 
concerns C. albicans (Debruyne et al., 1999). 
c
 Plasma and nail concentrations from De Doncker (1999) (Itraconazole and ciclopirox) and Palmeri et al. 
(2000) (Fluconazole and terbinafine). Amorolfine nail concentration from Polak (1993). 
 
Table 2 shows that antifungal drugs are usually at an efficient concentration in nails 
(however MICs were not determined in the nail tissue itself) and that topical application 
usually allows greater concentrations in nails than systemic treatments. However, both 
types of treatments are limited by their duration because 1) the nail concentrations 
presented in Table 2 are reached after, at least, a couple of weeks and 2) the nail cure is not 
obtained before months. Further, relapses or reinfections (the distinction is not always 
obvious) are frequent whichever the molecule used. It is interesting to note that systemic 
drugs are not only incorporated in the nail in formation via the three matrices but that they 
diffuse as well into the whole nail plate via the nail bed (Palmeri et al., 2000). 
Combination therapies coupling an oral and a topical drug such as terbinafine+ciclopirox 
or +amorolfine and itraconazole+amorolfine have been used for severe onychomycosis: 
they usually increase the cure rate significantly but the duration of the treatment remains 
unchanged. 
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2. Psoriasis 
 
Psoriasis is a chronic, incurable disease which affects 1.5 – 3 % of the population. Up to 90 
% of psoriatic people have their nails as well as their skin affected by the disease 
(Jiaravuthisan et al., 2007). The disease is related to an immunologic T-cells activation and 
skin manifestations are characterized by epidermal thickening and scaling. 
To name a few symptoms, nail psoriasis appears under the form of pitting, onycholysis, 
subungual hyperkeratosis or splinter haemorrhages (De Berker, 2004). 
Although several therapeutic options exist, there is a paucity of information concerning 
their outcomes on nail psoriasis and no reference treatment is established.  
Treatments consist in drugs administrated orally, topically, by local injection or by 
radiation. The systemic treatments are only indicated for severe, complicated psoriasis. The 
use of drugs such as methotrexate, cyclosporine or acitretin (to name a few) has been 
reported to treat skin psoriasis and to have effects on nail psoriasis (De Berker, 2004; 
Jiaravuthisan et al., 2007). However cyclosporine and methotrexate are immunomodulators 
and acitretin is a retinoid (teratogenic side effect) and therefore the use of systemic 
treatments for nail psoriasis is usually not recommended (De Berker, 2004).  
 
Topical therapies (ointment, cream, solutions and gels) must be applied at least once a day. 
It is to note that a single therapy is not efficient against all the manifestations of nail 
psoriasis. Topical therapies are based on: 
• Corticosteroids and vitamin D3 analogs. Both compounds have an anti-
inflammatory effect but long-term corticotherapy can be responsible for skin 
atrophy in the nail folds. This treatment is efficient on hyperkeratosis but has not 
been studied for any other nail dystrophies. 
• 5-Fluorouracil (5-FU) is an inhibitor of the nucleic acids synthesis. It has been 
reported that 5-FU could either improve or worsen the symptoms of nail psoriasis 
(Jiaravuthisan et al., 2007). 5-FU is efficient on nail pitting and hyperkeratosis but 
is not recommended for onycholysis. 
• Anthralin (also known as dithranol) is classified as an antipsoriatic agent. It is 
effective on hyperkeratosis and onycholysis but has no affect on nail pitting. 
Anthralin is a safe treatment which acts by decreasing inflammation and cellular 
proliferation and by increasing cellular differentiation. However this drug colours 
skin and clothing and can cause skin irritation. 
• Tazarotene is from the retinoid family. Its acts by normalising cell differentiation, 
reducing cell proliferation and decreasing inflammation. Tazarotene is efficient on 
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nail pitting and onycholysis but has little effect on hyperkeratosis. This treatment 
can be responsible for erythema, irritation or even peeling of the nail folds. 
• Cyclosporine is an immunosuppressive agent. Cyclosporine is efficient on nail 
pitting and onycholysis. It is thought that topical applications of tacrolimus and 
pimecrolimus (immunosuppressive agents) might be of interest for future 
treatments of nail psoriasis (Jiaravuthisan et al., 2007). 
 
Intralesional therapies consist in the injections of corticosteroids in the nail folds. 
Triamcinolone acetonide is the most frequently used drug. Although it is an efficient 
treatment, the injections are painful and can be responsible for hematomas. Further, the 
steroid itself can be responsible for skin atrophy. It has been suggested that this technique 
should be limited to severe nail psoriasis and to two or three injections per year (De 
Berker, 2004). 
 
Radiation therapies such as phototherapy and photochemotherapy (PUVA therapy: 
Psoralene + UVA) are thought to lead to an improvement of nail psoriasis. However these 
therapies mostly have been investigated for their skin effects.  
Superficial radiotherapy and other types of radiations have been used in the past but their 
use is declining. The main reason for this decline is the possible effects of the radiations on 
the body after the treatment which can be as serious as a risk of carcinomas or sarcomas. 
 
Drug formulations for transungual delivery 
 
As the previous sections of this chapter have shown, nails are characterized by a poor 
permeability which makes the treatment of nail diseases difficult. Therefore, efforts have 
been orientated towards the development of formulations to lengthen drug-nail contact and 
in the testing of substances to enhance drug delivery. 
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1. Formulations prolonging the contact of drugs with the nail surface: 
  
To ensure a prolonged release of drugs, it is important that the formulations adhere to the 
nail surface and therefore, lotions or solutions are of little use as these formulations do not 
remain long on the nail surface. 
Nail lacquers allow the drugs to remain in contact with the nail plate for long times. The 
applications can be performed either by brushing a new layer on top of the previous one or 
by cleaning off the nail from the previous application and applying a new layer of lacquer. 
The usual elements necessary in a nail lacquer formulation are: an organic solvent, a film 
forming polymer, some resins (to enhance the adherence of the lacquer) and plasticisers (to 
preserve the flexibility and enhance the durability of the film). Thus, nail lacquers are 
organic solutions of drug and polymer which form a water-insoluble film when the solvent 
evaporates. The drug diffuses from the film into the nail plate. The water-insoluble film is 
occlusive and leads to an increase of the hydration of the nail plate. It is to note that the 
hydration of the nail plate plays an essential role for drug permeability (Gunt et al., 2007b). 
The delivery of the drug from the lacquer to the nail plate follows diffusion law (Eq. 1): 
 
hCh
KDJ ••=   Eq. 1 
 
Where J is the flux, D is the diffusion coefficient, K is the partition coefficient of the drug 
between the formulation and the membrane, h is the depth of penetration and Ch is the 
concentration of the drug at the depth h. 
The essential factors affecting the drug delivery in nail lacquers are: 
• The solubility of the drug in the polymer film 
• The solubility of the drug in the nail 
• The diffusion coefficient of the drug in the polymer film 
• The diffusion coefficient of the drug in the nail 
• The drug content in the polymer film 
 
Amorolfine and ciclopirox described previously are commercialised as nail lacquers. Other 
types of formulation have been explored and some examples are given below. 
 
Repka et al. (2004) described the formulation of a hot-melt extruded nail lacquer and of a 
carbopol gel of ketoconazole. Hot-melt extrusion has the advantage to avoid the use of 
organic solvent and to require fewer steps than the formulation of a classic nail lacquer. 
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The authors performed their study by applying these formulations on non-etched or etched 
nail samples. This etching step was performed by applying a 10 % phosphoric acid 
solution on the surface of the nails during 60 seconds and aimed at improving the 
bioadhesion of the lacquer on the nail surface. Etching not only resulted in a better 
adhesion of the lacquer but also in a greater permeation of ketoconazole from both 
formulations compared to the non-etched nails (60 % more and 6 fold higher than the non-
etched nails for the gel and the lacquer, respectively). 
Hui et al. (2004) compared the nail delivery of a ciclopirox gel formulation (2 %) 
containing propylene glycol and urea with a commercialised gel (0.77 %) and a 
commercialised lacquer (8 %). The authors found that the commercialised gel, despite 
ciclopirox low concentration in the formulation, reached the highest concentration in the 
receptors of the diffusion cells. Their formulation reached higher concentration than the 
commercialised lacquer. 
 
Some more unusual formulations have been described: Donelly et al. (2005) formulated a 
bioadhesive patch whereas Monti et al. (2005) tested a water-soluble lacquer. 
The bioadhesive patch formulated by Donelly et al. (2005) contained 5-aminolevulinic acid 
(ALA), a drug used in oncology, which has a bactericidal and fungicidal action and is 
activated by visible light (Photodynamic therapy). The formulation contained Gantrez® 
AN-139 (a copolymer of methylvinylether and maleic anhydride), tripropylene glycol 
methyl ether, ethanol and 50 mg/cm2 of ALA. ALA penetrated well in the nail samples and 
microbiological tests on Sabouraud liquid medium showed that ALA associated with 
irradiation led to high percentages of kill for C. albicans and T. interdigitale. However, 
100 mM of ALA applied for 30 min for C. albicans and 6 hours for T. interdigitale + 
irradiation were necessary to kill 90 % of the microorganisms. This concentration was far 
away from what was reached in nail samples (6.9 mM after 72 h exposure to the patch) and 
moreover this concentration is probably as toxic for microorganisms as it is for human 
cells. Therefore ALA associated with photodynamic therapy did not seem to be applicable 
in practice. 
The formulation of ciclopirox in a water-soluble nail lacquer containing 
hydroxypropylchitosan was described by Monti et al. (2005). Thanks to their formulation, 
ciclopirox achieved much shorter lag time than Penlac® (3.36h versus 12.48h) whereas 
both formulations contained 8 % of the drug. Although the authors justified this water-
soluble nail lacquer by its short lag time and thus, by the possibility of applying it before a 
night of sleep, the usefulness of such a lacquer which can be so easily removed remains 
arguable. 
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2. Formulations interacting with the nail structure: 
 
Some chemical compounds are able to soften the nail plate or to break covalent bonds in 
the nail structure.  
Urea and salicylic acid have been typically used in skin applications to soften and remove 
the external layers of the stratum corneum. Although these two substances have an effect 
on the nail aspect (Quintanar-Guerrero et al., 1998), this did not lead to enhanced nail 
permeations for Kobayashi et al. (1998) (5-FU), for Quintanar-Guerrero et al. (1998) 
(miconazole, ketoconazole and itraconazole) or for Malhotra et al. (2002) (water).  
Repka et al. (2002) studied by SEM (Scanning Electron Microscopy) and AFM (Atomic 
Force Microscopy) the effect of urea, tartaric acid and phosphoric acid on the dorsal layer 
of the nail. Scanning electron micrographs of urea did not reveal any effect of the chemical 
on the nail whereas tartaric acid and phosphoric acid provoked significant etching and 
roughness visible on SEM and AFM images. Application times of tartaric acid and 
phosphoric acid were 90 and 30 seconds, respectively. As mentioned above, Repka et al. 
(2004) compared the permeation of two formulations with and without phosphoric acid 
pre-treatment and found that the pretreatment with phosphoric acid had an enhancing 
effect. 
Nail swelling is thought to be a good indicator for formulations potential (Gunt et al., 
2007b), it has therefore been used to screen penetration enhancers (Khengar et al., 2007). It 
is to note that nail swelling can be obtained, to a certain extent, by simply increasing nail 
hydration (Gunt et al., 2006).  
Khengar et al. (2007) described the screening of twenty compounds by comparing their 
nail swelling effect (weight gain) and found that the four best compounds for this criteria 
were thioglycolic acid, glycolic acid, urea mixed with hydrogen peroxide (H2O2) and 
hydrogen peroxide alone. Further, they studied the effect of thioglycolic acid pre-treatment 
(20 h) on caffeine permeation and found that the steady flux of caffeine was 3.8-fold 
higher than the control. 
Malhotra et al. (2002) tested twenty-two potential penetration enhancer formulations. They 
screened compounds coming from different classes: mercaptans which are known for 
breaking disulphide bounds, sulfites, keratolytics and surfactants. They ranked their 
chemical candidates by measuring their enhancing effect on water permeation. They 
concluded that the best enhancers were both mercaptans: N-(2-mercaptopropionyl) glycine 
(synergistic effect with urea) and pyrithione (non synergistic effect with urea). 
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Kobayashi et al. (1998) showed that N-acetyl-L-cysteine and 2-mercaptoethanol (both able 
to break disulphide bounds) significantly increased the in vitro permeation of 5-
fluorouracil and tolnaftate. 
Hui et al. (2002, 2003) showed that the penetration enhancer contained in Econail®, 2-n-
nonyl-1,3-dioxolane (SEPA: Soft Enhancement of Percutaneous Absorption), and a 
penetration enhancer formulation (containing DMSO, dimethylsulfoxide, and other 
excipients) were able to enhance the penetration of 1) econazole permeation with Econail® 
and 2) urea, salicylic acid and ketoconazole with their penetration enhancer formulation.  
To summarise, most of the nail penetration enhancers are molecules able to break the 
keratin disulphide bounds (2-mercaptoethanol, N-(2-mercaptopropionyl) glycine, 
pyrithione, N-acetyl-L-cysteine or thioglycolic acid) and thus, to provoke nail swelling and 
an increase in the water uptake. Keratolytics such as urea and salicylic acid are inefficient 
in enhancing drug permeation when used on their own. Sometimes, penetration enhancers 
efficient for transdermal applications are efficient as well for nail applications (e.g. 2- n-
nonyl-1,3-dioxolane). 
 
Principles of iontophoresis 
 
Iontophoresis is a minimally invasive technique which has been extensively studied for 
topical and transdermal delivery (Kalia et al., 2004) or drug monitoring (Leboulanger et 
al., 2004a). It consists in the application of a small electrical current to a membrane in 
order to provoke the migration of molecules according to their charge and/or polarity. Two 
main mechanisms of transport exist: electromigration and electrosmosis (known as well as 
convective solvent flow).  
Fig. 3 is a scheme of an iontophoretic circuit and shows the electrochemical reactions 
happening at each electrode. 
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Figure 3: Scheme of an iontophoretic circuit. Only electromigration is shown: sodium ions are repelled from 
the anode and attracted by the cathode whereas chloride ions are repelled by the cathode and attracted by the 
anode. 
 
In a simple way, electromigration is the repulsion of a charged molecule from the electrode 
presenting the same charge towards the electrode of the opposite charge. More precisely, 
when a current is applied, it produces electrochemical reactions at the surface of the 
electrodes resulting in ion fluxes. The ionic transports exist because the different 
compartments have to keep their electroneutrality (Fig. 3). The consumption of chloride at 
the anode provokes a depletion in anions in the anodal compartment and therefore, to keep 
the electoneutrality, the attraction of anions. At the cathode, the production of chloride ions 
provokes the repulsion of anions and the attraction of cations to keep the charge balance. 
As chloride carries only one charge, the reaction happens mole to mole (Fig.3) and the 
theoretical amount of chloride ions consumed/produced at the electrodes follows the Eq. 1: 
 
I.t/F = mol Cl-  Eq. 1 
 
where I is the intensity applied during the experiment in amperes, t is the length of the 
experiment in seconds and F is the Faraday’s constant (96500 coulombs/mol). This 
equation allows the determination of the amount of chloride salt to add to the anodal 
solution and how much chloride ions accumulate at the cathode. 
During iontophoresis, each ion only transports a fraction of the current applied and the sum 
of the current carried by each ion is equal to the total current applied. For each ion, this 
fraction, called transport number, depends on its physicochemical properties and on the 
electrochemical composition of the milieu. The transport number varies accordingly with 
the different species present in the milieu which means that ions are competing for current 
charge transport. The transport number, td, of an ionic drug can be expressed as: 
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where c, z and µ refer to concentration, valence and mobility inside the membrane of either 
a drug d or an ion i (Phipps et al., 1992). This equation means that 1) the “single-ion” is the 
best situation and results in the highest td and 2) ions present in large concentrations with a 
high electrical mobility will carry most of the charge. However, in practice, it is difficult to 
develop a pharmaceutical formulation containing only the drug without adding excipients 
and therefore, the drug delivery will depend on its ability to be an efficient charge-carrier 
in the presence of competing co- and counter-ions. Co-ions are the ions possessing the 
same sign and present in the same compartment as the drug. In case of iontophoretic drug 
delivery, the effect of co-ions in the drug formulation can be minimised by limiting the 
amount of highly mobile co-ions, by using only co-ions presenting very low mobility or by 
increasing the concentration (molar fraction) of the drug. The counter-ions are the ions of 
opposite sign to the drug present on the other side of the membrane. In vivo, because of 
their concentration and electrical mobility, the physiological counter-ions are sodium and 
chloride. Obviously, their competition cannot be avoided. 
As ions concentration and mobility inside a membrane cannot be predicted and are difficult 
to measure accurately, Eq. 2 has little practical application. Experimentally, Faraday’s 
equation allows the deduction of the transport number from the molecule flux, Jd: 
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where I is the electrical current passed, F, the Faraday’s constant and zd, the valence of the 
ion (Phipps et al., 1992). This equation demonstrates that the iontophoretic flux is 
proportional to the applied current. This is of great importance as it allows the control of 
the amount of drug delivered and offers the possibility to adapt the treatment to 
individuals. 
In addition, a charged membrane shows permselectivity which means that it allows the 
transport of counter-ions preferentially. For example, the skin is negatively charged which 
results in a higher transport number for cations than for anions.  
Electroosmosis is a consequence of the membrane permselectivity. In skin, electroosmosis 
happens in the anode to cathode direction because cations carry preferentially the current 
and, therefore, provoke a transport of solvent in the same direction (Burnette et al., 1987; 
Pikal et al., 1990). However, this net charge can be modulated by changing the pH of the 
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solution in contact with the membrane. For example, keratin, the main constituent of skin, 
presents a pI (isoelectric point) close to 5 and therefore at physiological pH, skin is 
negatively charge, but, at pH below 5, skin’s permselectivity is reversed allowing 
preferential transport to anions and exhibiting an electroosmotic flow in the cathode to 
anode direction. 
The transport of neutral compounds from the anode can be affected by the ionic strength of 
the donor by reducing the solvent flow (Santi et al., 1996). 
It is important to note that transport of molecules through a charged membrane is complex: 
transport of a molecule is normally due to the contribution of both mechanisms and not 
only one of them. The electromigration contribution is the most important for small and 
charged molecules whereas the electroosmotic contribution is increased for big, polar but 
uncharged molecules. When a molecule shows a low mobility (and thus a low transport 
number) both transports can have a role to its transport (Guy et al., 2000; Abla et al., 2005; 
Schuetz et al., 2005).  
 
Application of iontophoresis to the human nail plate 
 
In vitro nail iontophoresis has been recently under the scope of two teams who investigated 
nail charge and its permselectivity (Hao et al., 2008 a and c; Murthy et al., 2007a and b). 
They studied the electroosmotic transport of glucose, griseofulvin (Murthy et al., 2007a), 
mannitol and urea (Hao et al., 2008a and c). Electromigration was investigated using 
tetraethylammonium (Hao et al., 2008a and b) and salicylic acid (Hao et al., 2008a; Murthy 
et al., 2007b). During the last month, Nair et al. (2008, epub) published an article 
concerning the delivery of terbinafine (pKa ~7). 
Hao et al. used mannitol whereas Murthy et al. used glucose to determine the nail 
permselectivity. They both found that the transport of their permeants was maximal in the 
anode to cathode direction when the pH was above 5 and in the cathode to anode direction 
when the pH was below this value. This demonstrated that nail holds a net negative charge 
at physiological pH.  
Electromigration had a clear enhancing effect on the fluxes of the molecules previously 
cited when compared to passive diffusion. 
The effect of penetration enhancers on iontophoretic fluxes has been investigated by Hao 
et al. (2008b): thioglycolic acid was found to increase the transport number of 
tetraethylammonium but not to affect electroosmosis. 
To date, only one in vivo iontophoretic application has been performed by James et al. 
(1986) by investigating the plasma concentration of prednisolone after transdermal and 
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transungual iontophoresis. Unfortunately, the authors did not focus on the iontophoretic 
mechanisms involved during transungual iontophoresis. Nevertheless, this study proved 
the feasibility of in vivo nail iontophoresis. 
 
Clearly, the in vitro characterization of the mechanisms involved in nail iontophoresis just 
started being addressed and information about its in vivo application remains anecdotal. 
This thesis addresses different important points to clarify the mechanisms of iontophoretic 
nail delivery. 
The first chapter investigates the pathways used by two fluorescent markers as well as their 
depth of penetration in the nail layers under iontophoretic and passive conditions using 
confocal microscopy. This study was motivated by the fact that the main pathway of 
charged molecules during transdermal delivery is appendageal whereas this route does not 
exist in the nail plate. Thus it was of interest to determine if compounds were more likely 
to use a transcellular or a paracellular pathway. Further, the depth of penetration allows the 
evaluation of the effect of iontophoresis on compounds presenting different 
physicochemical properties (hydrophilic, lipophilic and anionic, cationic). 
The second and third chapter investigate electroosmosis and electromigration by studying 
the flux of mannitol and of two cations. Indeed, the result of the first chapter showed no 
differences in the pathways or in the penetration depth of the two ionic fluorescent markers 
and thus, it was important to design experiments to study the two forces involved during 
iontophoresis to determine the nail permselectivity. 
As the results obtained during the electromigration studies were extremely encouraging, 
chapter four investigates 1) the feasibility of an iontophoretic in vivo application in terms 
of voltage and participant comfort and 2) the extraction of sodium and chloride ions from 
the nail bed through the nail plate. 
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Chapter 2:      
  Visualisation of ungual penetration by laser scanning 
confocal microscopy. 
 
Overview 
The in vitro ungual penetration of sodium fluorescein (SF) and nile blue chloride (NBC), 
an anionic and a cationic fluorescent marker respectively, has been examined by Laser 
Scanning Confocal Microscopy (LSCM). The depth, uniformity and pathways of 
penetration of both markers into the human nail plate were compared after 18 hours of (a) 
iontophoresis at 0.1 and 0.4 mA (0.5 and 2 mA/cm² respectively) and (b) passive diffusion. 
SF was also used to investigate the role played by the dorsal, ventral and intermediate 
layers of the nail as permeation barriers. The possible binding of SF to the nail material 
was studied over a two week experiment. Two types of confocal images were used to 
assess the depth of penetration. In the first type, transversal images, the penetration of the 
marker was directly estimated (T) and compared to the whole thickness of the nail. This 
allowed for determination of the percentage of penetration (%T). In the second type, dorsal 
images, the penetration (D) was estimated taking xy-plans following the z axis into the 
nail. Iontophoresis resulted in deeper delivery of NBC and SF into the nail plate than 
passive diffusion, although the differences were quite moderate. Unexpectedly, an increase 
in current intensity from 0.1 to 0.4 mA did not modify ungual penetration. The two 
fluorescent markers typically penetrated 7-12 % of the nail thickness. SF permeation was 
independent of the nail layer exposed to the donor solution and showed no evidence of 
binding to the nail material. Finally, the images suggest that SF and NBC mainly penetrate 
into the nail following the transcellular pathway during both passive and iontophoretic 
experiments.  
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Introduction 
Laser Scanning Confocal microscopy (LSCM) allies the advantages of being non invasive 
and of creating high resolution images. It allows the visualization, at multiple depths and 
without mechanical sectioning, of images parallel to the surface of the sample. The main 
limitations are 1) the range of lasers available which limit the number of usable 
fluorophores and 2) the intensity of the laser which can be responsible for photobleaching 
(Alvarez-Román et al., 2004). Further auto-fluorescence of biological samples can 
interfere with fluorescence emission of the markers. It should be noticed that LSCM is a 
semi-quantitative technique and that attempts made to calibrate the fluorescence intensities 
(Turner et al., 1998) did not warrant the use of LSCM as a quantitative method. 
The main difference with conventional microscopy lies in the focus of the sample 
illumination. In conventional microscopy, most of the sample is simultaneously and 
uniformly illuminated so the areas above and below the plan of interest can be responsible 
for out-of-focus blurs. In contrast, during confocal microscopy, illumination is focused 
only on one spot at a time: the laser beam is focused via a scanning system on a spot of the 
sample, the whole sample emits fluorescence which is scattered in all the directions but 
only the fluorescence coming from the focal plan is collected by the objective and the 
scanning system and is then reflected off a dichroic mirror and focused onto the detector. 
This ability to focus on one plan at a time allows the acquisition of individual xy-plan 
images which can be subsequently used to build three-dimensional images following the z-
axis.  
LSCM has been previously used to visualize the skin structure and penetration pathways of 
fluorescent markers into the skin after passive and iontophoretic delivery. During 
transdermal passive diffusion of ionic fluorescent markers, the pathways have been shown 
to be paracellular and through the skin “pores”. Indeed, it has been established by 
Cullander (1992) and Alvarez-Román et al. (2004) that no transcellular route existed 
whereas the existence of a paracellular pathway via the lipid lamellae has been 
demonstrated by Cullander (1992) and Turner et al. (1998). Finally, the existence of a skin 
“pores” pathway has been described by Cullander (1992). It is to note that “pores” have 
been described to be not only and necessarily skin appendages (e.g. sweat glands and hair 
follicles) but as well to be skin imperfections.  
It has been shown (Cullander et al., 1992; Scott et al., 1992; Bath et al., 2001) that the main 
pathway followed by ionic fluorescent markers during transdermal iontophoresis was that 
of lower electrical resistance constituted by the “pores” and especially the hair follicles. No 
evidence has been found for the existence of a transcellular pathway but Cullander (1992) 
and Turner et al. (1997) observed evidence of a non follicular, paracellular pathway. 
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Turner et al. (1997) showed using calcein that iontophoresis led this compound into the 
skin primarily via the hair follicles but as well via a non follicular pathway. The same 
author (Turner et al., 1998) confirmed the coexistence of the two pathways during the 
iontophoresis of poly-L-lysines of different molecular weight. Bright fluorescent signal 
was emitted from the hair follicles whereas the signal was more diffuse for non follicular 
areas: the quantification and normalisation by the surface area showed that the transport 
through the “pores” was much greater than the non follicular transport. 
Pathways of drug permeation into the nail layers have not been studied until now. 
Obviously, because of the structural differences between the skin and the nail, only the 
transcellular and the paracellular pathways are possible routes for transungual permeation. 
Excluding their keratinous nature, skin and nail are very different in terms of composition 
and thickness. Indeed, unlike skin, the nail is considered to behave like a hydrophilic gel 
membrane (Mertin et al., 1997b) and has low lipid content (< 5 %). These lipids are known 
to be in the cytoplasm membrane of the onychocytes, in the space between the cells, and 
are thought to fill the ampular dilatations which link cells in the dorsal layer (Garson et al., 
2000). Lipids are more abundant in the dorsal and ventral layer than in the intermediate 
layer (Kobayashi et al., 1999). 
The nail is not a homogenous keratin block. It is commonly accepted that three layers – 
namely, dorsal, intermediate and ventral –contribute to the total thickness in a 3:5:2 ratio 
(Lewis, 1954) and differ in composition and other properties. According to Jarret and 
Spearman (1966), the dorsal layer has high calcium, phospholipid and sulfydryl group 
content and little acid phosphatase activity. The corneocytes are 2.2 µm thick (Garson et 
al., 2000). It was determined using synchrotron X-ray microdiffraction (Garson et al., 
2000) that nail is constituted of amorphous α-keratin (hair type) whose fibres were 60% 
perpendicularly and 40% parallel orientated to the growth axis in the dorsal and ventral 
layers.  
The intermediate layer shows high acid phosphatase activity, a high number of disulphide 
bonds and a low content of disulfydryl groups, phospholipid and calcium (Jarret and 
Spearman, 1966). The corneocytes are ~5.5 µm thick and all the keratin fibres are 
orientated perpendicularly to the growth axis (Garson, 2000; Farren, 2004). 
The ventral layer has a similar composition to the dorsal layer; high calcium, phospholipid 
and sulfydryl group content. As a difference with the dorsal layer, the ventral layer has 
high acid phosphatase activity and a high number of disulphide bonds.  
It has been suggested that this structure composed of an anisotropic layer sandwiched in 
two isotropic layers is responsible for the nail mechanical rigidity (Farren, 2004). 
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Some studies suggest that drug permeability differs across these three layers. For example, 
Kobayashi et al. (1999) studied the permeation of 5-fluorouracil (water soluble) and 
flurbiprofen (poorly water soluble) across the dorsal, ventral and intermediate layers 
isolated by filing human nail clippings. The authors showed that the dorsal layer was the 
less permeable for the two drugs whereas the intermediate was more permeable to the 
hydrophilic drug, 5-fluorouracil, and the ventral more permeable to the lipophilic drug, 
flurbiprofen. These results probably reflect the difference in composition of the three 
layers. 
There is, in conclusion, little information about the physicochemical properties of a drug 
determining nail permeation and the pathways followed during passive diffusion. Much 
less is known in the case of iontophoresis. LSCM has been used to study nail structure 
(Kaufman et al., 1995) and to assist on the diagnosis of onychomycosis (Hongsharu et al., 
2000; Arrese et al., 2003). In this thesis, LSCM was used, for the first time, to investigate 
the pathways, depth and the uniformity of the passive and iontophoretic penetration of two 
model fluorescent markers into human nail plate. The two markers were sodium 
fluorescein (Fig. 1), a negatively charged, acidic hydrophilic fluorescent marker and nile 
blue chloride (Fig. 2), a positively charged, basic lipophilic marker. 
 
 
Fig. 1: Sodium fluorescein (SF) molecular structure. MW 376.28; pKa1 ~ 4.5 and pKa2 ~ 6.5. The calculated 
Log P ( LogKow from Syracuse Research Corporation) is -0.67.  
 
 
Fig. 2: Nile blue chloride (NBC) molecular structure. MW 353.85; pKa ~ 9.5. Calculated Log P (software 
LogKow from Syracuse Research Corporation) is 4.99.  
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Materials and methods 
 
1. Materials  
Sodium fluorescein, nile blue chloride, sodium chloride and acetonitrile (HPLC grade) 
were obtained from Sigma Aldrich Co. (Gillingham, UK). Silver wire, silver chloride 
powder and platinum wire used to prepare the electrodes had a minimum purity of 99.99 % 
and were obtained from Sigma Aldrich Co. (Gillingham, UK). All aqueous solutions were 
prepared using high purity deionised water (18.2 MΩ.cm, Barnstead Nanopure 
DiamondTM, Dubuque, IA, USA). 
 
2. Nails 
Ethical approval was granted by the Bath Local IRB (Institutional Review Board) and 
finger nail clippings were obtained from fourteen healthy volunteers who gave their written 
informed consent (Forms in the Appendix 3). The harvested nails were washed with 
deionised water and kept at room temperature in desiccators until use. Prior to an 
experiment, the nail’s thickness was measured with a point micrometer (Point Anvil 
Micrometer, Mitutoyo, Andover, UK) on the portion of the nail which was the closest to 
the hyponychium. Some nails were filed in order to expose the intermediate layer to the 
donor solution. In this case the initial thickness was measured at the centre of the nail. 
Next, the dorsal layer of the nail was manually filed using a manicure metallic file until 
30% of the initial thickness had been removed.  
Each nail was soaked in deionised water during 10-15 minutes prior to the experiments in 
order to recover some flexibility, and then placed in 5 mm (0.20 cm2 transport area) nail 
adapters (PermeGear Inc., Bethlehem, PA, USA). 
The presence and possible interference of auto-fluorescence was investigated by LSCM 
examination of 3 nails which had been soaked in 154 mM NaCl for 18 hours. This control 
showed that the intensity of the laser used during the experiments was too low to cause any 
auto-fluorescence that could interfere with the images. 
 
3. Nile Blue Chloride experiments 
Nile Blue Chloride (NBC) is positively charged and was delivered by anodal 
iontophoresis. The three experiments performed with this marker, passive, 0.1 mA and 0.4 
mA iontophoresis, used a (3.2-3.6 mL) donor solution containing 1% (28 mM) NBC and 
50 mM NaCl. The receptor solution (700 µL) consisted of 0.9% (154 mM) NaCl. The 
donor concentration of NBC corresponds to its limit of solubility in water. The 50 mM 
sodium chloride present at the anodal donor solution provided enough chloride ions for the 
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electrode reaction but to avoid any depletion during the 0.4 mA experiments, the whole 
donor was replaced at 4 h during all the NBC experiments. The pH of the donor solution 
was ~3 which allowed NBC to be totally ionised (pKa ~9.5). The dorsal layer of the nail 
faced the donor anodal chamber in the three experiments indicated as NBC.Passive, 
NBC.0.1 and NBC.0.4 in Table 1. 
 
4. Sodium Fluorescein experiments 
Likewise NBC, experiments were performed on whole nails at 0.1 and 0.4 mA and passive 
diffusion was explored as well. Sodium fluorescein (SF) is negatively charged and was 
delivered by cathodal delivery. All the experiments used a donor solution (3.2-3.6 mL) 
containing 375 mM of SF in deionized water. The pH of the donor solution was ~8 
therefore SF (pKa1 ~4.5 and pKa2 ~6.5) was predominantly (97 %) in its di-anionic form. 
The anodal receptor solution (700 µL) consisted of 0.9 % (154 mM) NaCl in the passive 
and the 0.1 mA experiments. The 0.4 mA experiments used a 8 % (1.37 M) NaCl solution 
in order to provide enough chloride ions for the anodal reaction. The experimental 
conditions are listed in Table 1. Due to the cathode electrochemical reaction, the whole 
donor was replaced at 4 hours to minimize the competition of the chloride ions released by 
the cathode with SF (See Introduction chapter).  
The dorsal layer of the nail faced the donor cathodal chamber in the experiments coded as 
SF.Passive, SF.0.1 and SF.0.4 in Table 1. The ventral layer faced the cathodal donor 
solution in the experiments listed as SF.V.Passive and SF.V.0.1. Finally, the experiment 
listed as SF.I.0.1 was performed with nails whose dorsal layer had been removed by filing 
so the intermediate layer of the nail faced the donor solution.  
 
Table 1: Experiments performed with SF and NBC. n indicates the number of replicates. 
Experiment (n) Anode (Ag/AgCl) Cathode (Ag/AgCl) 
SF.Passive (3) 154 mM NaCl 
SF.0.1 (4) 154 mM NaCl 
SF.0.4 (3) 1.37 M NaCl 
SF.V.Passive (3) 154 mM NaCl 
SF.V.0.1 (4) 154 mM NaCl 
SF.I.0.1 (3) 154 mM NaCl 
375 mM SF 
NBC.Passive (3) 
NBC.0.1 (3) 
NBC.0.4 (3) 
28 mM NBC + 50 mM NaCl 154 mM NaCl 
 
5. Iontophoretic set up 
Experiments were performed in Franz vertical diffusion cells (PermeGear Inc., Bethlehem, 
PA, USA) presenting a transport area of 0.20 cm2. To facilitate the sampling of the 
receptor chamber, the bottom chamber was used to hold the donor solution while the 
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receptor was placed on the top. The nail adapter was placed so the nail’s dorsal layer faced 
the donor solution (Fig. 3). All experiments were performed at room temperature with a 
minimum of three replicates.  
 
 
Fig. 3: Picture of the experimental set up 
 
The current was applied by a power supply (Kepco APH 1000M, Flushing, NY) via 
homemade Ag/AgCl electrodes (Green et al., 1991). 
During constant, direct current iontophoresis, the power supply modifies the voltage 
imposed depending on the resistance of the electrical circuit (as indicated by Ohm’s law; 
V=I.R) so a constant current passes through the circuit. It was observed, that the voltage 
required for imposing 0.1 or 0.4 mA from time zero was unacceptable as it would have a 
deleterious effect on the nails. Thus, a ~30 minutes “pre-treatment” period was applied to 
each nail during which a maximum voltage output (200 V) was set on the power supply 
(Kepco APH 1000M, Flushing, NY, USA). Voltage was monitored during the first two 
hours of each iontophoretic experiment. 
 
6. Passive experiments 
Passive controls (NBC.Passive, SF.Passive and SF.V.Passive) were performed as the 0.1 
mA iontophoretic experiments except that no current was applied. The donor solutions 
were changed at 4 hours and the complete receptor compartments were sampled and 
replaced with fresh sodium chloride solution at 2, 4 and 18 hours.  
 
7. Binding study 
The possible binding of SF to the nail components was investigated in the following 
experiment. Three nails (D, E and F) were cut in three pieces (D1, D2, D3; E1, E2, E3 and 
F1, F2, F3). Each piece was placed in a vial containing 2 mL of 375 mM aqueous SF for 
24 h. After 24 h, each piece was rinsed twice in 5 mL of NaCl 0.9% and one piece of each 
nail (D1, E1 and F1) was placed in a dish containing NaCl 0.9% and prepared for confocal 
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microscopy (as described beneath). The remaining pieces (D2, D3, E2, E3, F2 and F3) 
were placed in vials containing 5 mL of NaCl 0.9% for a week, with the 5 mL of sodium 
chloride being replaced at the middle of the week. After a week, one piece of each nail 
(D2, E2 and F2) was prepared for confocal microscopy whereas the three remaining pieces 
(D3, E3 and F3) were placed in a fresh 0.9% NaCl solution for one more week, renewing 
NaCl solution at the middle of the week. Finally, two weeks after the beginning of the 
experiments the last three pieces of nails (D3, E3 and F3) were prepared for confocal 
microscopy. The NaCl solutions were assessed for SF by HPLC. 
 
 
Fig. 4: Diagram of the steps followed in the SF binding study (nail D in the example). 
 
8. Confocal microscopy analysis 
Table 1 indicates that several (3-4) replicates were performed for each condition. However, 
each replicate was performed in a different day so each nail could be prepared and 
examined by LSCM as soon as the experiment was finished.  
SF presents an excitation maximum λex at 494 nm and an emission maximum λem at 521 
nm, therefore samples were analysed using an argon laser (λex = 488 nm) and two different 
filters: a NFT 545 (wavelengths above 545 nm are going through, wavelengths below are 
reflected 90°) and a LP 505 (wavelengths higher than 505 nm pass to the detector).  
NBC has an excitation maximum λex of 630-640 nm and an emission maximum λem of 660 
nm, therefore samples were studied using a helium neon laser (λex = 633 nm) with a 
dichroic beam splitter HFT 488/543/633, a LP 650 (wavelengths higher than 650 nm pass 
to the detector) and a NFT 490 (wavelengths above 490 nm are going through, 
wavelengths below are reflected 90°). A plan objective of 10x or 20x was used.  
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At the end of the experiments, the surface of the nail which faced the donor solution was 
rinsed under a thin dribble of running deionised water (the nail was still clamped in the nail 
adapter) and patted dry. Then, the nail was removed from the nail adapter and washed 
successively in three Petri dishes containing deionised water. The nail was patted dry 
between each wash. In the third Petri dish, the nail was cut with a scalpel in both polygonal 
(typically triangular) pieces and thin slices used for dorsal and transversal observations 
respectively (Fig. 5). The cuts were performed in the opposite direction to the penetration 
to avoid pushing artificially deeper the fluorescent with the blade. For example, the cut 
started at the ventral side when the dorsal layer of the nail had faced the donor solution. A 
minimum of four polygonal pieces and four thin slices pieces were prepared for each nail 
and analysed by confocal microscopy (LSM Meta 510 microscope, Zeiss, Oberkochen, 
Germany). The images obtained were treated using Zeiss LSM image browser version 
4.0.0.157. 
 
 
Fig. 5: Scheme of the mechanical cuts prepared for confocal microscopy analysis 
 
Each piece was then patted dry and glued on a microscope slide to hold it in the right 
position; dorsal/ventral/intermediate layers facing upwards for dorsal views, and the side 
facing upwards for transversal views (Figure 5). Please note that the term “dorsal” view is 
used to indicate how the confocal examination took place: looking on top of the surface of 
the nail that had been in contact with the donor solution, and independently of the 
histological layer of the nail (dorsal, ventral, intermediate) that had been exposed to the 
donor.  
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Dorsal images: 
Dorsal observations at x10 objective were made on a black background and dorsal at x20 
objective observations were made under halogen light.  
Images were xy-planar images acquired at different depths following the z axis (z-stack). 
To examine the distribution of the fluorescent marker through the samples and its 
penetration, xy-planar images taken at x10 objective were used to obtain two kinds of 
images: a) a series of xy-plans from top to deeper parts of the sample separated by 2 (NBC) 
or 5 µm (SF) and b) a reconstruction of all the images of the z-stack to give a three 
dimensional image. The depth of penetration (D) was measured on the 3-D images. 
Because the separation between the xy plans was 2 or 5 µm, these values indicate the 
precision of the measurements. However, to simplify the treatment of the data, the analyses 
rely on the measurements performed with the software tool (step of 1.76 µm). For space 
reasons, the series of xy-planar images are shown only every 10 µm. 
Dorsal images taken at x20 objectives were used to follow the pathways of the fluorescent 
into the nail. They were xy-planar images taken from surface to deeper parts of the sample 
separated by 1 or 2 µm (NBC). For space reasons, the series of xy-planar images are 
shown only every 2 µm. 
 
Transversal images: 
Transversal images at x10 objective were taken under halogen light to allow the view of 
the fluorescent penetration and the complete nail section. The Zeiss software was used to 
measure the thickness of the nails and the penetration of the fluorescent marker in the 
images. Images were taken as cross-sectional images: by browsing the sequences of xy-
plans taken every 5 (NBC) or 10 µm (SF), the mechanically cut surface was localized and 
avoided for measurements. This was done because the scalpel could have transferred 
fluorescence at the cut surface, creating an artefact and invalidating the penetration 
measurement. 
Two types of measurements were performed on the transversal images: first a direct 
measurement of the marker penetration depth (T) was taken, next the fluorescent 
penetration depth (T) was normalised by the whole thickness of the nail measured on the 
same image and expressed as percentage (%T).  
 
9. HPLC analysis 
A high performance liquid chromatograph (Dionex Corporation, Sunnyvale, CA, USA) 
coupled with a fluorescence detector RF 2000 and equipped with a P680 pump, an ASI-
100 autosampler and a TCC-100 column oven thermostated at 65ºC was used to measure 
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SF concentration in all samples. A mixture of water and acetonitrile 70:30 was pumped 
under isocratic conditions (1 mL/min) through a C18 column (Acclaim 120, 5 µm, 120 Å, 
4.6x150 mm, Dionex). The wavelengths used were 495 nm for the excitation and 518 nm 
for the emission. Concentrations of SF were measured against calibration curves obtained 
from standard solutions (at least seven different concentrations) prepared in ultrapure water 
and ranging from 5 to 50 nM. The measurement error was below 5 %.  
No SF was found in any receptor sample. Further, the confocal images indicated that 
neither marker reached the receptor solution. Therefore no analytical method was 
developed to measure NBC concentration in receptor samples. 
 
10. Data analysis and statistics 
All data are presented as mean ± SD unless otherwise indicated. The means and SD for 
each treatment were calculated using all the measurements taken for all the nails used in 
the respective condition (as opposed to obtaining a first average /per nail and then a second 
average for the 3-4 nails). Data analysis was performed with Graph Pad Prism version 5.00 
(Graph Pad Software, San Diego California USA). Non-parametric Kruskal-Wallis 
followed by a Dunns’ post test was used to compare the depth of penetration measured 
under different experimental conditions (passive, 0.1 and 0.4 mA) via the three type of 
images previously described (D, T and %T). When only two sets of data were compared, 
for example to compare the permeation of the two fluorescents, a non-parametric unpaired 
Mann Whitney t-test was performed. The level for statistical significance was set to p < 
0.05. 
 
Results and discussion 
Confocal microscopy examination on nails after passive and iontophoretic transport 
experiments was done to determine how deeply and uniformly fluorescent markers 
penetrate the nail plate. The potential different SF penetration into the ventral and the 
intermediate layers, the effect of current intensity and a possible binding of SF to the nail 
components were also investigated. To date, this is the first study investigating the 
pathways involved in transungual penetration under passive and iontophoretic conditions 
via confocal microscopy. 
To validate the LSCM observations about depth of penetration, a considerable number of 
images were generated during this study. Only a representative selection is presented in 
this chapter. The complete collection of images can be found in the Appendix 1. 
It is pertinent to discuss the different methods used to measure penetration depth given 
they do not always result in equivalent results. When xy-plans are taken, one would expect 
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the fluorescence to be intense in superficial layers and progressively disappear in deeper 
layers. However, fluorescence was observed in deeper xy plans of some images when it 
had been absent at more superficial levels (see Fig. 14 for an illustrative example). This 
can be explained by the nail curvature; in fact the xy-plan at 0 µm only captures a fraction 
of the nail outmost layer and the rest is progressively captured in deeper pictures. Thus, the 
depth of fluorescence inside the nail cannot be unequivocally determined. Further, images 
were taken at 2 to 5 µm intervals limiting the precision of the measurement. D 
measurements were made on the B reconstructions in which the depth had a continuous 
dimension; however, it is difficult to accept that the precision of these D measurements 
could be more than that of the starting images.  
A T measurement seems to offer a better solution, the nail is looked at transversely, and all 
its width is included in the same xz-plan. The resolution for these measurements is 1.76 µm 
in a continuous scale, an improvement with respect to the 2-5 microns intervals. The 
measurement can take place at a certain depth of the specimen so the surface at which the 
cut took place is avoided. However, it is difficult to ensure a mechanical cut which is 
perfectly perpendicular to the nail. Thus, the measurements of depth and thickness could 
be slightly overestimated. This prompted the idea of the third parameter, %T, which would 
minimize any potential overestimation in the measurement by normalizing the depth of 
penetration by the total thickness of the nail. %T or percentage of penetration seem a very 
useful parameter from a drug delivery point of view, providing a quick appreciation of the 
efficiency of delivery achieved by different formulations. On the other hand, differences in 
%T can be equally caused by a real difference in the depth of penetration or in the 
thickness of the nails used.  
 
1. NBC experiments 
Table 2 shows the characteristics of the nails (participant’s gender and age, finger and hand 
of origin, and plate thickness) used in the NBC experiments. The 12 nails were donated by 
6 participants aged between 21 and 52 years old. The average thickness was 290 ± 30 µm 
for NBC.Passive, 300 ± 80 µm for NBC.0.1, and 290 ± 40 µm for NBC.0.4.  
 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 43 
Table 2: Nails used in NBC experiments. 
Experiment  
code 
Nail code * Gender  Age (year) 
Thickness 
(µm) 
4RF2 Female 44 280 
12LF5 Female 22 260 NBC.Passive 
14RF4 Female 52 320 
2LF5 Female 26 250 
12RF1 Female 22 390 NBC.0.1 
7LF4 Female 28 260 
4LF4 Female 44 260 
12LF3 Female 22 270 NBC.0.4 
13LF3 Female 21 330 
* The first digit in the nail code indicates the participant number, L or R indicates left or right hand and 
F+digit indicates the finger where F1 = thumb. 
 
The voltage of the electrical circuit was monitored during the two first hours of each 
experiment (Fig. 6, Table 3). 
 
Table 3: Evolution of the voltage during the first two hours of NBC.0.1 and NBC.0.4 experiments. 
Voltage (V) 
Experiment Nail code 
Nail 
thickness 
(µm) 1 min 15 min 30 min 1 hour 2 hours 
2LF5 250 200 33 14 7 5 
12RF1 390 200 200 125 29 12 NBC.0.1 
7LF4 260 200 117 40 16 9 
4LF4 260 200 62 37 24 16 
12LF3 270 200 56 36 22 21 NBC.0.4 
13LF3 330 200 200 101 38 24 
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Fig. 6: Evolution of voltage during the first two hours of the NBC.0.1 (filled symbols) and NBC.0.4 (open 
symbols) experiments. 
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With two exceptions the voltages were lower than the limit (200 V) in 15 minutes, 
indicating a relatively quick decline of the nail resistance. After 30 minutes all the voltages 
were less than 200 V, thus the required intensity of current was effectively passed across 
the circuit. After 1 hour all the values were lower than 40 V. The voltages of the electrical 
circuits involving the thickest nails (12RF1 at 0.1 mA and 13LF3 at 0.4 mA) were slightly 
higher than the others. After two hours, the voltage reached values between 5 and 12 V for 
0.1 mA and between 16 and 24 V for 0.4 mA.  
The depth of penetration of NBC into the nail was examined at the end of the experiments 
as described in Materials and Methods. The following figures illustrate NBC penetration 
after 18 hours of passive diffusion (Fig.7), 0.1 mA iontophoresis (Fig.8) and 0.4 mA 
iontophoresis (Fig.9)  
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Fig. 7: Representative confocal images illustrating NBC passive penetration into the nail plate 
(NBC.Passive). Panel A shows transversal cuts allowing direct measurement of the marker penetration depth 
T and %T. Panel B shows 3-D reconstructions of xy-planar images of dorsal images obtained at different 
depths, the nail surface in contact with the donor solution (dorsal layer in this case) faces the right of the 
image. The depth of penetration (D) was taken from B. Panel C shows xy-planar images of dorsal images 
taken at 2 µm intervals (but only shown at 10 µm) which were used to construct the 3-D images shown in 
Panel B. All the pictures were obtained at 10x magnification. 
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Fig. 8: Representative confocal images illustrating NBC iontophoretic penetration into the nail plate during 
the 0.1 mA experiment (NBC.0.1). Panel A shows transversal cuts allowing direct measurement of the 
marker penetration depth T and %T. Panel B shows 3-D reconstructions of xy-planar images of dorsal images 
obtained at different depths, the nail surface in contact with the donor solution (dorsal layer in this case) faces 
the left of the image. The depth of penetration (D) was taken from B. Panel C shows xy-planar images of 
dorsal images taken at 2 µm intervals (but only shown at 10 µm) which were used to construct the 3-D 
images shown in Panel B. All the pictures were obtained at 10x magnification. 
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Fig. 9: Representative confocal images illustrating NBC iontophoretic penetration into the nail plate during 
the 0.4 mA experiment (NBC.0.4). Panel A shows transversal cuts allowing direct measurement of the 
marker penetration depth T and %T. Panel B shows 3-D reconstructions of xy-planar images of dorsal images 
obtained at different depths, the nail surface in contact with the donor solution (dorsal layer in this case) faces 
the right of the image. The depth of penetration (D) was taken from B. Panel C shows xy-planar images of 
dorsal images taken at 2 µm intervals (but only shown at 10 µm) which were used to construct the 3-D 
images shown in Panel B. All the pictures were obtained at 10x magnification. 
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The following figure (Fig. 10) summarizes the depth of penetration estimated for each nail, 
type of experiment and measurement technique as well as the average values for each 
experimental condition.  
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Fig. 10: NBC delivery into the nail plate by passive diffusion and iontophoresis (NBC.Passive, NBC.0.1 and 
NBC.0.4). The two top panels and bottom-left panel show the depth of penetration (expressed as T, D and 
%T) measured for each nail (Mean ± SD of 5-8 images). The bottom-right panel shows the average depth of 
penetration for each condition studied (Mean ± SD). The symbols * and ** indicate significant (p = 0.01 to 
0.05) and very significant (p = 0.001 to 0.01) differences between pairs of bars.  
 
Taking multiple images and corresponding measurements is a laborious procedure, 
however it is necessary to validate results obtained from microscopic examination. Further, 
it allows investigating inter-nail variability and comparing the three different methods used 
to report depth of penetration. For example, the depth of passive penetration reported as D, 
was significantly greater for nail 14RF4 than for 4RF2 (Fig.10). The iontophoretic 
penetration (NBC.0.1) reported as %T was significantly lower for nail 12RF1. However, 
these differences are probably explained by the greater thickness of the nail 12RF1 used as 
there were no differences in the value of T.  
When the three delivery conditions were compared (Figure 10, panel right-bottom, Table 
4) it was shown that the depth of penetration reported as T and %T was greater after 
iontophoresis than after passive diffusion. However, NBC penetration was not significantly 
improved when the intensity was increased to 0.4 mA which was a surprising observation. 
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Table 4: NBC penetration as reported by T, %T and D, into the nail plate after 18h of iontophoretic or 
passive delivery. All values are given as mean ± SD of 16-27 measurements (n) taken on 3 nails. 
 T (µm) na D (µm) na %T  na 
NBC.Passive 22 ± 5 19 25 ± 11 17 6.7 ± 1.6 19 
NBC.0.1 28 ± 6* 20 33 ± 11 16 8.3 ± 2.3* 27 
NBC.0.4 30 ± 7* 20 34 ± 9 19 8.0 ± 1.6* 20 
a
 n, number of measurements performed  * Significantly different to passive at p < 0.05 
 
Comparison of T and %T indicated that iontophoresis at 0.1 and 0.4 mA delivered NBC to 
~ 8 % of the nail thickness, only ~ 1-2% more of what was achieved with passive 
diffusion. No differences were found when D was compared, probably due to the bigger 
variability in D values. It is not known at the moment how predictive this data is with 
respect to therapeutic drugs. In fact, NBC (log P = 4.99 MW = 353.85) can not be 
considered as an ideal candidate for iontophoretic delivery. Further, NBC was delivered 
from a donor solution containing 50 mM NaCl, and a significant ion competition is 
expected from the highly mobile sodium ions, resulting in a low NBC transport number. 
Because NBC is delivered from the anode, electroosmosis also contributes to the transport. 
Thus the physicochemical properties of the drugs and the composition of the formulation 
must be seriously considered to achieve useful iontophoretic deliveries. Otherwise, one 
could argue that a moderate enhancement such that here described would not justify the 
development of a complicate and expensive iontophoretic device. 
 
2. SF dorsal penetration experiments 
Table 5 shows the characteristics of the nails (participant’s gender and age, finger and hand 
of origin, and plate thickness) used during these experiments. The 13 nails were donated by 
4 participants aged between 22 and 44 years old. The average thickness was 240 ± 25 µm 
for SF.Passive, 265 ± 50 µm for SF.0.1, and 250 ± 20 µm for SF.0.4.
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Table 5: Nails used for SF dorsal penetration experiments. 
Experiment  
code 
Nail code * Gender  Age (year) 
Thickness 
(µm) 
2LF5 Female 26 210 
4R Female 44 240 SF.Passive 
12LF2 Female 22 260 
2LF4 Female 26 230 
12LF1 Female 22 330 
4LF5 Female 44 230 
SF.0.1 
7LF4 Female 28 270 
12RF4 Female 22 240 
2LF4 Female 28 270 SF.0.4 
4LF5 Female 44 230 
* The first digit in the nail code indicates the participant number, L or R indicates left or right hand and 
F+digit indicates the finger where F1 = thumb. 
 
Voltage measurements were taken during the first two hours of the experiments with the 
following results (Table 6, Fig. 11). 
 
Table 6: Evolution of voltage during the first two hours of SF.0.1 and SF.0.4 experiments 
Voltage (V) 
Experiment Nail code 
Nail 
thickness 
(µm) 1 min 15 min 30 min 1 hour 2 hours 
2LF4 230 120 117 55 22 19 
12LF1 330 121 120 120 62 11 
4LF5 230 154 57 34 20 18 
SF.0.1 
7LF4 270 200 185 98 39 11 
12RF4 240 200 134 67 36 14 
2LF4 270 200 200 151 62 34 SF.0.4 
4LF5 230 200 168 79 46 29 
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Fig. 11: Evolution of voltage during the first two hours of the SF.0.1 (filled symbols) and SF.0.4 (open 
symbols) experiments.  
 
During two of the 0.1 mA iontophoretic experiments performed (2LF4 and 12LF1) the 
limiting voltage was set on 120 V instead of 200 V as shown in the Fig. 11. As previously 
observed the voltage decreased quickly being equal to or less than 62 V after an hour of 
current application in all cases. After two hours, the voltage dropped to 11-19 V (0.1 mA) 
and 14- 34 V (0.4 mA) reflecting the different intensities applied. There was no obvious 
relation between the voltage of the electrical circuit and the thickness of the nails. 
 
The depth of penetration of SF into the nail was examined at the end of the experiments as 
described in Materials and Methods. The following figures illustrate SF penetration after 
18 hours of passive diffusion (Fig.12), 0.1 mA iontophoresis (Fig.13) and 0.4 mA 
iontophoresis (Fig.14).  
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Fig. 12: Representative confocal images illustrating SF passive penetration into the nail plate (SF.Passive). 
Panel A shows transversal cuts allowing direct measurement of the marker penetration depth T and %T. 
Panel B shows 3-D reconstructions of xy-planar images of dorsal images obtained at different depths, the nail 
surface in contact with the donor solution (dorsal layer in this case) faces the right of the image. The depth of 
penetration (D) was taken from B. Panel C shows xy-planar images of dorsal images taken at 5 µm intervals 
(Only shown every 10 µm) which were used to construct the 3-D images shown in Panel B. All the pictures 
were obtained at 10x magnification. 
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Fig. 13: Representative confocal images illustrating SF iontophoretic penetration into the nail plate during the 
0.1 mA experiment (SF.0.1). Panel A shows transversal cuts allowing direct measurement of the marker 
penetration depth T and %T. Panel B shows 3-D reconstructions of xy-planar images of dorsal images 
obtained at different depths, the nail surface in contact with the donor solution (dorsal layer in this case) faces 
the right of the image. The depth of penetration (D) was taken from B. Panel C shows xy-planar images of 
dorsal images taken at 5 µm intervals (Only shown every 10 µm) which were used to construct the 3-D 
images shown in Panel B. All the pictures were obtained at 10x magnification. 
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Fig. 14: Representative confocal images illustrating SF iontophoretic penetration into the nail plate during the 
0.4 mA experiment (SF.0.4). Panel A shows transversal cuts allowing direct measurement of the marker 
penetration depth T and %T. Panel B shows 3-D reconstructions of xy-planar images of dorsal images 
obtained at different depths, the nail surface in contact with the donor solution (dorsal layer in this case) faces 
the right of the image. The depth of penetration (D) was taken from B. Panel C shows xy-planar images of 
dorsal images taken at 5 µm intervals (Only shown every 10 µm) which were used to construct the 3-D 
images shown in Panel B. All the pictures were obtained at 10x magnification. 
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The following figure (Fig. 15) summarizes the depth of penetration estimated for each nail, 
type of experiment and measurement technique as well as the average values for each 
experimental condition.  
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Fig. 15: SF delivery into the nail plate by passive diffusion and iontophoresis (SF.Passive, SF.0.1 and 
SF.0.4). The two top panels and bottom-left panel show the depth of penetration (expressed as T, D and %T) 
measured for each nail (Mean ± SD of 4-8 images). The bottom-right panel shows the average depth of 
penetration for each condition (Mean ± SD). The symbols *, **, and *** indicate significant (p = 0.01 to 
0.05), very significant (p = 0.001 to 0.01) and extremely significant (p < 0.001) differences between pairs of 
bars.  
 
As observed for NBC, some inter-nail variability was observed and the use of T, %T and D 
resulted in slightly different outcomes. For example, SF passive penetration into the nail 
2LF5 as reported by D was significantly greater than into nail 12LF2. During SF.0.1 
experiments and according to the T depth values, SF penetration was deeper into nail 
12LF1 than into nail 7LF4. No statistical differences were found between the images 
obtained from the nails of SF.0.4. On the whole these differences are quite small and lack 
any practical relevance. However they suggest that the technique here developed is robust 
and able to find differences caused by formulation or physiological reasons and can have 
applications in future studies. 
The three parameters (T, %T and D) indicate that iontophoresis (either 0.1 or 0.4 mA) 
enhances SF penetration with respect to passive diffusion. Moreover, the difference was 
clearly noticeable in the confocal images which showed a more uniform and intense band 
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of fluorescence in the nails when SF was delivered via iontophoresis. However, the depth 
of SF penetration (T, %T and D) was the same for the 0.1 mA and 0.4 mA experiments. 
 
Table 7: SF penetration as reported by T, %T and D, into the nail plate after 18h of iontophoretic or passive 
delivery. All values are given as mean ± SD of 15-27 measurements (n) taken on 3-4 nails. 
 T (µm) na D (µm) na %T  na 
SF.Passive 26 ± 4 17 19 ± 4 15 7.8 ± 1.5 17 
SF.0.1 34 ± 7* 27 34 ± 9* 25 9.4 ± 2.2* 27 
SF.0.4 39 ± 8* 21 37 ± 6* 19 11.3 ± 2.6* 21 
a
 n, number of measurements performed  * Significantly different to passive at p < 0.05 
 
In conclusion SF was delivered to 9-11 % of the whole thickness of the nail with 
iontophoresis, whereas passive diffusion delivered the marker to ~8%. The little efficiency 
of SF iontophoretic delivery was unexpected; first of all SF is more hydrophilic (log P= -
0.67) than NBC and was introduced in the donor chamber as a single ion (i.e., without 
competition), which would suggest SF has a higher transport number than NBC despite 
being anionic. One could suggest that chlorides released from the cathode could compete 
with the marker although the donor solution was refreshed at 4 hours as described in 
Materials and Methods. Further, recent work (Sylvestre et al., 2008) on chloride 
competition and transdermal iontophoresis of dexamethasone phosphate suggests this 
effect to be small in our experimental conditions. 
 
3. SF ventral and intermediate layer penetration experiments 
Table 8 shows the characteristics of the nails (participant’s gender and age, finger and hand 
of origin, and plate thickness) used during these experiments. The 10 nails were donated by 
7 participants aged between 21 and 44 years old. The average thickness was 250 ± 30 µm 
for SF.V.Passive, 245 ± 35 µm for SF.V.0.1 and 200 ± 45 µm for SF.I.0.1.  
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Table 8: Nails used for SF ventral and intermediate layer experiments 
Experiment  
code 
Nail code * Gender  Age (year) 
Thickness 
(µm) 
1RF5 Female 25 270 
2RF5 Female 26 220 SF.V.Passive 
12RF4 Female 22 270 
12RF3 Female 22 240 
2LF3 Female 26 250 
7LF5 Female 28 200 
SF.V.0.1 
13RF4 Female 21 280 
12LF1 Female 22 240 
8LF4 Female 31 210 SF.I.0.1 
4LF4 Female 44 150 
* The first digit in the nail code indicates the participant number, L or R indicates left or right hand and 
F+digit indicates the finger where F1 = thumb. 
 
Voltage measurements were taken during the first two hours of the experiments with the 
following results (Table 9, Fig. 16). 
 
Table 9: Evolution of voltage during the first two hours of SF.V.0.1 and SF.I.0.1. The values in bracket 
indicate the thickness of the filed nails. 
Voltage (V) 
Experiment Nail code 
Nail 
thickness 
(µm) 1 min 15 min 30 min 1 hour 2 hours 
12RF3 240 202 200 200 52 22 
2LF3 250 200 200 84 27 11 
7LF5 200 200 42 24 13 7 
SF.V.0.1 
13RF4 280 200 175 83 42 23 
12LF1 310 (240) 200 134 44 18 7 
8LF4 300 (210) 50 27 16 10 6 SF.I.0.1 
4LF4 220 (150) 39 24 16 9 5 
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Fig. 16: Evolution of voltage during the first two hours of the SF.V.0.1 (left panel, filled symbols) and 
SF.I.0.1 (right panel, open symbols) experiments.  
 
Voltage versus time profiles during SF.V.0.1 was similar to that described before for 
SF.0.1: the high values decreased and were ≤ 52 V after 1 hour, and between 7-23 V after 
two hours. As expected, exposing the dorsal or the ventral face of the nail to the cathodal 
chamber had no effect on the voltage of the circuit. 
Interestingly, the voltages measured with the filed nails, exposing the intermediate layer to 
the cathode (SF.I.0.1) were different from the previously described. In two out of the three 
replicates the initial voltages were less than 100 V, the values reached a peak in the three 
first minutes of current application and then decreased. After one hour, the voltage was 
between 9 and 18 V and after two hours, it had dropped to less than 7 V. It seems so, that 
filing the nail had a certain effect on the nail resistance which may be partially due to the 
decreased thickness. 
 
The depth of penetration of SF into the nail was examined at the end of the experiments as 
described in Materials and Methods. The following figures illustrate SF penetration into 
the ventral layer after 18 hours of passive diffusion (Fig.17), 0.1 mA iontophoresis (Fig.18) 
and into the intermediate layer after 18 hour of 0.1 mA iontophoresis (Fig.19)  
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Fig. 17: Representative confocal images illustrating SF passive penetration into the ventral layer 
(SF.V.Passive). Panel A shows transversal cuts allowing direct measurement of the marker penetration depth 
T and  %T. Panel B shows 3-D reconstructions of xy-planar images of dorsal images obtained at different 
depths, the nail surface in contact with the donor solution (ventral layer in this case) faces the left of the 
image. The depth of penetration (D) was taken from B. Panel C shows xy-planar images of dorsal images 
taken at 5 µm intervals (only shown every 10 µm) which were used to construct the 3-D images shown in 
Panel B. All the pictures were obtained at 10x magnification. 
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Fig. 18: Representative confocal images illustrating SF iontophoretic penetration into the ventral layer 
(SF.V.0.1). Panel A shows transversal cuts allowing direct measurement of the marker penetration depth T 
and  %T. Panel B shows 3-D reconstructions of xy-planar images of dorsal images obtained at different 
depths, the nail surface in contact with the donor solution (ventral layer in this case) faces the left of the 
image. The depth of penetration (D) was taken from B. Panel C shows xy-planar images of dorsal images 
taken at 5 µm intervals (only shown every 10 µm) which were used to construct the 3-D images shown in 
Panel B. All the pictures were obtained at 10x magnification. 
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Fig. 19: Representative confocal images illustrating SF iontophoretic penetration into the intermediate layer 
(SF.I.0.1). Panel A shows transversal cuts allowing direct measurement of the marker penetration depth T 
and  %T. Panel B shows 3-D reconstructions of xy-planar images of dorsal images obtained at different 
depths, the nail surface in contact with the donor solution (ventral layer in this case) faces the right of the 
image. The depth of penetration (D) was taken from B. Panel C shows xy-planar images of dorsal images 
taken at 5 µm intervals (shown only every 10 µm) which were used to construct the 3-D images shown in 
Panel B. All the pictures were obtained at 10x magnification. 
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In agreement with previous results, the confocal images showed that the band of SF 
fluorescence was more uniform and intense after iontophoresis (SF.V.0.1, Fig. 18 B and C) 
than after passive diffusion (SF.V.Passive, Fig. 17 B and C). When the dorsal layer was 
filed the band of SF fluorescence obtained after iontophoresis was also strong and uniform 
(Fig. 19), however SF did not permeate deeper into filed nails than into full-thickness 
specimens. 
The following figure (Fig. 20) summarizes the depth of penetration estimated for each nail, 
type of experiment and measurement. 
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Fig. 20: SF delivery into the nail plate by passive diffusion and iontophoresis (SF.V.Passive, SF.V.0.1 and 
SF.I.0.1). Panels show the depth of penetration (expressed as T, D and %T) measured for each nail (Mean ± 
SD of 5-8 images). The symbols * and ** indicate a significant (p = 0.01 to 0.05) and very significant (p = 
0.001 to 0.01) difference between pairs of bars.  
 
As previously discussed, some inter-nail variability was observed and the use of T, %T and 
D resulted in slightly different outcomes. For example, passive penetration as %T into the 
nail 2RF5 was significantly greater than into 1RF5; but given there were no differences in 
T values this was probably a result of the different nail thicknesses. During ventral 
iontophoresis, the T values indicate that SF went significantly deeper into nail 2LF3 than 
into 12RF3 while %T values suggested a deeper penetration into 7LF5 than into 12RF3. 
Filing the nails to expose the intermediate layer did not increase variability, and only one 
significant difference was found between the relative penetration (% T) into 12LF1 and 
4LF4.
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Fig. 21 and Table 4 summarize the average depth of penetration estimated for each 
experimental condition and compare the effect of exposing dorsal, ventral or intermediate 
(filed nails) on SF penetration.  
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Fig. 21: SF delivery into the nail plate by passive diffusion and iontophoresis (SF.Passive, SF.V.Passive, 
SF.0.1, SF.I.0.1 and SF.V.0.1). The panels show the average depth of penetration for each condition studied 
(Mean ± SD): the left panel compares SF passive penetration into the dorsal and ventral layer and the right 
panel compares SF iontophoretic penetration into the dorsal, intermediate and ventral layer. The symbols * 
and *** indicate significant (p = 0.01 to 0.05) and extremely significant (p < 0.001) differences between 
pairs of bars.  
 
Comparison of the different type of measurements indicated that SF penetration (D, T and 
%T) into the ventral layer was significantly increased by iontophoresis compared to 
passive diffusion (Table 4).   
 
Table 4: SF penetration (as reported by T, %T and D) into the ventral and intermediate layers of the nail plate 
after 18h of iontophoretic or passive delivery. All values are given as mean ± SD of 15-27 measurements (n) 
taken on 3-4 nails. 
 T (µm) na D (µm) na %T  na 
SF.V.Passive 26 ± 5 18 15 ± 4 15 7.5 ± 2.0 18 
SF.V.0.1 31 ± 7* 27 21 ± 3*#¤ 24 9.3 ± 2.3* 27 
SF.Passive 26 ± 4# 17 19 ± 4*# 15 7.8 ± 1.5# 17 
SF.0.1 34 ± 7 27 34 ± 9 25 9.4 ± 2.2 27 
SF.I.0.1 30 ± 6 18 30 ± 6 19 11.2 ± 2.7 18 
a
 n, number of replicate measurements performed * Significantly different to SF.V.Passive at p < 0.05 
# Significantly different to SF.0.1 at p < 0.05 ¤ Significantly different to SF.I.0.1 at p < 0.05 
 
As it is known that the dorsal layer contributes to 30 % of the nail thickness and that it has 
been said that this layer was a limiting factor for drug permeation (Kobayashi et al., 1999 
and 2004), one would therefore expect a deeper penetration of SF into the ventral and 
intermediate layers compared to the dorsal. However, this was not the case: during passive 
experiments (Fig. 21, Table 4), measurements of the penetration depth were either 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 64 
equivalent (T and %T) or the dorsal penetration (D) was greater than the ventral and during 
iontophoretic experiments (Fig. 21, Table 4), the depth of penetration (D) in dorsal and 
intermediate layers were both significantly greater than in the ventral layer. 
This emphasizes the fact that the different types of measurements (D, T and %T) do not 
give equivalent results. 
 
4. Comparison between SF and NBC penetration 
Fig 22 shows penetration depth of the two fluorescent markers reported as T, D and %T 
after passive and iontophoretic experiments.  
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Fig. 22: Depth of SF and NBC penetration (T, D and %T) into the nail after 18 hours of passive or 
iontophoretic conditions. The dorsal layer of the nail faced the donor in all the experiments. The error bars 
are SD. The symbols *, **, and *** mean a significant (p = 0.01 to 0.05), very significant (p = 0.001 to 0.01) 
and extremely significant (p < 0.001) difference between bars. 
 
According to T values, SF permeated significantly deeper into the nail plate than NBC 
under all experimental conditions. D values, suggest on the contrary, a deeper passive 
penetration for NBC passive experiments but no differences in iontophoresis.  
Interestingly, none of the fluorescent markers went deeper than 11.2 % of the nail 
thickness whereas the dorsal layer represents 30 % of the thickness. This showed that both 
markers did not go further than the dorsal layer. 
 
5. SF binding study 
The little difference observed between SF permeation under different conditions was 
unexpected. 
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During transdermal experiments, it had been reported that keratin binds with antifungals 
such as omoconazole, bifonazole, clotrimazole (Hashiguchi et al., 1998) and cationic 
lipophilic peptides such as poly-L-lysines presenting MW greater than 2700 Da (Turner et 
al., 1997). For these cationic lipophilic peptides, it is thought that the positive charge of the 
peptide associates with fixed negative charge of the skin and that the lipophilic part of the 
molecule acts like an “anchor”. This phenomenon is believed to reduce the net negative 
charge of the skin and therefore to cancel its permselectivity and the electroosmotic flow. 
Similar binding phenomena have been observed during ungual experiments with salicylic 
acid (Hui et al. 2002; Murthy et al., 2007b ) and griseofulvin (Murthy et al., 2007a). So, the 
possible binding of SF onto nail material which would stop the penetration of the marker 
into deeper layers was therefore investigated.  
Three nails (D, E and F) were cut in three pieces (1, 2 and 3) and left in a 375 mM SF 
solution for 24 hours (see Materials and Methods). After this 24 hours exposure, one piece 
of each nail (D1, E1 and F1) was examined by confocal microscopy in order to determine 
the depth of penetration reached by the marker during the 24 hours period. The two other 
sets of samples were placed in sodium chloride solution for one (D2, E2, F2) and two 
weeks (D3, E3, F13), after which they were examined by confocal microscopy. The 
objective was to determine if the fluorescent band had or not been modified during these 
“washings”, indicating further diffusion of the marker into the nail or its release in the 
washing solution. Had the bands been very similar to those observed for the first set, it 
could be argued that SF was irreversibly bound to the nail material, and that this binding 
could be hindering its penetration into the nail. One transversal image illustrative of each 
piece is shown in Fig. 23 and Table 5 reports the average thickness of the ventral and 
dorsal bands measured for each nail piece. 
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Fig. 23: Top panel: Passive penetration of SF into human nails after 24 hours exposure. Middle and bottom 
panels: subsequent diffusion of SF into deeper section of the nail and/or into the washing solution. The nails 
were completely submerged, i.e., both the ventral and dorsal layers of the nail faced the exposure and 
washing solutions, which explains the appearance of two fluorescent bands.  
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Table 5: SF Depth of penetration in the ventral and dorsal layers of the nail pieces during the binding study. 
Penetration depth 
(µm) 
D1 D2 D3 E1 E2 E3 F1 F2 F3 
Ventral 25 ± 3 80 ± 54 0 30 ± 3 66 ± 13 38 ± 23 24 ± 6 43 ± 6 0 
Dorsal 36 ± 4 121 ± 42 66 ± 70 30 ± 6 87 ± 16 0 43 ± 5* 99 ± 41 0 
Thickness 300 ± 35 300 ± 20 350 ± 25 
* significantly different from its ventral depth of penetration (p < 0.05) 
 
These images allow further comparison of the permeability of the ventral and dorsal layers, 
the advantage, in this case, is that paired comparisons can be made. Statistical tests 
(parametric paired t-test) deduced that the depth of penetration in the two layers was 
significantly different only for piece F1 (Table 5). The evolution of the fluorescence bands 
width between the pieces 1 (24 h) and 2 (one week) are shown in Fig. 24. 
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Fig 24: SF depth of penetration into the specimens D1, E1, F1 (24 h) and D2, E2, F2 (one week). Each panel 
shows the ventral and dorsal depths of penetration for each nail (mean±SD of 2-6 images). The symbols *, 
**, and *** mean a significant (p = 0.01 to 0.05), very significant (p = 0.001 to 0.01) and extremely 
significant (p < 0.001) difference between bars. 
 
After one week, the following observations were made: (a) the fluorescent bands were less 
intense than at 24 hours but had broadened (Fig. 23) and an unpaired t-test showed that, for 
all the pieces (except the ventral diffusion of nail D), the depth of penetration in the ventral 
and dorsal layers was significantly greater at one week than at 24 h (Fig. 24) and (b) a thin 
dark layer, fluorescence depleted, wherever the nail had been in contact with the bathing 
solution (Fig. 23). These two observations indicate that SF had diffused both (a) into 
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deeper layers of the nails and (b) into the bathing solution. The confocal examination 
performed at two weeks found no fluorescence in specimen F3, a little fluorescence in a 
central area of specimen D3, and a ventral band, relatively weak and broad in specimen E3 
(Fig. 23). These observations were in agreement with the analysis of the rinsing solutions 
performed (Fig. 25).  
 
The amount of SF recovered in the rinsing solutions sequentially used in the study is 
shown in Fig. 25. The results indicate that SF effectively diffused from inside the nail into 
the solution. Two rinses were performed at 24 hours to remove SF from the surface of the 
nail and contained 662 ± 773 and 12.5 ± 9.8 nmoles of SF respectively. This important 
decline demonstrates the efficiency of the rinsing and that the SF recovered in subsequent 
washing solutions had been released from the inner part of the nail and was not originating 
from surface contamination.  
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Fig. 25: SF (nmoles) recovered from the rinsing solutions used during the binding study. Note that two rinses 
were performed after the 24 hours exposure. The bars show the mean ± SD of nine (24 h), six (1 week) and 
three (2 weeks) replicates.  
 
It was then investigated if the width of the fluorescence bands obtained on the 24 h images 
could be related to the cumulative amount of SF released during the two weeks of 
experiments (Fig.26). 
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Fig. 26: Cumulative amount of SF released during the two weeks of experiment (excluding the 24 h rinses) in 
function of the average width of the fluorescence bands (ventral + dorsal band) is shown. The dotted line 
represents the regression line and was not significant. 
 
Fig. 26 shows that the nail exhibiting the broader fluorescent bands did release more SF to 
the medium. The other two nails show similar bands and release. A regression line can be 
drawn through these points (r2 = 0.8) but is not significant. More replicates are required to 
confirm this trend.  
Finally, the cumulative amounts recovered into the rinsing solutions, 700 nmoles, 
represented only 0.09% of the total SF, 7.5 . 105 nmol, present in the donor (2 mL, 375 
mM). These results reinforced the idea of the limited passive permeability. In summary, 
results show that little difference existed between dorsal and ventral passive penetrations 
which confirmed the results obtained in a previous section (Fig. 21, Table 4), and that SF 
was not bound to the nail material. 
 
6. Pathways of passive and iontophoretic transungual permeation 
This study used images obtained with a x20 magnification objective (Fig. 27) and involved 
1) passive and iontophoretic penetration of NBC and SF into the dorsal layer, 2) passive 
and iontophoretic penetration of SF into the ventral layer and 3) iontophoretic SF 
penetration into the intermediate layer.  The images of SF passive penetration onto the 
ventral layer are shown (Fig. 27D) but the little fluorescence present prevents a good 
comparison with the other images. Likewise, no fluorescence was observed in the images 
concerning SF passive penetration into the dorsal layer and thus those images are not 
shown.  
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Fig. 27: Panel A: NBC.Passive, Panel B: NBC.0.4. Black and white was used for both fluorescent markers to 
facilitate the comparison. All the pictures were obtained at x20 magnification. 
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Fig. 27 (continued): Panel C: SF.0.1. Panel D: SF.V.Passive, Panel E: SF.V.0.1. Panel F: SF.I.0.1. Black and 
white was used for both fluorescent markers to facilitate the comparison. Dark dots observed in images 
obtained after SF experiments are indicated by white arrows. All the pictures were obtained at x20 
magnification. 
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No differences were observed between the images of passive and iontophoretic permeation 
of NBC (Fig. 27A and B). In general, the fluorescence was quite spread across the 
onychocytes suggesting a transcellular pathway in both cases. In some zones the 
intercellular pathway seemed slightly darker demarcating the cells.  
In the case of SF (Fig. 27C, E and F) the images also support that the marker followed a 
transcellular pathway during iontophoresis independently of the layer (dorsal, ventral, and 
intermediate) which was exposed to the donor solution. However, in some images, the 
intercellular pathway was very bright and the transcellular was darker. As mentioned 
before, it has been shown that ionic compounds use both the appendegeal and intercellular 
pathways during transdermal iontophoresis (Cullander et al., 1992, Turner et al., 1998). 
Obviously, the appendegeal pathway is not possible for nails. More interestingly the 
distribution of SF and NBC fluorescence indicated a main role for the transcellular 
pathway which apparently would be that opposing the least resistance to the passage of 
current. This is probably the consequence of the different structure and chemical 
composition of the two membranes, but a clear discussion is difficult given how little is 
known about the nail. These results also reinforce the message that nails and skin are 
different and that specific studies on nail iontophoresis are required.  
Cells of the ventral layer revealed by SF (Fig. 27E) showed a pitted and rough surface 
compared to the dorsal layer (Fig. 27C). This difference in the aspect of the ventral and 
dorsal layers had already been demonstrated by Scanning Electron Microscopy (Forslind et 
al., 1975), by light microscopy after dying the nail (Kobayashi et al., 1999) and by Atomic 
Force Microscopy (Repka et al., 2002). 
The surface of the filed nails, i.e. the intermediate layer (Fig. 25F), was irregular which 
was probably due to the filing. 
Finally, SF images often showed round regular dark intracellular spots while NBC stained 
the whole content of the cells. A NBC parent compound, nile blue sulphate (nile blue A, 
NBA), is commonly used as an intercalating dye because it interacts with nucleic acids 
(Huang et al., 1999). Nails are constituted of dead cells which still contain DNA fragments 
(which can be used for forensic investigations (Cline et al., 2003)), thus it was expected 
that NBC would colour the entire content of the corneocytes including the remnant nuclei 
if present. This could suggest that the small round dark areas which were not dyed by SF 
delimited the shape of the disintegrated nuclei (Germann et al., 1980; Kaufman et al., 
1995).  
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Conclusions of chapter 2 
A new method to estimate the depth of penetration into human nail plate via confocal 
microscopy has been developed and the value of three depth parameters compared. Despite 
their different physicochemical properties, NBC and SF presented similar depth of 
penetration under passive and iontophoretic conditions. Iontophoresis delivered the two 
markers slightly deeper into the nail than passive diffusion, but the level of enhancement 
was very moderate and independent of the intensity of current applied. SF passive and 
iontophoretic delivery into the dorsal, ventral or intermediate layer of the nail was very 
similar. SF did not irreversibly bind to keratin. Finally, the transcellular pathway was 
predominant for both markers and delivery methods. 
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Chapter 3:      
  Transungual iontophoresis of mannitol:    
 The electroosmotic contribution to transungual    
   iontophoretic transport. 
 
Overview 
The application of an electrical current, namely – iontophoresis –, to biological membranes 
such as skin and cornea efficiently enhances drug transport into and across these 
membranes and therefore, this method recently attracted interest as a possible tool to 
improve nail drug delivery. However, a rational approach to this new opportunity requires 
the permselective properties of the nail to be characterized. The permselective properties of 
a charged membrane result in two phenomena: (a) preferential passage (higher transport 
numbers) of counter-ions (i.e., ions possessing a charge of opposite sign to that of the 
membrane) and (b) electroosmosis or convective solvent flow in the same direction of 
transport than that of the counter-ions. This solvent flow carries with it neutral polar 
molecules and assists in the transport of counter-ions. Electroosmosis is the scope of this 
chapter. The transungual fluxes of mannitol, a well established marker of electroosmosis, 
were determined during anodal and cathodal iontophoresis and performed with vehicles of 
different pH. The effect of inter-nail variability, and the passive contribution to the total 
transport was also investigated. The results showed evidence for nail cation-
permselectivity at physiological pH (as such observed for the skin) i.e., preferential anode-
to-cathode mannitol transport when a single-nail was considered. However, the wide inter-
nail variability and the unexpectedly high passive transport of mannitol observed 
overwhelmed the results and did not allow a clear interpretation of the data. These results 
suggest that the electroosmotic contribution during transungual iontophoresis might be 
very variable and difficult to predict and thus, of limited use for practical applications. 
Future research should address the validity of the present observations in the in vivo 
conditions as well as the sources for the important variability observed.  
 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 76 
Introduction 
The human nail can be affected by two main diseases: onychomycosis and psoriasis 
(Murdan, 2002). The treatment of onychomychosis which represents 40-50% of all 
onychopathies (Gaburri et al., 2008) is long and difficult due to the adverse effects (mainly 
hepatic problems related to the insufficient specificity of the antifungals to target only the 
fungi cytochromes) and drug interactions (Debruyne et al., 2001). Topically applied 
therapies could be the answer but, in this case, drugs are facing the nail plate. High drug 
concentrations are easily achieved in the dorsal upper layers but reaching therapeutic levels 
at the nail bed, where the onychomycosis lie, is a challenge.  
Different approaches have been considered to enhance ungual topical penetration: 1) 
chemical penetration enhancers (Hui et al., 2003 and Kobayashi et al, 1998) have been 
used with more or less success and 2) iontophoresis, a minimally invasive technique, has 
started being evaluated recently (Murthy et al, 2007a and b; Hao et al., 2008 a, b and c).  
Murthy et al. (2007) performed the iontophoresis of salicylic acid, griseofulvin and glucose 
across human nail tips whereas Hao et al. (2008) studied the iontophoretic transport of 
mannitol, tetraethylammonium and urea, with and without chemical enhancers, across 
finger nail plates and nail tips. These two groups investigated the iontophoretic transport of 
both neutral and charged compounds at different pHs providing some information about 
the contribution of electrorepulsion and electroosmosis to transungual iontophoretic fluxes. 
It is pertinent to quickly revise what is known about electroosmosis in transdermal drug 
delivery applications. However, precaution must be taken before applying this knowledge 
to the nail as these membranes are significantly different both in structure and in chemical 
composition. Pikal et al. (1990) demonstrated visually the electroosmotic flow occurring 
during transdermal iontophoresis: a piece of hairless skin mouse was fixed between the 
two halves of a diffusion cell which had capillary tubes fixed onto the cathodal and anodal 
chambers. The initial level of solution in both capillary tubes was registered and the 
current was started. The position of the meniscus in each tube was monitored during 
iontophoresis and, for example, a meniscus displacement of up to 4 cm indicating a 30 µL 
solvent flow could be measured. This data clearly showed the solvent movement between 
the two chambers during iontophoresis. 
Pikal’s experiment was extremely laborious and, in practice, electroosmosis is usually 
determined indirectly by measuring the flow of an electroosmotic marker. The most 
frequently used marker is mannitol: a neutral, polar (logP -3.9) sugar with a similar 
molecular weight to glucose (182 and 180 for mannitol and glucose, respectively). 
Mannitol is preferred to glucose because it is an exogenous material which is not 
metabolized by cells. Thus, mannitol fluxes are neither confounded by metabolism or by 
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endogenous contributions (such as the skin glucose reservoir (Sieg et al., 2004a)). Further, 
despite of being neutral, it is an extremely hydrophilic compound which limits the 
contribution of passive diffusion to negligible levels during transdermal iontophoresis 
(Kim et al., 1993). 
The electroosmotic flow is a less efficient mechanism of transport than electrorepulsion, 
however its contribution is the only possible for neutral, uncharged or zwitterionic, polar 
molecules. Further, it becomes progressively more important for charged molecules as 
their transport numbers decrease (typically as molecular weight increases and electrical 
mobility is reduced). Thus, its contribution could be critical in the case of onychomycosis; 
potent antifungal drugs have a relatively high molecular weight (207 to 706 Da) and are 
either neutral or partially ionised at physiological pH (Table 1).  
 
Table 1: Physicochemical properties of commonly used antifungals for onychomycosis 
Administration Molecules MWa Acid/Basea pKaa 
% ionisation at 
pH 7.4b 
Itracononazole 706 Weak base ~6.5 ~11 
Ketoconazole 531 Weak base ~6.9 ~24 
Griseofulvin 368 Weak acid ~11 
~0.02 
Fluconazole 306 
Weak acid 
Weak base 
~11 
~3 ~0.02 
Systemic 
Terbinafine 291 Weak base ~7 
~28 
Amorolfine 318 Weak base ~7.5 
~56 Topical 
Ciclopirox 207 Weak acid ~6.2 
~94 
a
 data taken from Scifinder Scholar and Medchem online. 
b data calculated from “Physicochemical principles of Pharmacy” from Florence and Attwood, 2nd edition 
(1988). 
 
The direction of the electroosmotic flow is directly related to the membrane’s net charge. 
For example, skin and cornea membranes are negatively charged at physiological pH 
which induces an electroosmotic flux in the anode-to-cathode direction (Rojanasakul et al., 
1989; Guy et al., 2000). In vitro experiments (Marro et al., 2001b) which gradually 
lowered the pH of the solutions bathing the skin, showed a progressive reduction of the 
anode-to-cathode mannitol flux suggesting a concomitant neutralization of the skin’s 
positive charges. Ultimately, at pHs below the apparent isoelectric point of the membrane, 
the skin becomes positively charged and mannitol net flow occurs in the cathode-to-anode 
direction. The characterization of the effect of pH on mannitol flux has become a standard 
tool on studies addressing the permselective properties of human, pig, mice and rabbit skin 
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as well as rabbit cornea (Marro et al., 2001b; Kim et al., 1993; Nicoli et al., 2003, Li et al., 
2005).  
As previously discussed, the net negative charge of the skin at physiological pH also 
induces cation permselectivity (Burnette et al., 1987; Pikal et al., 1990). For example, 
transport numbers in a 0.1 M NaCl aqueous solution are 0.4 and 0.6 for Na+ and Cl-, 
respectively, but change to 0.6 and 0.3 during transdermal iontophoresis (Burnette et al., 
1987). This indicates the preferential passage of cations (counter-ions as sodium) across 
the negatively charged membrane. Thus, the measurement of small inorganic transport 
numbers is another indirect evidence of the membrane charge and the existence of 
electroosmosis. However, electroosmosis and transport numbers are related but not 
interdependent phenomena, as evidenced by the next finding: the transport number of 
lidocaine (Marro et al., 2001a) in the single-ion situation (absence of competing co-ions in 
the donor solution) was 0.1 which indicated that the counter-ion (chloride) had a transport 
number close to 0.9. Despite the fact that most of the ionic charge was being transported by 
chloride ions in the cathode-to-anode direction, it was shown that the electroosmotic flow 
of mannitol occurred in the anode-to-cathode direction which demonstrated that 
electroosmosis is directly linked to the membrane charge and not necessarily associated to 
the ion with the highest transport number. Thus, our work has attempted a complete 
characterization of the nail permselective properties by investigating both phenomena: (a) 
the existence of an electroosmotic contribution during transungual iontophoresis as 
evidence by mannitol transport as a function of pH and (b) the preferential passage of 
cations/anions again as a function of pH (subject of the next chapter)  
Keratin being the main component of skin and nail, nails are expected to be negatively 
charged at physiological pH. The strongest evidence supporting this hypothesis is the data 
reported by Murthy et al. (2007b) on the transungual iontophoresis of glucose and 
griseofulvin. These authors measured the anodal and cathodal electroosmotic fluxes of 
glucose as a function of pH across nail tips that had been hydrated for 6 hours before the 
experiments. The pattern (anodal and cathodal flux versus pH) observed was very similar 
to that demonstrated for the skin and suggested that (a) the isoelectric point of nail is close 
to 5 (human skin pI ~ 4.8 (Marro et al., 2001b)) and (b) human nails hold a net negative 
charge at physiological pH. The apparent solvent flux at pH 7 and a current intensity of 
0.125 mA can be estimated from the data to be 0.3 µl/h, a value relatively high when 
compared to the 0.65 µl/h reported for human skin at pH 7.4 and 0.4 mA (Marro et al., 
2001b). The iontophoretic transport of griseofulvin (weak acid, pKa~11) at pH 3, 5 and 7 
also supported this evidence. For example, griseofulvin highest fluxes at pH 3 and 7 were 
obtained using cathodal and anodal iontophoresis respectively, again indicating 
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electroosmosis occurring in the cathode-to-anode direction at pH 3 (nail positively 
charged) and in the anode-to-cathode at pH 7 (nail negatively charged). Griseofulvin fluxes 
were about a half of those reported by glucose; this could be due to the drug’s higher 
molecular weight (368 Da), increased lipophilicity (logP 2.2) or its extensive binding to 
keratin.  
However, the 6-fold enhancement caused by iontophoresis at 0.125 mA on glucose fluxes 
with respect to passive conditions and the unambiguous distinction between anodal and 
cathodal fluxes is in contradiction with other data. Hao et al. (2008a) reported a very small 
enhancement (less than 3-fold) on the permeability coefficient of mannitol even when 0.1 
and 0.3 mA iontophoresis had been used and that the nails had been hydrated for 24 hours 
prior the experiments. Unfortunately, Hao et al. (2008a, b and c) reported their results as 
permeability coefficients and Peclet numbers which limits their direct comparison with the 
fluxes reported by Murthy (2007a) and with those in this work. 
It seems therefore that nail permselectivity has not been demonstrated unambiguously and 
the aim of the work reported in this chapter was to investigate this phenomenon. In line 
with Hao et al. (2008) and a multitude of skin and cornea studies (Marro et al., 2001b; Kim 
et al., 1993; Nicoli et al., 2003; Li et al., 2005) we have preferred the use of mannitol to 
avoid any confounding contribution to the fluxes originating from endogenous sources. 
The passive, anodal (anode-to-cathode) and cathodal (cathode-to-anode) electroosmotic 
flux of mannitol was measured at pH 4.0, 5.0 and 7.4. The significance of inter-nail 
variability was also considered and integrated in the experiment design. As a difference 
with other authors, we have limited prior hydration of the nail to a maximum of 15 minutes 
expecting this short hydration to mimic more closely a practical in vivo application. 
 
Materials and methods 
 
1. Materials  
Mannitol, sodium chloride, HEPES free acid, hydrochloric acid and sodium hydroxide 
were obtained from Sigma Aldrich Co. (Gillingham, UK). 14C-mannitol (200 µCi/mL 
equivalent to 7.4 Bq/mL) was obtained from Amersham plc (Little Chalfont, UK). Ultima 
Gold XR, Hionic Fluor and Solvable were obtained from Perkin Elmer (Waltham, MA, 
USA). Silver wire, silver chloride powder and platinum wire used to prepare the electrodes 
had a minimum purity of 99.99 % and were obtained from Sigma Aldrich Co. (Gillingham, 
UK). All aqueous solutions were prepared using high purity deionised water (18.2 MΩ.cm, 
Barnstead Nanopure DiamondTM, Dubuque, IA, USA). 
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2. Nails 
Ethical approval was granted by the Bath Local IRB and finger nail clippings were 
obtained from fourteen healthy volunteers who gave their written informed consent 
(Documents provided in the Appendix 3). The harvested nails were washed with deionised 
water and kept at room temperature in a dessicator until use. Prior to an experiment, the 
thickness of the nail in the site closest to the hyponychium was measured with a point 
micrometer (Point Anvil Micrometer, Mitutoyo, Andover, UK). Next, each nail was 
soaked in deionised water during 10-15 minutes in order to recover some flexibility, and 
placed in 5 mm (0.2 cm2 area) nail adapters (PermeGear Inc., Bethlehem, PA, USA). 
 
3. Mannitol iontophoresis 
Mannitol experiments were performed in Franz vertical diffusion cells (PermeGear Inc., 
Bethlehem, PA, USA) presenting a transport area of 0.2 cm2. To facilitate sampling of the 
receptor chamber, the bottom chamber was used to hold the donor solution while the 
receptor was placed on the top. The nail adapter was placed so the nail’s dorsal layer faced 
the donor solution (Fig. 1).  
 
 
Fig. 1: Picture of the experimental set-up 
 
Experiments were performed with donor and receptor solutions adjusted to an identical pH: 
4.0, 5.0 or 7.4.  
Preliminary experiments indicated that nails exhibit a high resistance to the passage of 
current. During constant, direct current iontophoresis, the power supply modifies the 
voltage imposed depending on the resistance of the electrical circuit (as indicated by 
Ohm’s law; V=I.R) so a constant current passes through the circuit. It was observed, that 
the voltage required for imposing 0.2 mA from time zero was unacceptable as it would 
have a deleterious effect on the nails. Thus, a ~30 minutes “pre-treatment” period was 
applied to each nail during which a maximum voltage output (200 V) was set on the power 
supply (Kepco APH 1000M, Flushing, NY, USA). During this time the current applied 
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could be lower than 0.2 mA and varied with the resistance of each nail. Once the nail 
resistance drops enough, the voltage required to pass 0.2 mA is less than the limit imposed. 
Typically, the voltage required for passing 0.2 mA was 30-40 V and was reached in ~30 
minutes. During this pre-treatment time the receptor and donor chamber were filled with 
HEPES buffer at the appropriate pH (containing no mannitol). Once this pre-treatment had 
been performed for the three nails, the donor and receptor chambers were filled with the 
appropriate mannitol donor and receptor solutions. The donor chamber (3.6 mL) was filled 
with a 10 mM mannitol solution containing 154 mM NaCl in 25 mM HEPES buffer. This 
solution was spiked with 14C-mannitol (200 µCi/mL equivalent to 7.4 Bq/mL) to get 2.5-3 
µCi/cell (around 0.1 Bq/cell). The receptor chamber (700 µL) contained 154 mM NaCl in 
25 mM HEPES buffer. The pH of the solutions was adjusted to 4, 5 and 7.4 by addition of 
sodium hydroxide or hydrochloric acid as appropriate.  
The three cells were then connected in series and the experiment started. A constant 
current of 0.2 mA (1 mA/cm2) was applied via homemade Ag/AgCl electrodes prepared as 
previously described (Green et al., 1991).  
Four set of experiments were performed as described in Fig. 2. Set I comprised three 
independent experiments studying the effect of one factor (pH 4, 5 and 7.4). This 
experiment indicated that a wide inter-nail variability could confound the effect of the 
factors under investigation. Thus, the next Sets (II-IV) comprised only experiments that 
modified either pH or polarity sequentially. In experiments comprising several pH stages, 
the donor and receptor solutions were rinsed 3 times and filled with the new buffer solution 
before proceeding with the next stage. The donor and receptor were rinsed 3 times as well 
at the very end of each experiment with some receptor solution at the appropriate pH. In all 
cases three replicates were done. 
Passive experiments were performed in the same way except that no current was applied 
and that the pre-treatment was not necessary. 
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Fig. 2: Mannitol experiments. Each line represents one experiment which used 3 nails. A dotted line means 
that mannitol delivery occurred in the anode-to-cathode direction, a black continuous line indicates cathode-
to-anode delivery and a light gray continuous line, passive diffusion. Square and circle symbols represent 
sampling times.  
 
4. Mannitol quantification 
The whole content of the receptor chamber (700 µL) was sample at the indicated times 
(Fig. 2) and the chamber refilled with fresh receptor buffer. Each receptor sample was 
mixed with 15 mL Ultima Gold XR before being assessed for its 14C-mannitol content on a 
Liquid Scintillation Analyzer Tri-Carb 2800TR equipped with the software QuantaSmart 
4.01 (Perkin Elmer, Waltham, MA, USA). At the end of each experiment, nails were 
carefully removed from their adapters, placed in pre-weighed glass scintillation vials and 
weighed. 5 mL of Solvable were added to each nail and the vials were subsequently placed 
in an oven (Heraeus Function Line, Weiss-Gallenkamp, Loughborough, UK) at 60 ºC for 
nail digestion. The vials were taken out of the oven upon complete digestion of the nails 
(minimum 6 hours) and 10 mL Hionic Fluor scintillation cocktail were added once they 
were at room temperature. The nail content in mannitol was assessed by liquid scintillation 
counting (LSC) (Data shown in the Appendix 2). 
Appropriate background samples were prepared for each experiment. Three 700 µL 
samples of buffer solution were mixed with 15 mL of Ultima Gold XR to obtain an 
average radioactivity background for the receptor samples. 5 mL of Solvable combined 
with 10 mL Hionic Fluor scintillation cocktail was used as background counting for 
digested nails. 
Three reference samples were prepared by mixing 100 µL of the spiked donor solution 
with 15 mL of Ultima Gold XR. LSC of these references provided the ratio hot-to-cold 
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mannitol in the donor solution and allowed estimation of the equivalent cold mannitol 
present in the samples. 
 
5. Mannitol binding study 
The possible binding of mannitol to the nail material was studied. Three nails (A, B and C) 
were cut in three pieces (A1, A2, A3; B1, B2, B3; C1, C2, C3). Each piece was weighed 
and placed for 24 h in a vial containing 2 mL of a 10 mM mannitol in a pH 7.4, 25 mM 
HEPES buffer spiked with 14C-mannitol (200 µCi/mL equivalent to 7.4 mBq/mL). After 
24 h, all pieces were taken out of the mannitol solution and rinsed twice in 5 mL of a 25 
mM HEPES buffer at pH 7.4. Samples A1, B1 and C1 were then mixed with Solvable and 
placed in the oven for nail digestion and subsequently 10 mL Hionic Fluor were added 
prior to LSC analysis.  The remaining nail samples (A2, A3; B2, B3; C2, C3) were placed 
in individual vials containing 5 mL of HEPES 25 mM for one week. The buffer solution 
was completely refreshed in the middle of the week. At the end of the first week, the 
samples A2, B2 and C2 were prepared for digestion and LSC analysis as previously 
described. Samples A3, B3 and C3 were left in 5 mL of HEPES 25 mM for one more 
week. The buffer solution was replaced at the end of the first week and in the middle of 
week two. Finally, samples A3, B3 andC3, were prepared for digestion and LSC analysis 
at the end of the second week. The rinsing and buffer solution were also analyzed by LSC 
after addition of 15 mL Ultima Gold.  
 
6. Data analysis and statistics 
All data is presented as mean and standard deviation of at least three replicates. Linear 
regressions and statistics were performed using Graph Pad Prism V5.00 (Graph Pad 
Software Inc., San Diego, CA). When relevant, sets of data were compared by a one way 
ANOVA followed by a Tukey’s post-test and by paired t-test. Alternatively, non-
parametric tests (Kruskall-Wallis followed by Dunn’s post-test and Wilcoxon paired t-test) 
were also used due to the small number of replicates. The slopes obtained from the 
mannitol amounts for each nail were compared at each pH and condition by using a 
comparison tool in the Graph Pad Prism V5.00 software. The level of statistical 
significance was fixed at p < 0.05. All linear regressions were significant (p < 0.05) unless 
otherwise indicated. 
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Results and discussion 
 
1. Mannitol electroosmotic transport 
Set I: 
The nails used during these experiments came from female participants (21-44 years old). 
The average thickness of the nails used at pH 4, 5 and 7.4 was 290 ± 20 µm, 290 ± 80 µm 
and 220 ± 20 µm, respectively (Table 2). 
 
Table 2: Nails used in Set I. 
pH of the experiment Nail code* Gender  Age (year) Thickness (µm) 
4LF3 Female 44 270 
12LF3 Female 22 290 pH 4.0 
13RF3 Female 21 310 
2LF5 Female 26 210 
7LF1 Female 28 360 pH 5.0 
13LF4 Female 21 290 
2LF5 Female 25 220 
7LF5 Female 28 200 pH 7.4 
9RF5 Female 24 230 
 
*The first digit in the nail code indicates the participant number, L or R indicates left or right hand and 
F+digit indicates the finger where F1 = thumb 
 
As described in Materials and Methods, Set I comprised three independent experiments 
which lasted for 52 h (Fig. 3). Mannitol was always delivered from the anode.  
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Fig. 3: Schematic diagram of the experimental conditions followed in Set I. Each line represents an 
independent experiment involving 3 nails. Each symbol represents a sampling time. The dotted line indicates 
that mannitol delivery occurred in the anode-to-cathode direction. 
 
The cumulative amounts of mannitol delivered to the receptor solution for each nail and 
pH were plotted against time (Fig. 4). The total amount of mannitol delivered at each pH 
stage is shown in Table 3. The slopes of the linear regressions (Fig. 4) of each of these 
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lines were obtained using Graph Pad Prism V5.00 and used as an average flux for each nail 
and pH. 
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Fig. 4: Cumulative amounts of mannitol obtained for each nail at each pH. Dotted lines are linear regressions. 
 
Table 3: Total amount of mannitol delivered (nmoles) during set I. The order of the nail is the one indicated 
in Table 2. 
 pH 4.0 pH 5.0 pH 7.4 
Nail 1 192.5 323.6 34.4 
Nail 2 327.8 101.2 11.7 
Nail 3 231.1 182.4 14.4 
Mean ± SD 250.5 ± 69.7 202.4 ± 112.5 20.2 ± 12.4 
 
First of all, it was observed that the data was very variable (Fig. 4, Table 3). A simple test 
for comparison of the slopes (Zar, 1984) indicated that the three slopes (fluxes) obtained 
for each pH were significantly different (Fig. 4).  
This variability was particularly manifest for the experiment performed at pH 5 and 7.4. 
The mean flux (± SD) was 5.48 ± 1.46, 4.39 ± 2.66 and 0.43 ± 0.26 nmol/h at pH 4.0, 5.0 
and 7.4, respectively (Figure 5).  
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Fig. 5: Anodal delivery of mannitol as a function of pH. 
 
Surprisingly, the fluxes measured at pH 7.4 were clearly the lowest of the set. The non-
parametric Kruskall-Wallis could not demonstrate any significant difference between the 
data; however a parametric ANOVA indicated that the flux at pH 7.4 was statistically 
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different to that measured at pH 4.0 (Table 3, Fig. 5). In any case, the trend “anodal flux 
versus pH” was completely unexpected at it seemed to suggest that anodal electroosmosis 
decreased as pH increased, in other words that the nail was negatively charged at pH 4 and 
became progressively uncharged or positively charged at pH 7.4. This is in complete 
contradiction with previous data and with the physicochemical properties of keratin 
(Marshall, 1983; Murthy et al., 2007a; Hao et al., 2008). A wide inter-nail variability has 
been mentioned previously (Hao et al., 2008a) although not quantitatively reported. It was 
then hypothesised that experiments should be implemented in such a way that inter-nail 
variability could be separated from the experimental error, thus allowing an improved 
investigation of the effects of pH and polarity on the delivery. This justified the 
experimental approach followed in all the in vitro subsequent experiments of this thesis.  
 
Set II: 
All the nails used in this experiment came from the middle finger of female participants 
(26-44 years old). Their average thickness was 270 ± 10 µm (Table 4). 
 
Table 4: Nails used in Set II. 
Nail code* Gender  Age (year) Thickness (µm) 
2LF3 Female 26 270 
4RF3 Female 44 280 
7LF3 Female 28 260 
 
*The first digit in the nail code indicates the participant number, L or R indicates left or right hand and 
F+digit indicates the finger where F1 = thumb 
 
In this experiment, mannitol was delivered from the anode at pH 7.4 during 28 hours after 
which the donor and receptor solutions were replaced by equivalent solutions at pH 4. The 
anodal iontophoresis of mannitol at pH 4 was then studied for another 24 h (28-52h) (Fig. 
6). 
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Fig. 6: Schematic diagram of the experimental conditions applied in Set II. Each symbol represents a 
sampling time. The dotted line means that mannitol was delivered in the anode-to-cathode direction. The pH 
of both the donor and receptor solutions was changed from 7.4 to 4.0 after 28 h. 
 
As previously, the cumulative mannitol delivered for each pH stage was represented as a 
function of time (Figure 7) and the fluxes for each nail/pH stage obtained from the slope of 
the respective linear regression. The total amount of mannitol delivered at each pH stage is 
shown in Table 5. 
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Fig. 7: Mannitol delivered by anodal iontophoresis during the pH 7.4 and pH 4.0 stages. Dotted lines are 
linear regressions. The linear regression of the nail 2LF3 at pH 4.0 was not significant. 
 
Table 5: Total amount of mannitol delivered (nmoles) during set II. 
 pH 7.4 pH 4.0 
2LF3 44.7 20.7 
4RF3 82.5 19.4 
7LF3 24.0 12.3 
Mean ± SD 50.4 ± 29.7 17.5 ± 4.5 
 
Again, an important variability was observed at pH 7.4 were the three slopes were 
significantly different; no differences were found between the slopes corresponding to the 
pH 4.0 stage (Fig. 7). The average fluxes (±SD) measured at each pH are shown in Figure 
8. 
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Fig. 8: Anodal delivery of mannitol as a function of pH. The arrow indicates that the first stage of the 
experiment was performed at pH 7.4 and the second at pH 4.0.  
 
Table 5 clearly indicates that, if each nail is taken separately, changing the pH from 7.4 to 
4.0 results in cutting the total amount of mannitol delivered by a factor 2 to 4. Mannitol 
flux at pH 7.4 (1.91 ± 1.04 nmol/h) was higher than at pH 4.0 (0.44 ± 0.13 nmol/h) but 
there were not statistically significant differences among the two values or between the 
mean total mannitol delivery of Table 5 (Wilcoxon paired test). However, the trend here 
observed was more consistent with a net negative charge for nail at pH 7.4 and with what 
is known about keratin (pI ~ 5) and the literature (Murthy et al., 2007; Hao et al., 2008). 
Indeed, anodal mannitol fluxes slightly decrease (although not to the level of statistical 
significance) as the bathing solutions become more acidic indicating the loss of negative 
charges in the nail. The variability observed at pH 7.4 suggests that the factors determining 
the magnitude of the convective flow (Hao et al., 2008c) (for example, the amount of fixed 
charge in the membrane and the geometry of the pathway of penetration) may vary 
considerably among different nails. In any case, it seemed a sensible step to perform 
subsequent experiments in the same fashion, i.e., use the same nails and sequentially 
modify the factor (pH or the current polarity) investigated. 
 
Set III: 
The nails used during this experiment came from the little finger of female participants 
(21-44 years old) and their average thickness was 230 ± 10 µm (Table 6). 
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Table 6: Nails used in set III. 
Nail code* Gender  Age (year) Thickness (µm) 
2RF5 Female 26 220 
4LF5 Female 44 240 
13LF5 Female 21 240 
 
*The first digit in the nail code indicates the participant number, L or R indicates left or right hand and 
F+digit indicates the finger where F1 = thumb. 
 
This experiment comprised four stages (Fig. 9). Mannitol was delivered from the anode at 
pH 4.0 during the first stage (0 to 28 h) and at pH 7.4 (28 to 52 h) during the second one. 
The polarity of mannitol delivery was switched at 52 hours and mannitol was subsequently 
delivered from the cathode at pH 7.4 (52 to 76 h) in a third stage and at pH 4.0 (76 to 100 
h) in a final fourth stage.  
 
Set III
0 10 20 30 40 50 60 70 80 90 100
3
4
5
6
7
8
Anode to Cathode
Cathode to Anode
time (h)
pH
 
Fig. 9: Schematic diagram of the experimental conditions applied in Set III. Each symbol represents a 
sampling time. The dotted line means that mannitol was delivered in the anode-to-cathode direction, the 
black line means it was in the cathode-to-anode direction. 
 
The amount of mannitol delivered for each pH/polarity stage was represented as a function 
of time (Fig. 10) and the fluxes for each nail/stage were obtained from the slope of the 
respective linear regressions.  
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Fig. 10: Effect of pH and polarity on mannitol transport across the nail. The following regressions were not 
significant: (a) anodal delivery: 13LF5 at pH 4.0 (B) cathodal delivery, 2RF5 at pH 7.4, 4LF5 at both pHs 
and 13LF5 at both pHs. 
 
As before it seemed that the variability observed was higher for anodal delivery at pH 7.4 
but formal comparisons were not performed in this case because many slopes were not 
significant (Fig. 10). 
The average fluxes obtained from the slopes of the linear regressions have been plotted 
against the pH and according to the electrode of delivery (Fig. 11).  
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Fig. 11: Anodal and cathodal mannitol fluxes measured at pH 4 and 7.4. A dotted line means that mannitol 
was delivered in the anode-to-cathode direction whereas a black line indicates that it was in the cathode-to-
anode direction. The arrows indicate in which way the pH was changed. 
 
In this experiment, the results show the expected trend: anodal delivery increases from 
0.02 ± 0.01 nmol/h at pH 4 to 0.11 ± 0.07 nmol/h at pH 7.4 and cathodal delivery 
decreased from 0.15 ± 0.02 nmol/h at pH 4 to 0.06 ± 0.01 nmol/h at pH 7.4. However, a 
non parametric paired t-test (Wilcoxon t-test) could only show statistically significant 
differences for the cathodal fluxes. 
As indicated in Fig. 10, half of the fluxes used in the previous analysis originated from 
linear regression that were not significant, it could be argued that these fluxes had an 
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unacceptable error associated. Therefore, it was decided to analyse the total amount of 
mannitol delivered at each pH/polarity stage (Table 7). 
 
Table 7: Total amount of mannitol delivered (nmoles) during set III. 
Anode to cathode Cathode to anode 
 
pH 4 pH 7.4 pH 7.4 pH 4.0 
2RF5 0.96 2.51 2.05 2.86 
4LF5 0.59 0.96 1.31 2.38 
13LF5 0.45 0.89 1.41 2.50 
Mean ± SD 0.67 ± 0.27 1.45 ± 0.91 1.59 ± 0.40 2.58 ± 0.25 
 
Table 7 shows that, for each nail: 1) in the anode to cathode direction, the total amount of 
mannitol delivered at pH 7.4 was systematically higher than at pH 4 (factor 2.6, 1.6 and 2.0 
for 2RF5, 4LF5 and 13LF5, respectively) and 2) in the cathode to anode direction, the total 
amount of mannitol delivered at pH 4.0 was higher than at pH 7.4 (factor 1.4, 1.8 and 1.8 
for 2RF5, 4LF5 and 13LF5, respectively). However, these observations did not attain the 
level of statistical significance (Wilcoxon paired t-test). 
 
Passive diffusion: 
The nails used during this experiment came from the right middle finger of female donors 
(22-44 years old). Their average thickness was 240 ± 40 µm (Table 8). 
 
Table 8: Nails used in Set IV - passive experiment. 
Nail code* Gender  Age (year) Thickness (µm) 
2RF4 Female 26 200 
4RF4 Female 44 240 
12RF4 Female 22 270 
 
*The first digit in the nail code indicates the participant number, L or R indicates left or right hand and 
F+digit indicates the finger where F1 = thumb. 
 
As described in the introduction there are contradictory reports on the degree of 
enhancement caused by the iontophoresis of glucose and mannitol (Murthy et al., 2007a; 
Hao et al., 2008a). Thus it was decided to perform a passive control in our experimental 
conditions. The passive diffusion experiment had a total duration of 96 h and comprised a 
first stage at pH 4.0 (0 to 48 h) and a second stage at pH 7.4 (48 to 96 h) (Fig. 12). 
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Fig. 12: Schematic diagram of the experimental conditions applied in Set IV (passive). Each symbol 
represents a sampling time.  
 
The cumulative mannitol delivered for each pH stage was represented as a function of time 
(Fig. 13) and the fluxes for each nail/stage were obtained from the slope of the respective 
linear regressions. In this case the inter-nail variability was greater at pH 4 as the slopes at 
this pH were significantly different; there were no differences observed among the slopes 
corresponding to pH 7.4.  
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Fig. 13: Passive diffusion of mannitol across nail at pH 4.0 and 7.4. All the regression lines were significant. 
 
The average fluxes are plotted against the pH in Fig. 14. 
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Fig. 14: Average mannitol fluxes during passive diffusion. 
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The passive fluxes were 0.03 ± 0.02 and 0.17 ± 0.02 nmol/h at pH 4.0 and 7.4, respectively 
and were significantly higher (paired t-test) at pH 7.4.  
The total amount of mannitol delivered during the passive experiments is reported in Table 
9. 
Table 9: Total amount of mannitol delivered (nmoles) during passive experiment. 
 pH 4.0 pH 7.4 
2RF4 1.92 8.43 
4RF4 0.67 6.45 
12RF4 1.89 8.22 
Mean ± SD 1.49 ± 0.71 7.70 ± 1.08 
 
Surprisingly, the cumulative amount of mannitol obtained at pH 7.4, for each nail, was 
higher than at pH 4.0 (by a factor 4.4, 9.6 and 4.3 for 2RF4, 4RF4 and 12RF4, 
respectively). However, a Wilcoxon paired t-test did not reveal any statistical differences 
between the two means. 
 
Comparison of all results: 
Fig. 15 shows the passive and iontophoretic mannitol fluxes measured during the four sets 
of experiments and according to the pH and polarity of delivery. 
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Fig. 15: Iontophoretic and passive mannitol fluxes (nmol/h).  
Passive: nails F4  Set I: nails F3 (pH 4.0), F5 (pH 7.4) Set II: nails F3 Set III: nails F5 
 
 
It was pertinent to examine all the data gathered in this work (Fig. 15) and to compare it 
with the starting hypothesis and previous data. On the one hand, (Murthy et al., 2007a), 
data suggests that the nail behaves like the skin (Kim et al. 1993) and that the following 
should be observed: (1) a passive flux which is always smaller than the iontophoretic 
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fluxes at any pH, (2) a cathodal flux greater than the anodal at pH 4.0 and (3) an anodal 
flux greater than the cathodal at pH 7.4. On the other hand, Hao et al (2008a and c) 
observed an extremely low enhancement and a practically negligible effect of pH and 
polarity of delivery on mannitol transport. 
Individual experiments performed with the same nails (Set II and III) indicates that the 
nails behave as a cation permselective membrane at physiological pH, however, Fig. 15 
suggests that this fact might be overwhelmed by other factors when a bigger population of 
nails is considered. Thus, while cathodal electroosmosis at pH 4 is higher for a given set 
(Set III), it is clear that for other sets anodal electroosmosis is even higher (set I and II). 
Similarly, while set III shows that anodal iontophoresis at pH 7.4 is the best condition of 
delivery for a given set, it is also true that higher fluxes can be obtained for other sets with 
cathodal delivery at pH 4 (Set I and II). Moreover, even when the nails come from the 
same finger of different volunteers, this does not make the results more comparable: at pH 
4.0, nails in set I and II were all from F3 and at pH 7.4, nails in set I and III came from F5 
but no clear similarities could be noticed. On the whole, these data suggest that nails are 
possibly negatively charged at physiological pH, but that there is a huge inter-nail 
variability in the magnitude of the electroosmotic fluxes caused by iontophoresis. It can 
also be deduced the need of considering inter-nail variability in future studies and more 
crucially, of studying electroosmosis across the nail plate in vivo. If these findings about 
nail clippings in vitro are representative of the in vivo situation it will be extremely 
difficult to predict transungual fluxes of a drug which is only transported by 
electroosmosis.   
A final point can be made on the degree of enhancement caused by iontophoresis. It is 
easily seen (Figure 14) that the level of enhancement varies from zero to 100 fold 
depending on the pair of experiments compared. Unfortunately, passive controls were done 
in a separate study and the effect of nail variability can not be separated. However, these 
results could help to understand the contradictory observations previously reported by 
different groups. Hao et al. used the same nails for passive, anodal and cathodal and 
observed a very moderate enhancement caused by iontophoresis; it seems that Murthy used 
different nails for each conditions and it could be possible that, by chance, the least 
permeable nails were used as passive controls. Unfortunately, there is not enough 
information on Murthy’s published work to discuss more deeply this detail. In any case, if 
the results here reported are predictive of the in vivo situation, one could difficulty support 
the use of iontophoresis, a more complex and expensive technique, with respect to passive 
diffusion delivery systems.  
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Comparison with other works: 
The anodal and cathodal mannitol fluxes measured at pH 7.4 have been summarised in 
Table 10 for comparison with the glucose nail results of Murthy et al. (2007a) and with the 
mannitol skin results of Marro et al. (2001b). 
 
Table 10: Comparison of skin and nail iontophoretic fluxes (nmol/h) and convective solvent flow normalized 
by the current intensity, Js (µL/h/mA), of mannitol or glucose at pH 7 and 7.4. 
 
This work  
mannitol pH 7.4 
Murthy et al. (2007a) 
glucose pH 7.0 
Marro et al. (2001b) 
mannitol pH 7.4 
Current (mA) 0.2 0.125 0.4 
 
Fluxes 
(nmol/h) 
Js 
(µL/h/mA) 
Fluxes 
(nmol/h) 
Js 
(µL/h/mA) 
Fluxes 
(nmol/h) 
Js 
(µL/h/mA) 
SetI 0.43 ± 0.26 0.21 ±0.13 
Set II 1.91  ± 1.04 0.95 ± 0.52 Anodal 
Set III 0.11 ± 0.07 0.05 ± 0.03 
3.10 ± 0.32 2.48 ± 0.26 0.66 ± 0.26 1.65 ± 0.65 
Cathodal Set III 0.06  ± 0.01 0.03  0.28  ±0.05 0.22 ± 0.04 0.04 ± 0.03 0.10 ± 0.07 
 
Murthy et al. (2007a) worked on the transport of a 10 mM solution of glucose across nail 
by anodal and cathodal delivery at 0.125 mA. Marro et al. (2001b) studied the transport of 
a 1 mM mannitol solution across human skin by anodal and cathodal delivery at 0.4 mA. 
Murthy et al. (2007a) were using glucose and so they performed a 10 h control experiment 
to check that no glucose was released from nails and did not find any. This statement is in 
accordance with a preliminary experiment that we performed and revealed the absence of 
glucose in nails. Briefly, we dissolved three nails over night in NaOH 2 M and analysed 
them by amperometry on ion chromatography using NaOH as the eluent (Data not 
reported).  
Murthy et al. (2007a) obtained results extremely consistent with a negative charge held by 
nails at pH 7 but, interestingly, the convective solvent flows that they obtained, 2.48 and 
0.22 µL/h/mA for anodal and cathodal delivery respectively, were higher than what Marro 
et al. (2001b) obtained with human skin, 1.65 and 0.10 µL/h/mA for anodal and cathodal 
delivery respectively.  
The anodal convective solvent flows obtained during our work were higher than the 
cathodal flow (0.03 µL/h/mA) and this latter flow was fairly similar with the one obtained 
in skin (0.10 µL/h/mA). Again, these findings suggest that nails hold a net negative charge 
at physiological pH. The anodal convective solvent flows that we found here are between 
0.05 and 0.95 µL/h/mA. These values are smaller than the one found in skin, 1.65 
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µL/h/mA (Marro et al., 2001b), and much smaller than the one found in nails, 2.48 
µL/h/mA (Murthy et al., 2007a). It is surprising to observe that Murthy et al. (2007a) could 
find anodal convective solvent flow 1.5 times higher than what Marro et al. (2001b) 
measured in skin.  
 
Variability in nail permeation:  
It is well known that membrane thickness plays an important role during passive diffusion 
via the permeability coefficient as defined in Eq. 1. 
 
P = K . D / h  Eq. 1  (Walters et al. 1981) 
 
where P is the permeability coefficient in cm/h, K is the membrane-solution partition 
coefficient, D is the diffusion constant of the permeant within the membrane and h is the 
membrane thickness. However, we could not find any relation between the thickness of the 
three nails used in passive diffusion and the fluxes measured. This may be due to the 
limited number of replicates available. For example, Walters et al. (1981) demonstrated 
that a nonlinear relationship existed between methanol and ethanol permeability and the 
nail thickness. 
In the case of iontophoresis, transport by electrorepulsion has been shown to be mostly 
controlled by the relative concentration and mobilities of the competing ions, and to be 
much less dependent on the skin animal model (Phipps et al., 1989; Mudry et al., 2006b) or 
even on the skin damage (Sekkat et al., 2002; Abla et al., 2005) than passive diffusion. 
However, a comparable information concerning transport by electroosmosis is not 
available, although it could be anticipated to be probably more dependent on the skin 
properties as it relies on the membrane charge. However, previous studies by Hao and Li 
(2008) and Murthy et al. (2007) did not report any effect of nail thickness in the fluxes. 
Similarly our data seems to suggest the same, for example, if one compares the three sets 
of experiments performed by anodal iontophoresis at pH 7.4: Set II performed with the 
thickest group of nails (270 ± 10µm) provided the highest flux while Set I (220 ± 20µm) 
and III (230 ± 10µm) which were very similar in thickness provided very different 
mannitol fluxes.  
It could be hypothesized that nail permeability is related to their use or exposure to 
external factors. As an example, in every day life activities, the thumb and the forefinger 
are almost permanently under stress and their nails could either (a) have adapted to these 
aggressions by presenting a higher barrier to exogenous compounds (like the skin of the 
foot sole) or (b) be more damaged. Because nail tips have no mechanisms for “recovery” 
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this damage may result in a higher permeability. Thus, it was interesting to compare the 
results obtained with nail tips originating in different fingers. For example, Set II used only 
nails from the middle finger and Set III from the little finger. Fig. 15 shows that the results 
in Set III were consistently lower than those in Set II. There is not sufficient data at this 
point to be sure of the meaning of this observation which, ideally, should be confirmed in 
the future. Unfortunately, nails are very difficult to collect, which makes very hard the 
development of these systematic studies.  
Another important factor suggested by Hao et al. (2008) and by Gunt et al. (2006) is the 
effect of nail hydration over permeability. Nail hydration has been related to nail swelling 
which is considered to be a prerequisite for enhanced drug penetration (Khengar et al., 
2007) and Gunt et al. (2006) have related passive permeability across the nail with nail 
hydration. However, one would expect that all nails were similarly hydrated in our studies, 
and that would not be a cause of variability. On the other hand, it is interesting to notice 
that the level of hydration in previous studies have been much longer than in our work 
which obviously had an impact on the nails electrical resistance. Hao et al. (2008) soaked 
nails in PBS for 24 h prior to an experiment and Murthy et al. (2007) for 6 h in buffer. The 
increased hydration decreased the nail resistance dramatically so an Iomed Phoresor II 
(battery operated device) could be used for iontophoresis application. In this work, the 
nails were soaked for only 10-15 min in deionised water and therefore the resistance of the 
nails implied the use of a mains operated power supply able to maintain higher voltages. 
The use of this short time was based on a work from Wessel et al. (1999) who studied the 
nail hydration by NIR-FT-Raman spectroscopy and stated that “the water uptake of the nail 
showed a saturating effect after around 10 min” and on preliminary studies (not reported). 
It was also considered to represent a closer approach to a practical in vivo application. In 
any case, the different hydration times could cause inter-study differences but they cannot 
explain the inter-nail differences observed in our case. 
Finally, it has been suggested that some drugs such as salicylic acid, griseofulvin, 
terbinafine or itraconazole (Hui et al., 2002; Murthy et al., 2007a; Leyden, 1998) 
extensively bind to keratin in skin and nails. Drug binding can considerably delay transport 
across the membrane as the drug accumulates into the skin or the nail rather than diffuse to 
the receptor. Thus a final experiment was performed to examine whether mannitol binds to 
nails and if its binding could be a factor contributing to variability. The results are shown 
in the following section. 
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2. Mannitol binding 
Three nails cut in three pieces were placed in a 10 mM radioactive mannitol solution for 24 
h (see Materials and Methods) and the amount of mannitol accumulated into the nail 
during this time was determined with samples A1, B1 and C1. The remaining samples 
were left in buffer for one (A2, B2 and C2) or two weeks (A3, B3 and C3). This allowed 
for determination of mannitol released from the nail. It was expected that any significant 
binding to keratin would result in a considerable amount of mannitol remaining in the nails 
after one or two weeks. 
Table 11 and Fig. 16 show the amount and concentration of mannitol remaining in the nail 
at the end of each stage. 
 
Table 11. Mannitol recovered in each nail sample. 
 A1 A2 A3 B1 B2 B3 C1 C2 C3 
Mannitol amount (nmol) 13.60 5.71 0.89 18.56 2.91 1.06 10.40 2.00 1.15 
Sample dry mass (mg) 5.89 8.15 6.51 12.70 7.55 12.86 6.74 7.15 6.82 
Mannitol concentration 
(nmol/mg) 2.31 0.70 0.14 1.46 0.39 0.08 1.54 0.28 0.17 
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Fig. 16: Mannitol recovered from nails at 24h, one week and two weeks. 
 
The average nail content was 1.77 ± 0.47, 0.46 ± 0.22 and 0.13 ± 0.04 nmol/mg at 24 h, 
one week and two weeks, respectively. The content of mannitol in nails A, B and C 
decreased to 30, 28 and 18 % of the initial value after 1 week and to 6, 5 and 11 % after 
two weeks. The value show little inter-nail variability. 
The amount of mannitol release to the rinsing solutions was also measured (Fig. 17).  
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Fig. 17: Average mannitol (nmol) released by the nails in the rinsing solutions. 
 
The amount of mannitol recovered from the second rinses performed at 24 h was much 
smaller than the amount recovered from the first rinse or from the rinse at the middle of the 
first week. This showed that the mannitol recovered from the rinses after 24h was 
effectively coming from inside the nail and not from the surface. 
After one week, 0.46 ± 0.22 nmol of mannitol per mg remained in the nails (Fig. 16) and 
2.55 ± 4.61 nmol was found in the rinsing solutions (Fig. 17). By the end of the second 
week, only 0.13 ± 0.05 nmol of mannitol per mg remained in the nails and no mannitol was 
detectable in the rinsing solutions. On the whole these results showed that mannitol does 
not irreversibly bind to nail material. 
 
Conclusions of chapter 3 
The electroosmotic flux resulting from the application of iontophoresis to human nail tips 
has been studied using mannitol as a marker. It has been shown that mannitol transport was 
not hindered by binding to keratin. 
Due to the important inter-nail variability observed in the Set I, experiments keeping the 
same nail clippings all along the different stages were performed in order to minimize this 
phenomenon. Subsequent sets of experiments showed results which were in favour of a 
negative charge held by nails at physiological pH. However, values obtained during the 
three sets of experiments remained very different suggesting that the transport of drugs by 
electroosmosis may not be easily predictable. 
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Chapter 4:     
 Transungual iontophoresis of lithium and sodium:   
  Electromigration and transport numbers.  
 
 
Overview 
The use of iontophoresis to enhance drug penetration into and across the nail has been 
suggested. However, basic knowledge about the permselective properties of human nails 
and the behaviour of transungual iontophoretic fluxes are still missing. The previous 
chapter studied the iontophoretic transport of mannitol, a neutral and polar compound, as a 
marker of electroosmosis and nail permselectivity. This chapter investigates the 
transungual fluxes of sodium and lithium, two small inorganic cations. The objective was 
to investigate whether nails show cation permselectivity at physiological pH and to 
improve our understanding of transport numbers during transungual iontophoresis. The 
donor solutions comprised single ion and binary mixtures of the two cations at different 
pHs. Cationic transport numbers showed, at all the ratios studied, a clear increase when the 
pH was sequentially changed from 4.0 to 7.0 suggesting that human nails carry a net 
negative charge at physiological pH. Iontophoretic fluxes showed very low inter-nail 
variability and were clearly superior to passive fluxes, suggesting key differences between 
iontophoresis delivery governed by the electroosmotic and the electromigrative 
mechanisms of transport. Sodium transport number (i.e., the fraction of charge transported 
by this ion) was maximal when the ion was formulated as a single ion (no presence of 
competing co-ions) and decreased as the molar fraction of lithium was increased in the 
vehicle. The magnitude of the transport numbers measured and their response to changes in 
the cations’ molar fraction and pH in the donor solution were remarkably similar to those 
observed during transdermal iontophoresis. Another interesting similarity was the 
existence of a cationic transport number threshold. On the whole, this work provided some 
key information about nail permselectivity and transungual transport numbers which will 
help in developing this technique to efficiently deliver therapeutic compounds into the nail 
plate.  
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Introduction 
As discussed in the introduction chapter, iontophoresis is driven by electrorepulsion and 
electroosmosis. It has been demonstrated, at least in the case of transdermal iontophoresis 
(Guy et al., 2000), that electrorepulsion (or electromigration) is the most efficient of both 
mechanisms. The magnitude of the electromigrative fluxes resulting from the direct 
interaction of charged molecules with the electric field is given by Faraday’s law (Eq. 1): 
 
Ji = ti.I / Zi.F   Eq. 1  (Phipps et al. 1992) 
 
where Ji is the flux of the ion “i” in mol/sec, ti is the transport number of the ion “i”, I is the 
current intensity in coulombs/sec, Zi is the valence of the ion “i” and F is the Faraday 
constant (~  96500 coulomb/mol). 
When the electrical circuit is started, ions at both sides of the biological membrane 
compete for transporting the charge; and ions present in large concentrations and 
possessing high electrical mobilities will carry most of it. The transport number 
corresponds to the fraction of the total charge carried by a specific ion and is one of the key 
parameters that determine the feasibility of drug delivery by iontophoresis. The transport 
number of a given ion (drug) depends on the ability of the ion (drug) to be a charge carrier 
(electrical mobility) in the presence (relative concentration and electrical mobilities) of 
competing co- and counter-ions. Co-ions are the ions in the formulation presenting a 
charge of the same sign than the ion (drug) of interest and transporting charge from the 
vehicle into the body across the biological membrane. The presence of co-ions can be 
minimized with a judicious formulation. Counter-ions have an electrical charge of opposite 
sign than the ion (drug) of interest and carry charge from underneath the skin or nail into 
the formulation. The most important competing counter-ions are sodium and chloride due 
to their high mobility and concentration in the physiological fluids. Obviously, competition 
by counter-ions can not be avoided in an in vivo application and drug transport numbers 
are typically optimized by minimizing the sources of co-ions in the vehicle. It has been 
shown that maximum transport numbers during transdermal iontophoresis are measured 
(Luzardo-Alvarez et al., 2003; Mudry et al., 2006a) in the “single-ion” situation where 
competition only comes from the counter-ions (for example chloride ions in the case of 
cationic drug) arriving from the inner side of the membrane (Mudry et al., 2007). Further, 
it has been predicted by Kasting et al. (1989) and shown experimentally (Marro et al., 
2001a) that single-ion fluxes (Eq. 1) are independent of the drug concentration in the 
vehicle being solely controlled by the relative diffusivities of the two ions involved 
(positively charged drug and chloride ions present in the subdermal compartment): 
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tM = DM / (DM + DCl-)  Eq. 2 
 
where tM is the transport number of the drug, DM and DCl- are the diffusion coefficient of 
the ionic drug M and chloride ion, respectively. 
A “single ion” formulation provides the best transport numbers for a given drug however; 
practical issues (stability, pH, etc) usually require the introduction of additional 
components in a formulation. If possible, preference should be given to uncharged or low 
mobile species added at the lowest possible concentration so competition with the drug is 
minimized. Because of these practical issues it is fundamental to understand how transport 
numbers respond to the introduction of competing ions. Phipps.et al (1992) proposed an 
equation linking concentration, mobility and valence of the ions (Eq. 3): 
 
3.Eq
zc
zc
t
i
iii
ddd
d
∑
=
µ
µ
 
 
where td, cd, µ d and zd represent transport number, concentration, mobility and valence of 
the ionic drug, “d”, within the membrane, respectively. Eq. 3 emphasizes the importance of 
the ions mobility and concentration which are going to determine the extent of competition 
involved by the introduction of co-ions. 
Mudry et al (2006a and b) showed that the relative concentration of the drug with respect 
to that of competing co-ions (as expressed by the drug’s molar fraction) is a better 
predictor of the transport number than the drug’s nominal concentration in the formulation. 
For example, the transport number of lithium delivered from two binary solutions of 
sodium and lithium 20:20 and 100:100 mM was 0.21 ± 0.03 and 0.26 ± 0.05, this is due to 
the fact that lithium had the same molar fraction in both vehicles (Mudry et al., 2006b). A 
good linear relationship has been observed between the transdermal transport number of 
small ions and lidocaine (Marro et al., 2001a) and their molar fraction in the vehicle. 
Further, the transport number in the single ion situation was reasonably well predicted 
from the regression equation (Mudry et al., 2006a). 
The measurement of transport numbers during transdermal iontophoresis is standard; this 
is not the case in transungual iontophoresis. There are no systematic investigations on this 
matter and transport numbers of drugs have not been reported. For example, Hao et al., 
(2008a) have studied the anodal iontophoresis of tetraethylammonium which enhanced 
transport ~29 fold as compared to passive conditions but did not explore the effect of 
competing ions. Further, because the authors reported the results as permeability 
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coefficients and Peclet numbers, the available data does not provide any information about 
fluxes or transport numbers. Murthy et al (2007b) studied the cathodal delivery of salicylic 
acid across nail tips and included in their study the effect of drug concentration and of the 
ionic strength of the buffer. Salicylic acid fluxes increased with the drug concentration (0.2 
-2 mg/mL) as expected. In another series of experiments different amounts of sodium 
chloride (0 to 140 mM) were added to the 10 mM phosphate buffer saline containing 2 
mg/mL of the drug. The effect of the ionic strength of the donor solution on the drug flux 
was not clear, the drug flux unexpectedly increased (10-50 mM ionic strength) and then 
plateau/decreased when additional sodium chloride was introduced in the buffer (100-200 
mM ionic strength). According to the authors the results indicate the requirement of a 
minimal ionic strength for iontophoresis delivery. However, it should be noticed that the 
concentration of sodium chloride in the receiver (anodal) buffer was modified in parallel 
with the cathodal buffer. It is known that iontophoresis with anodal buffers containing 
none or little sodium chloride results in anomalous anodal electrochemistry at the Ag/AgCl 
anode (water electrolysis) and that the pH quickly turns very acidic in these conditions. 
Thus, a pH shift could also have modified the drug fluxes. In conclusion, the available 
literature offers very little information about ionic competition during nail iontophoresis 
and we addressed this lack of knowledge to facilitate a rational development of transungual 
iontophoretic drug delivery systems.  
The aims of this work were 1) to investigate the rules that govern ion competition and 
transport numbers during transungual iontophoresis and 2) to measure the transport 
numbers of sodium and lithium across the nail as an additional proof of nail 
permselectivity.  
 
Materials and Methods 
 
1. Materials 
Lithium chloride, sodium chloride, HEPES free acid (MW 238.3), magnesium chloride, 
hydrochloric acid, methanesulfonic acid, sodium hydroxide 50 % (Ion chromatography 
grade) and potassium hydroxide were obtained from Sigma Aldrich Co. (Gillingham, UK). 
Silver wire, silver chloride powder and platinum wire used to prepare the electrodes had a 
minimum purity of 99.99 % and were obtained from Sigma Aldrich Co. (Gillingham, UK). 
All aqueous solutions were prepared using high purity deionised water (18.2 MΩ.cm, 
Barnstead Nanopure DiamondTM, Dubuque, IA, USA). 
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2. Nails 
Ethical approval was granted by the Bath Local IRB and finger nail clippings were 
obtained from fourteen healthy volunteers who gave their written informed consent (see 
Appendix 3). The harvested nails were washed with deionised water and kept at room 
temperature in a dessicator until use. Prior to an experiment, the thickness of each nail was 
measured with a point micrometer (Point Anvil Micrometer, Mitutoyo, Andover, UK) as 
close as possible to the hyponychium. Each nail was then soaked in deionised water during 
10-15 minutes in order to recover some flexibility, and finally placed in 5 mm nail adapters 
(PermeGear Inc., Bethlehem, PA, USA). 
 
3. Sodium and lithium iontophoresis 
The nail adapter containing the fingernail clipping was clamped between the two halves 
(3.5 mL donor, 2 mL receptor, transport area of 0.2 cm2) of a side-by-side diffusion cell 
(PermeGear Inc., Bethlehem, PA, USA) with the nail dorsal surface facing the anodal 
chamber. Three replicates were performed for each experiment. The anodal chamber was 
filled with the respective donor solution (Table 1) containing either sodium as a single 
cation or a binary mixture of sodium and lithium ions. Both donor and receptor solutions 
were prepared in HEPES 5 mM and the pH was adjusted either with hydrochloric acid or 
with potassium hydroxide.  
 
Table 1: Experiment code and composition of the five donor solutions tested. 
Experiment code Donor  (HEPES 5 mM) 
A 100 mM NaCl 
B 50 mM NaCl and 25 mM LiCl 
C 50 mM NaCl and 50 mM LiCl 
D 50 mM NaCl and 250 mM LiCl 
E 50 mM NaCl and 500 mM LiCl 
 
The halide salts and their concentration in the anodal solution provided the necessary 
chloride ions for the anodal electrochemical reaction. 5 mM of MgCl2 was added to the 
receptor buffer to provide a source of chloride which represented the main endogenous 
competing ion and to avoid analytical interferences between the sodium and lithium peaks 
of the chromatogram. KOH was preferred for correcting the pH of the buffer solution to 
avoid the introduction of sodium ions. The HEPES concentration was reduced to the 
minimum that would keep a constant pH throughout the experiments. HEPES is a 
switterion and has a pKa1 ~3 and a pKa2 ~7.55. Therefore, it is expected that HEPES will 
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be mainly transported by electroosmosis at both pH experimented and will not compete 
with lithium and sodium. 
Following the observations on inter-nail variability reported in the previous chapter the 
parameters investigated (pH and molar fraction) were compared in the same nail. The pH 
of the HEPES buffered solutions was identical on both sides of the nail and was 
sequentially modified from 4.0 to 5.0 and then from 5.0 to 7.0. Each pH stage, started with 
16 hours of passive diffusion followed by 8 hour of 0.2 mA direct constant current 
iontophoresis applied via homemade Ag/AgCl electrodes (Green et al., 1991) and a power 
supply (Kepco APH 1000M, Flushing, NY, USA). All the experiments started by passive 
diffusion and it was possible to connect all the nails in series without involving any “pre-
treatment” (at the opposite of the confocal microscopy and mannitol experiments in the 
previous chapters). Figure 1 represents schematically the experimental design followed.  
 
0 10 20 30 40 50 60 70 80
3
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passive Iontophoresis Sampling time
time (h)
pH
 
Figure 1: Schematic diagram of the experimental design. A discontinued line indicates passive diffusion 
while the continuous line represents the iontophoretic stage. 
 
The whole content of the receptor chamber (2 mL) was sampled and refilled with fresh 
receptor buffer at the end of the passive diffusion step (16 hours) and every 2 hours during 
iontophoresis. At the end of each pH stage, both chambers were rinsed at least 3 times with 
the respective donor and receptor solutions at the pH subsequently tested. 
 
4. Cation quantification 
Ion chromatography (IC) with suppressed conductivity detection (AS50 autosampler and 
thermal compartment, GP50 gradient pump, ED50 electrochemical detector, Chromeleon 
software, Dionex, Sunnyvale, CA) was used to measure the concentrations of sodium and 
lithium in all samples. 25 mM methanesulfonic acid eluent was pumped under isocratic 
conditions (1 mL/min) through an IonPacTM CS12A column (Dionex, 250 x 4 mm) 
thermostated at 30ºC and a CSRS ULTRA II suppressor (Dionex, 4 mm) set at a current of 
80 mA. The concentrations of Na+ and Li+ in the samples were measured against 
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calibration curves obtained at the adequate pH. Calibration curves were prepared at pH 4.0, 
5.0 and 7.0 with at least seven standard solutions, ranging from 50 µM to 5 mM, prepared 
in 5 mM HEPES buffer containing 5 mM MgCl2. Standard solutions contained both NaCl 
and LiCl at the same concentration at the pH 4.0, 5.0 and 7.0. For both cations, the 
measurement error was below 5 %. 
 
5. Data analysis and statistics 
Cationic fluxes for each sampling period were directly determined by dividing the amount 
of ion delivered to the receptor solution (as determined by IC) by the corresponding time.  
The results showed that iontophoretic fluxes were not stable by the end of the experiments. 
Therefore, the use of an average 0-8 hours iontophoretic flux would not be appropriate and 
the 6-8 hours iontophoretic flux, expected to be the closest to the steady value, was used 
for all comparisons. 
Cationic transport numbers were calculated using the previously described Faraday’s law 
(Eq. 1). 
Linear regressions and statistics were performed using Graph Pad Prism V5.00 (Graph Pad 
Software Inc., San Diego, CA).  
Sodium and lithium fluxes and their transport numbers measured at different pH were 
compared by one way ANOVA followed by a Tukey’s post-test. The level of statistical 
significance was fixed at p < 0.05. All linear regression presented were significant (p < 
0.05) unless otherwise indicated. All data are presented as mean and standard deviation 
unless otherwise stated. 
 
Results and discussion 
 
1. Sodium and lithium iontophoresis 
Table 2 shows the characteristics of the nails used according to the donor composition: 
origin – namely, participant’s gender and age – and thickness that were used for each 
experiment. The nail average thickness was 240 ± 10 µm for experiment A, 340 ± 50 µm 
for B, 280 ± 40 µm for C, 380 ± 80 µm for D and 270 ± 20 µm for E. On the whole, the 15 
nails used came from 8 participants. The age of the participants ranged from 21 to 52 years 
old, only one of whom was a male. 
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Table 2: Nails used for lithium and sodium experiments. 
Experiment  
code 
NaCl:LiCl concentration (mM) 
[XNa+ : XLi+ #] 
Nail code * Gender  
Age 
(year) 
Thickness 
(µm) 
2LF4 Female 26 230 
7LF4 Female 28 250 A 
100:0 
[1:0] 
12LF4 Female 22 230 
2RF1 Female 26 340 
4LF1 Female 44 290 B 
50:25 
[0.67:0.33] 
14LF1 Female 52 380 
7LF3 Female 28 280 
12LF3 Female 22 250 C 
50:50 
[0.5:0.5] 
14LF3 Female 52 320 
5LF2 Male 33 460 
12LF2 Female 22 310 D 
50:250 
[0.17:0.83] 
13LF2 Female 21 320 
4LF4 Female 44 250 
10RF4 Female 25 290 E 
50:500 
[0.09:0.91] 
12RF4 Female 22  250 
#
 X stands for molar fraction 
* The first digit in the nail code indicates the participant number, L or R indicates left or right hand and 
F+digit indicates the finger where F1 = thumb. 
 
As a first clear difference with the previous chapter, all the experiments on cation 
iontophoresis indicated that current application caused a clear enhancement of lithium and 
sodium transport as compared to passive diffusion.  
A second difference was the reduced variability observed in cation electromigration as 
compared with mannitol electroosmosis. 
A third difference lies on the voltage measured for the three cells in series. At the 
beginning of each iontophoretic period, the voltage was between 11 and 130 V (usually 30-
60 V). At 2 hours and at 8 hours, the voltage ranged between 14 and 47 V and 11 and 31 
V, respectively. It is assumed that the application of the current without pre-treatment was 
possible thanks to the 16-hour passive stage applied before each iontophoretic period 
resulting in an increase of the nails hydration and a decrease of the nails resistance. 
A considerable amount of data was generated during these experiments which are 
organized in the following manner: 
• Figures 2 to 6 show the sodium and lithium fluxes measured for each nail, donor 
composition, pH and sampling time. Tables 3 to 11 show the corresponding 
average (± SD) cationic fluxes and transport numbers.  
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• Figures 7 to 11 show the 8 hours sodium and lithium iontophoretic fluxes (mean ± 
SD) as a function of pH. Statistical differences found are shown as appropriate. 
• Figures 12 to 16 show the 8 hours sodium and lithium transport numbers (mean ± 
SD) as a function of pH. Statistical differences found are shown as appropriate. 
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Fig. 2: Passive and iontophoretic sodium fluxes measured for each nail during experiment A (100:0). 
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Fig. 3: Passive and iontophoretic sodium and lithium fluxes measured for each nail during experiment B 
(50:25) 
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Fig. 4: Passive and iontophoretic sodium and lithium fluxes measured for each nail during experiment C 
(50:50). 
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Fig. 5: Passive and iontophoretic sodium and lithium fluxes measured for each nail during experiment D 
(50:250). 
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Fig. 6: Passive and iontophoretic sodium and lithium fluxes measured for each nail during experiment E 
(50:500). 
 
Table 3: Passive and iontophoretic fluxes (µmol/h) and transport numbers of sodium (tNa+) during 
experiment A (100:0). The data shows the mean ± the standard deviation of three replicates. 
pH 4.0 pH 5.0 pH 7.0 
Time (h) 
Flux tNa+ 
Time (h) 
Flux tNa+ 
Time (h) 
Flux tNa+ 
16 0.09 ± 0.11 passive 40 0.28 ± 0.13 passive 64 0.06 ± 0.01 passive 
18 3.03 ± 0.38 0.41 ± 0.05 42 3.42 ± 0.24 0.46 ± 0.03 66 4.85 ± 0.39 0.65 ± 0.05 
20 2.98 ± 0.52 0.40 ± 0.07 44 3.65 ± 0.38 0.49 ± 0.05 68 5.95 ± 0.60 0.80 ± 0.08 
22 2.77 ± 0.27 0.37 ± 0.04 46 3.79 ± 0.23 0.51 ± 0.03 70 6.31 ± 0.55 0.85 ± 0.07 
24 2.63 ± 0.21 0.35 ± 0.03 48 4.02 ± 0.35 0.54 ± 0.05 72 6.59 ± 0.36 0.88 ± 0.05 
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Table 4: Passive and iontophoretic fluxes (µmol/h) and transport numbers of sodium (tNa+) during 
experiment B (50:25). The data shows the mean ± the standard deviation of three replicates. 
pH 4.0 pH 5.0 pH 7.0 
Time (h) 
Flux tNa+ 
Time (h) 
Flux tNa+ 
Time (h) 
Flux tNa+ 
16 0.03 ± 0.11 passive 40 0.03 ± 0.00 passive 64 0.05 ± 0.00 passive 
18 1.52 ± 0.20 0.20 ± 0.03 42 2.03 ± 0.20 0.27 ± 0.03 66 2.90 ± 0.11 0.39 ± 0.01 
20 1.81 ± 0.37 0.24 ± 0.05 44 2.60 ± 0.24 0.35 ± 0.03 68 3.09 ± 0.38 0.41 ± 0.05 
22 2.03 ± 0.59 0.27 ± 0.08 46 2.69 ± 0.08 0.36 ± 0.01 70 3.37 ± 0.28 0.45 ± 0.04 
24 2.07 ± 0.69 0.28 ± 0.09 48 3.04 ± 0.17 0.41 ± 0.02 72 3.54 ± 0.30 0.47 ± 0.04 
 
Table 5: Passive and iontophoretic fluxes (µmol/h) and transport numbers of lithium (tLI+) during experiment 
B (50:25). The data shows the mean ± the standard deviation of three replicates. 
pH 4.0 pH 5.0 pH 7.0 
Time (h) 
Flux tLi+ 
Time (h) 
Flux tLi+ 
Time (h) 
Flux tLi+ 
16 0.00 passive 40 0.01 ± 0.00 passive 64  0.01 ± 0.00 passive 
18 0.49 ± 0.07 0.07 ± 0.01 42 0.67 ± 0.05 0.09 ± 0.01 66 1.08 ± 0.04 0.15 ± 0.01 
20 0.64 ± 0.15 0.09 ± 0.02 44 0.88 ± 0.08 0.12 ± 0.01 68 1.19 ± 0.16 0.16 ± 0.02 
22 0.72 ± 0.21 0.10 ± 0.03 46 0.92 ± 0.05 0.12 ± 0.01 70 1.31 ± 0.13 0.18 ± 0.02 
24 0.73 ± 0.23 0.10 ± 0.03 48 1.05 ± 0.02 0.14 ± 0.00 72 1.37 ± 0.14 0.18 ± 0.02 
 
Table 6: Passive and iontophoretic fluxes (µmol/h) and transport numbers of sodium (tNa+) during 
experiment C (50:50). 
pH 4.0 pH 5.0 pH 7.0 
Time (h) 
Flux tNa+ 
Time (h) 
Flux tNa+ 
Time (h) 
Flux tNa+ 
16  0.01 ± 2.10-3 passive 40  0.02 ± 0.01 passive 64  0.07 ± 0.08 passive 
18 1.09 ± 0.23 0.15 ± 0.03 42 1.43 ± 0.21 0.19 ± 0.03 66 2.34 ± 0.38 0.31 ± 0.05 
20 1.65 ± 0.31 0.22 ± 0.04 44 1.84 ± 0.16 0.25 ± 0.02 68 2.48 ± 0.69 0.33 ± 0.09 
22 1.82 ± 0.16 0.24 ± 0.02 46 1.77 ± 0.35 0.24 ± 0.05 70 3.06 ± 0.40 0.41 ± 0.05 
24 1.79 ± 0.15 0.24 ± 0.02 48 1.91 ± 0.09 0.26 ± 0.01 72 3.14 ± 0.41 0.42 ± 0.05 
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Table 7: Passive and iontophoretic fluxes (µmol/h) and transport numbers of lithium (tLi+) during experiment 
C (50:50). 
pH 4.0 pH 5.0 pH 7.0 
Time (h) 
Flux tLi+ 
Time (h) 
Flux tLi+ 
Time (h) 
Flux tLi+ 
16  2.10-3 ± 1.10-3 passive 40  0.02 ± 3.10-3 passive 64  0.01 ± 2.10-3 passive 
18 0.87 ± 0.34 0.12 ± 0.05 42 0.98 ± 0.17 0.13 ± 0.02 66 1.83 ± 0.33 0.25 ± 0.04 
20 1.13 ± 0.24 0.15 ± 0.03 44 1.29 ± 0.12 0.17 ± 0.02 68 1.97 ± 0.57 0.26 ± 0.08 
22 1.23 ± 0.11 0.16 ± 0.01 46 1.26 ± 0.23 0.17 ± 0.03 70 2.47 ± 0.36 0.33 ± 0.05 
24 1.23 ± 0.11 0.17 ± 0.01 48 1.35 ± 0.07 0.18 ± 0.01 72 2.58 ± 0.31 0.35 ± 0.04 
 
Table 8: Passive and iontophoretic fluxes (µmol/h) and transport numbers of sodium (tNa+) during 
experiment D(50:250). 
pH 4.0 pH 5.0 pH 7.0 
Time (h) 
Flux tNa+ 
Time (h) 
Flux tNa+ 
Time 
(h) Flux tNa+ 
16  2.10-3 ± 1.10-3 passive 40  0.02 ±  5.10-3 passive 64  0.02 ± 8.10-3 passive 
18 0.78 ± 0.09 0.10 ± 0.01 42 0.71 ± 0.06 0.09 ± 0.01 66 0.85 ± 0.11 0.11 ± 0.02 
20 0.82 ± 0.14 0.11 ± 0.02 44 0.80 ± 0.12 0.11 ± 0.02 68 1.05 ± 0.10 0.14 ± 0.01 
22 0.86 ± 0.15 0.12 ± 0.02 46 0.80 ± 0.04 0.11 ± 0.01 70 1.09 ± 0.06 0.15 ± 0.01 
24 0.92 ± 0.04 0.12 ± 0.01 48 0.86 ± 0.09 0.11 ± 0.01 72 1.21 ± 0.13 0.16 ± 0.02 
 
Table 9: Passive and iontophoretic fluxes (µmol/h) and transport numbers of lithium (tLi+) during experiment 
D (50:250). 
pH 4.0 pH 5.0 pH 7.0 
Time (h) 
Flux tLi+ 
Time (h) 
Flux tLi+ 
Time (h) 
Flux tLi+ 
16  2.10-3 ± 2.10-3 passive 40  0.04 ± 4.10-3 passive 64  0.04 ± 3.10-3 passive 
18 2.52 ± 0.47 0.34 ± 0.06 42 2.66 ± 0.32 0.36 ± 0.04 66 3.44 ± 0.57 0.46 ± 0.08 
20 3.20 ± 0.54 0.43 ± 0.07 44 2.93 ± 0.52 0.39 ± 0.07 68 4.22 ± 0.48 0.57 ± 0.06 
22 3.36 ± 0.58 0.45 ± 0.08 46 2.96 ± 0.10 0.40 ± 0.01 70 4.58 ± 0.18 0.61 ± 0.02 
24 3.51 ± 0.25 0.47 ± 0.03 48 3.30 ± 0.46 0.44 ± 0.06 72 5.08 ± 0.73 0.68 ± 0.10 
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Table 10: Passive and iontophoretic fluxes (µmol/h) and transport numbers of sodium (tNa+) during 
experiment E (50:500). 
pH 4.0 pH 5.0 pH 7.0 
Time (h) 
Flux tNa+ 
Time (h) 
Flux tNa+ 
Time (h) 
Flux tNa+ 
16  0.02 ± 6.10-3 passive 40  0.02 ±  0.01 passive 64  0.02 ± 8.10-3 passive 
18 0.25 ± 0.04 0.03 ± 0.01 42 0.33 ± 0.02 0.04 ± 0.00 66 0.51 ± 0.06 0.07 ± 0.01 
20 0.33 ± 0.02 0.04 ± 0.00 44 0.37 ± 0.02 0.05 ± 0.00 68 0.59 ± 0.09 0.08 ± 0.01 
22 0.35 ± 0.02 0.05 ± 0.00 46 0.37 ± 0.02 0.05 ± 0.01 70 0.62 ± 0.07 0.08 ± 0.01 
24 0.35 ± 0.02 0.05 ± 0.00 48 0.39 ± 0.02 0.05 ± 0.00 72 0.66 ± 0.09 0.09 ± 0.01 
 
Table 11: Passive and iontophoretic fluxes (µmol/h) and transport numbers of lithium (tLi+) during 
experiment E (50:500) 
pH 4.0 pH 5.0 pH 7.0 
Time (h) 
Flux tLi+ 
Time (h) 
Flux tLi+ 
Time (h) 
Flux tLi+ 
16 0.02 ± 0.00 passive 40  0.06 ± 3.10-3 passive 64  0.07 ± 7.10-3 passive 
18 1.73 ± 0.27 0.23 ± 0.04 42 2.22 ± 0.09 0.30 ± 0.01 66 3.44 ± 0.36 0.46 ± 0.05 
20 2.25 ± 0.27 0.30 ± 0.04 44 2.39 ± 0.18 0.32 ± 0.02 68 3.95 ± 0.53 0.53 ± 0.07 
22 2.41 ± 0.30 0.32 ± 0.04 46 2.48 ± 0.21 0.33 ± 0.03 70 4.27 ± 0.50 0.57 ± 0.07 
24 2.40 ± 0.20 0.32 ± 0.03 48 2.62 ± 0.24 0.35 ± 0.03 72 4.47 ± 0.46 0.60 ± 0.06 
 
To the best of our knowledge this is the first time that passive and iontophoretic fluxes of 
sodium and lithium across the nail have been reported. Both cations were easily measured 
in passive and iontophoretic samples.  
Lithium was introduced as a competing ion in these experiments because of similar 
previous experiments done with skin and because it can be considered as an exogenous ion 
and thus, it can assess the effective transport of the two cations across the nail plate. 
Indeed, trace amounts of sodium (19 µmol/g of nail) have been found in nails (Walters et 
al., 1983a; Vellar, 1970) and thus, it seemed sensible to study sodium delivery along with 
lithium delivery to characterize the cations electrorepulsive flux. Therefore, lithium fluxes 
reported here originate not from the nail (as could be the case for the ubiquitous sodium) 
but from the donor solution and thus, showed that lithium has been transported across the 
complete nail thickness. It could be concluded that the iontophoretic transport of small 
inorganic ions is relatively fast.  
On one hand, Murthy et al. (2007b) reported a lag time of ~8 h for salicylic acid during 
iontophoresis and passive diffusion and Hao et al. (2008a) found that the lag time for 
mannitol was around 12 h during passive diffusion. In our case, no conclusion can be 
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drawn on the passive lag time as only one sample was taken during this period. Although 
iontophoresis provoked a very quick response for both cations, iontophoretic fluxes had 
not completely stabilized after 8 hours of current application and this delay was more 
evident at pH 7.0. Hao et al. (2008a) reported that the iontophoretic fluxes of 
tetraethylammonium were not stable even after 36 h of current applications. However, 
comparison of the data is difficult given the different experimental conditions applied. It 
must be noticed that the concept of steady-state in passive diffusion is not applicable to 
iontophoresis. In fact, the factors determining the iontophoretic fluxes stability are not 
known: factors such as depletion of the membrane ion reservoir have been cited (Nixon et 
al., 2007; Wascotte et al., 2008) but the role played by the ion physicochemical properties 
has not been clarified.  
The iontophoretic fluxes of both lithium and sodium were always greater than their 
respective passive controls. Iontophoretic fluxes were 13 to 615 fold more than passive 
diffusion. Another interesting observation is that passive fluxes fall to pre-iontophoresis 
values upon current termination suggesting that the nail permeability had not been 
permanently damaged (increased) by current application.  
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Fig. 7: Sodium flux (Mean ± SD) measured after 8 hours of iontophoresis during experiment A (100:0). ** 
and *** denote a very significant (p = 0.001 to 0.01) and an extremely significant (p < 0.001) difference 
respectively. 
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Fig. 8: Sodium and lithium fluxes (Mean ± SD) measured after 8 hours of iontophoresis during experiment B 
(50:25). * indicates a significant (p = 0.01 to 0.05) difference. 
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Fig. 9: Sodium and lithium fluxes (Mean ± SD) measured after 8 hours of iontophoresis during experiment C 
(50:50). ** indicates a very significant (p = 0.001 to 0.01) difference. 
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Fig. 10: Sodium and lithium fluxes (Mean ± SD) measured after 8 hours of iontophoresis during experiment 
D (50:250). * indicates a significant (p = 0.01 to 0.05) difference. 
 
pH 4.0 pH 5.0 pH 7.0
0
2
4
6
Sodium
**
**
flu
x
 
(µm
o
l/h
)
 
pH 4.0 pH 5.0 pH 7.0
0
2
4
6
Lithium
**
**
flu
x
 
(µm
o
l/h
)
 
Fig. 11. Sodium and lithium fluxes (Mean ± SD) measured after 8 hours of iontophoresis during experiment 
E (50:500). ** indicates a very significant (p = 0.001 to 0.01) difference.  
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Fig. 12: Sodium transport number (Mean ± SD) after 8 hours of iontophoresis during experiment A (100:0). 
** and *** denote a very significant (p = 0.001 to 0.01) and an extremely significant (p < 0.001) difference 
respectively. 
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Fig. 13: Sodium and lithium transport numbers (Mean ± SD) after 8 hours of iontophoresis during 
experiment B (50:25). * indicates a significant (p = 0.01 to 0.05) difference. 
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Fig. 14: Sodium and lithium transport numbers (Mean ± SD) after 8 hours of iontophoresis during 
experiment C (50:50). ** indicates a very significant (p = 0.001 to 0.01) difference. 
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Fig. 15: Sodium and lithium transport numbers (Mean ± SD) after 8 hours of iontophoresis during 
experiment D (50:250). * indicates a significant (p = 0.01 to 0.05) difference. 
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Fig. 16: Sodium and lithium transport numbers (Mean ± SD) after 8 hours of iontophoresis during 
experiment E (50:500). ** indicates a very significant (p = 0.001 to 0.01) difference. 
 
Two main observations are easily drawn from these data: 
1. Sodium and lithium fluxes and transport numbers (Figs 7 to 16, Tables 3 to 11) 
increased with the pH of the bathing solutions. The effect was more evident and often 
statistically significant when the pH was raised to 7.0. The results suggest that the nail net 
charge is positive at pH 4 and negative at pH 7.0. It follows that the nail would exhibit 
anion permselectivity at low pH and cation permselectivity (shown in cationic transport 
numbers > 0.5) at pH 7.0. 
2. Sodium and lithium fluxes and transport numbers (Figs 7 to 16, Tables 3 to 11) were 
clearly related to the molar fraction and mobility of each cation. tNa+ decreases 
progressively as the concentration of competing lithium is increased. tLi+ continuously 
increased as the donor solution became richer in this ion. The effect of molar fraction and 
mobility on tNa+ and tLi+ is very similar to that observed during transdermal iontophoresis 
(Mudry et al., 2006 a). The results are next discussed in detail.  
 
2. Effect of cation mobility and concentration ratio on cationic transport numbers 
Phipps and Gyory (1992) proposed a model to predict transport numbers during 
transdermal iontophoresis (Eq. 3). The model assumes: (1) the biological membrane to be 
homogenous and uncharged, (2) constant current application and (3) the total cation 
concentration at the anodal chamber to be the same as the anion concentration at the 
cathodal solution.   
 
∑
=
i
iii
ddd
d
zc
zc
t
µ
µ
 Eq. 3 
 
where ti, ci, µ i and zi represent transport number, concentration, mobility and valence of the 
ion, “i”, within the membrane, respectively. The sum term includes all ions on both sides 
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of the membrane, thus chloride, lithium and sodium (considering negligible the 
contribution of the HEPES charged species). 
The above equation indicates that both concentration and mobility are equally important in 
determining the magnitude of transport numbers. If lithium and sodium (having the same 
valence) were present at equal concentration in the donor solution, their transport numbers 
would be different unless their respective mobilities in the membrane were the same. In 
fact, it has been shown for the skin (Mudry et al., 2006a), and now for the nail (Experiment 
C, Figs 9 and 14, Tables 6 and 7) that tLi+ was lower than tNa+ in these conditions. This 
suggests the mobility of lithium in the nail and the skin to be lower than that of sodium, 
which is in agreement with their respective aqueous mobilities of 4.01 and 5.19 x 10-4 
cm2.s−1.V−1 for lithium and sodium respectively (Brett et al., 1993). 
It was interesting to test the validity of Eq. 3 even when most of the assumptions are 
clearly not respected in skin and nail iontophoresis. Further, the values of ion mobility and 
concentration in the membrane are not necessarily the same as the aqueous mobility and 
concentration in the donor formulation are those usually known.  
Eq. 3 can be rewritten for sodium and lithium transport numbers. Chloride is the counter-
ion and all ions are monovalent (z =1). This gives Eq. 4 and 5: 
 
tNa+ = (CNa+ . µNa+) / (CLi+ . µLi+ + CNa+ . µNa+ + CCl- . µCl-) Eq. 4 
 
tLi+ = (CLi+ . µLi+) / (CLi+ . µLi+ + CNa+ . µNa+ + CCl- . µCl-) Eq. 5 
 
By multiplying numerator and denominator in Eq. 5 by (CNa+ . µNa+) the following 
expression (Eq. 6) is obtained: 
 
tLi+ = (CLi+ . µLi+) . (CNa+ . µNa+) / (CNa+ . µNa+)(CLi+ . µLi+ + CNa+ . µNa+ + CCl- . µCl-  Eq. 6 
 
which can be rearranged by use of Eq. 4 to give Eq. 7: 
 
tLi+ = tNa+ . (CLi+ . µLi+ ) / (CNa+ . µNa+)  Eq. 7 
 
and Eq. 8: 
 
tLi+ / tNa+ = (CLi+ / CNa+) . (µLi+ / µNa+)  Eq. 8 
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Eq. 8 predicts that the ratio of lithium and sodium transport numbers is directly related to 
their relative concentration and mobility inside the membrane.  
If ion mobilities were independent of ion concentration and pH, the ratio (µLi+ / µNa+) 
would be constant for each series of experiments performed at a given pH. If this is true, 
the ratio tLi+ / tNa+ would be linearly dependent on the cations concentration ratio (CLi+ / 
CNa+). The validity of this relationship has been investigated and the results are shown in 
Fig. 17 for the nail experiments at pH 4, 5 and 7. The same approach (Fig. 18) was used for 
transdermal iontophoresis plotting data previously reported (Mudry et al., 2006a). The 
results of the linear regression analysis are presented in Table 12.  
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Fig. 17: Relationship between the ratio of lithium and sodium transport numbers (tLi+/tNa+ calculated from the 
average transport number values) measured during transungual iontophoresis at three different pHs and the 
ratio of cation concentration in the donor solution ([Li+]/[Na+]). All linear regressions were significant (p < 
0.05) with r2 > 0.98.  
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Fig. 18: Relationship between the ratio of lithium and sodium transport numbers (tLi+/tNa+) measured during 
transdermal iontophoresis and the ratio of cation concentration in the donor solution ([Li+]/[Na+]). The linear 
regression was significant (p < 0.05) with  r2 > 0.9) (Data taken from Mudry et al., 2006a). 
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Table 12: Linear regression analysis examining the dependence of the ratio of cation transport number (tLi+ / 
tNa+ ) on the ratio of cation concentration (CLi+ / CNa+) according to Eq. 8: tLi+ / tNa+ = (CLi+ / CNa+) . (µLi+ / 
µNa+). The values of the slope (µLi+ / µNa+) and Y-intercept are reported as estimate ± SE 
 pH Y intercept Slope (µLi+ / µNa+). r2 
4.0 0.19 ± 0.31 0.65 ± 0.05 0.99 
5.0 0.06 ± 0.23 0.71 ± 0.04 0.99 Nail 
7.0 0.28 ± 0.39 0.67 ± 0.07 0.98 
Pig skin(1) 5-6 -0.01 ± 0.02 0.79 ± 0.03 0.99 
(1) Data taken from Mudry et al., 2006a. 
 
Figures 17-18 and Table 12 show that equation 8 fits well the data; a very good linear 
relationship between the ratio of cation transport numbers and the ratio of cation 
concentration was observed in nail and skin. The lithium-to-sodium mobility ratio ranged 
between 0.65 and 0.71 in nail experiments and was 0.79 for the skin. These values are 
remarkably similar among them. Further, the ratio of the aqueous mobility of lithium and 
sodium is 0.77 (4.01 x10-4 for lithium and 5.19 x10-4 cm2.s−1.V−1 for sodium (Brett et al., 
1993)). It seems that the mobility ratios (µLi+ / µNa+) in nails, skin and water are fairly 
similar. This suggests that the ionic pathway followed by small inorganic ions across nail 
and skin has a certain hydrophilic nature.  
 
3. Effect of cation molar fraction on cationic transport number 
It has been demonstrated that cations transport number in in vivo and in vitro transdermal 
iontophoresis are linearly dependent to their molar fraction in the vehicle (Mudry et al. 
2006b). The relationship is described by Eq.(9): 
 
tC+ = a.XC+ + b  Eq. 9 
 
where tC+ is the transport number of the cation C+, “a” is the slope of the linear regression, 
XC+ is the molar fraction of cation C+ in the donor aqueous solution and “b” is the intercept 
of the linear regression with the Y axis. 
Further, it has been shown that by substitution of XC+ = 1 in the above equation, the value 
of the transport number in the “single-ion” situation (tC+,SI) could be reasonably well 
predicted. Finally the slope of the linear regression was directly related to the aqueous 
mobility of the ion considered. For example, when the aqueous mobilities of lidocaine, 
lithium and sodium were 1.5, 4.01 and 5.19 x10-4 cm2.s−1.V−1 respectively, the values of 
the slopes were 0.18, 0.54 and 0.56 for lidocaine, lithium and sodium, respectively (Mudry 
et al., 2006b). It seemed interesting to examine the validity of this relationship during 
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transungual iontophoresis and for this, sodium and lithium transport numbers were plotted 
against their respective molar fraction (Fig. 19) in the donor solution. The analysis of 
regression was done for each pH and cation and the results are summarised in Table 13. 
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Fig. 19: Linear relationships between cation transport number (tC+) and molar fraction (xC+). The transport 
numbers were determined in experiments involving binary ion donor solutions. The symbols represent 
experimental values and the lines are linear regressions. All r2 > 0.78. All regressions were significant 
(p<0.05) except for tLi+ versus XLi+ at pH 4 and 5.  
 
Table 13: Linear regression analysis examining the dependence of cation transport number (tC+) on molar 
fraction (XC+): tC+ = a XC+ + b. The values of the slope (a) and Y-intercept (b) are reported as estimate ± SE. 
The experimental transport numbers in the “single-ion” situation (tC+, SI) for sodium are also presented. 
Lithium Sodium 
  
a b a b 
Experimental 
tNa+, SI  
pH 4.0 0.54 ± 0.20 -0.08 ± 0.10 0.38 ± 0.06 0.04 ± 0.02 0.35 ± 0.03 
pH 5.0 0.48 ± 0.15 -0.03 ± 0.10 0.57 ± 0.06 4.10-3 ± 0.03 0.54 ± 0.05 Nail 
pH 7.0 0.84 ± 0.16 -0.10 ± 0.11 0.61 ± 0.12 0.05 ± 0.05 0.88 ± 0.05 
Skin pH 5-6(1) 0.54 ± 0.01 
-0.01 ± 
1.10-3 
0.56 ± 0.02 0.06 ± 0.01 0.59 ± 0.06 
(1)
 Mudry et al. (2006 b), pig skin. 
 
The slopes of the regressions obtained with nail data increased clearly with the pH. As 
previously discussed the value of the slope is an excellent predictor of the transport number 
in the single ion situation and is directly related to the ion aqueous mobility. Thus the data 
in Table 13 indicates that sodium and lithium transport numbers in the single ion situation 
increase with pH. This agrees with the experimental data. We believe the increase in the 
values to reflect the switch from anion to cation permselectivity in the nail which translates 
into higher transport numbers at pH 7.  
The transport numbers measured during transdermal and transungual iontophoresis are also 
in a relatively good agreement. It should be noticed that the values in Table 13 were 
obtained with dermatomed frozen pig skin and were used in the Table because of the very 
similar experimental conditions followed in both this and Mudry’s work. However, the 
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variation of sodium transport number with pH has also been reported for human skin. For 
example, Kasting et al. (1990) used frozen dermatomed (0.25 µm) human skin and PBS 
buffer finding that tNa+ was 0.24 and 0.51 at pH 4.0 and pH 7.4, respectively. Burnette et al. 
(1987) used freshly excised dermatomed (0.8 mm) human skin and pH 7.4 HEPES buffer 
finding that tNa+ was 0.62. Given the variability observed for the same skin model and for 
different skin models (pig versus human skin) it could be considered that the difference 
between nails and skin is relatively low.  
It remains to be seen if the relationship here observed between the transungual transport 
number of an ion and its molar fraction in the vehicle can be extended to therapeutic 
molecules. If that is the case, drug transport numbers in the “single-ion” situation could be 
predicted from experiments performed in binary mixtures, as it has been shown for 
lidocaine and lithium in transdermal iontophoresis (Mudry et al., 2006b). This is handy in 
the case of cationic drug not available as chlorhydrate salts or possessing limited solubility 
that must be combined with chloride salts in the anodal formulation. 
 
4. Total cationic transport number (Σ tC+= tNa+ + tLi+).  
Mudry et al. (2006a) measured the transport numbers of small inorganic ions (lithium, 
sodium, ammonium and potassium), in “single-ion” formulation and in binary and 
quaternary vehicles during transdermal iontophoresis. It was observed that the total 
cationic transport number (Σ tC+), defined as the sum of the transport number of the cations 
present in solution, was remarkably similar despite of the big variation in total cation 
concentration used in these experiments. This suggests that it is not possible to eliminate 
completely chloride competition from underneath the skin, and the existence of a cationic 
threshold ranging between 0.65 and 0.85 for a total ionic concentration of 125 to 200 mM. 
Thus, unless extreme differences are introduced in the overall mobility of a donor (anodal) 
formulation, changes in the vehicle composition will result in a re-arrangement of the 
cations transport numbers but chloride transport number will remain unchanged. For 
example, if a drug is present in a buffer, additional amounts of sodium chloride to the 
buffer will reduce the transport number of the drug, but will not decrease that of chloride. 
Based on these observations, we have calculated the total cation transport number in all our 
experiments as defined by Σ tC+= tNa+ + tLi+. The values are shown in Fig. 20.  
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Fig 20: Total cation transport number (Σ tC+= tNa+ + tLi+.) at the 8 hour sampling and for each experiment and 
pH. The symbols *, **, and *** indicate a significant (p = 0.01 to 0.05), very significant (p = 0.001 to 0.01) 
and extremely significant (p < 0.001) difference.  
 
Fig. 20 shows that Σ tC+ increased with pH, pointing towards a modification in nail 
permselectivity. It must be noticed that the experiments involved very different total cation 
ionic concentration in the donor solution, which ranged from 75 mM (Expt B) to 550 mM 
(Expt. E). However there was no sign that total molarity had an effect on Σ tC+. 
• At pH 4.0, Σ tC+ ranged between 0.35 and 0.59, experiments A and D, respectively. 
• At pH 5.0, Σ tC+ ranged between 0.40 and 0.56, experiments E and D, respectively. 
• At pH 7.0, Σ tC+ ranged between 0.58 and 0.88, experiments B and A, respectively. 
During skin experiments at pH 5-6, Σ tC+ ranged between 0.65 and 0.85 (Murthy et al., 
2006 a).  
There are some differences between the values reported between nail and skin which 
probably reside in the slightly different experimental approach. Mudry et al. (2006 a) did 
not use any buffer or pH adjustment to perform their experiments to avoid the presence of 
any ion other than the cations investigated. In the present work, buffered solutions were 
required to investigate the effect of pH. HEPES was incorporated as the free acid and the 
pH adjusted either with hydrochloric acid or potassium hydroxide. It was considered that 
the competition induced by these co and counter-ions (0.6-0.8 mM HCl at pH 4.0, 0.07-
0.08 mM HCl at pH 5.0 and 0.9-1.4 mM KOH at pH 7.0) was negligible. Indeed, the 
decrease in the cation transport numbers of sodium and lithium (at least 75 mM) by a 
maximum 1.4 mM KOH at pH 7.0 would be certainly small. Another difference between 
the two studies is the total cation concentration employed: 125 to 200 mM for Mudry et al. 
(2006a) and 75 to 550 mM for our work. 
On the whole these results suggest that despite huge variations in the total cation 
concentration (75-550 mM) in the anodal chamber, chloride being present at only 10 mM 
keeps a minimum transport number of ~0.12. This agrees with the threshold observed in 
skin experiments. 
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Conclusions of chapter 4 
This work has demonstrated that several principles concerning transdermal iontophoresis 
were also applicable to transungual iontophoresis. We have demonstrated (a) a relationship 
between the ratio of tLi+/tNa+ and the ratio [Li+]/[Na+] for the first time, (b) a linear 
relationship between a cation transport number and its molar fraction, (c) the existence of a 
threshold or maximal total cation transport number achievable by manipulation of the 
formulation and (d) evidence of nail cation permselectivity at pH 7.  
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Chapter 5:       
  In vivo transungual iontophoresis: Effect of current  
 application on ion transport and on transonychial water loss 
 
Overview 
The in vitro nail iontophoretic experiments described in the previous chapters and 
elsewhere in the literature indicate the potential of using iontophoresis to improve drug 
penetration into the nail. However, there is almost no information concerning transungual 
iontophoresis in vivo. Nothing is known about key issues such as the effect of current 
application on ionic transport and on transonychial water loss (TOWL) and the magnitude 
of the voltages required for a practical use of the technique. This work describes the 
application of transungual iontophoresis to six healthy human volunteers. Each volunteer 
participated in three experiments: passive control, 0.2 mA anodal transungual 
iontophoresis and 0.2 mA cathodal transungual iontophoresis. A commercial electrode on a 
skin site was used to complete the electrical circuit. The outward extraction of sodium and 
chloride ions by passive diffusion and iontophoresis was also quantified. Iontophoresis 
enhanced chloride and sodium transport ~8 and 27 folds respectively compared to passive 
diffusion. Only sodium transport numbers could be measured with certainty to be tNa+ = 
0.51 ± 0.11. TOWL was used as a potential marker of nail damage and hydration. Basal 
TOWL was measured before each experiment, and the return to baseline values was 
monitored for one hour after the treatment (passive or iontophoresis application) was 
finished. TOWL was increased after both iontophoretic and passive experiments and 
typically returned to baseline values in one hour post-treatment. The voltages of the nail-
skin circuits were monitored during iontophoresis and the values compared to a skin-skin 
circuit. Nail-skin circuit voltages were generally ~50 V when the current was started and 
dropped fast to 20-30 V, a value comparable to that observed in the skin-skin circuit. On 
the whole, the clear enhancement of ionic transport observed, the feedback from 
volunteers, the small effects in TOWL, and the magnitude of voltages indicate that nail 
iontophoresis is feasible and probably a safe technique. 
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Introduction 
The treatment of nail diseases such as onychomycosis is far from satisfactory. Oral 
treatments are efficient in delivering the drug but cause numerous side effects and 
interactions. Given the prevalence and cost of the disease (Elewski, 2000; Einarson et al., 
1996) it is not surprising that the development of new topical treatments has received 
increased interest. However, research in nail drug delivery is usually limited by the 
difficulties associated with nail sourcing. Human nails consists of three layers (Dawber, 
1980; Kobayashi et al., 1999) which are different in composition and keratin fibres 
orientation as described in the first two chapters of this thesis, although their respective 
roles in drug permeation have not been completely characterized (Kobayashi et al., 1999). 
Hooves and keratin disks have been used to screen topical formulations but their 
usefulness as a predictive tool for human nail permeation has not been established. Nail 
plates are scarce, expensive and difficult to obtain as they are typically sourced from 
cadaver or amputations. Thus, the use of nail clippings or nail tips as a model to study 
transungual drug delivery seems the most sensible approach. However, the nail plate is 
firmly attached to the nail bed, while nail clippings are obtained from the free edge. It 
follows that the hydration of the free edge and of the attached nail plate must be 
significantly different. No information is available about differences in the structure of 
these two parts of the nail except for an increase in the nail thickness during its growth 
which has been reported by Johnson et al. (1994). At the present time, it is not known if 
any of these differences could be significant in drug permeation in general and even less in 
iontophoresis. 
In vivo transungual iontophoresis has hardly been reported. James et al. (1986) measured 
plasma levels of prednisolone after anodal iontophoresis applied with a metal electrode. 
The thumbnails were first soaked in soapy water for 5 min to decrease their electrical 
resistance and then, a current density of 0.63 mA/cm2 was applied for 10 minutes. 
Prednisolone plasma concentrations were ~50 ng/mL after only 15 minutes of 
iontophoresis and remained detectable for 15 days. This study was the first to show the 
feasibility of transungual iontophoresis. However the amount of drug delivered is very 
surprising. For example, taken an average volume of distribution for the central 
compartment of 36 L (Magee et al., 2001), it follows that ~1.8 mg (~5 µmoles) of drug 
were delivered in only 10 minutes. The actual size of the patch used on the nail is not given 
but one could assume an average thumb nail to be a 2 cm2 square, so the current effectively 
passed was 1.3 mA, or in 10 minutes, ~8 µmoles of electrons. This means that a charged 
drug would have transported ~60% of the total charge (i.e., 0.6 transport number) a value 
extremely high. These results are further problematic because prednisolone (MW 360) is a 
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neutral drug (Vogt et al., 2007). Thus, prednisolone could have only been transported by 
electroosmosis a much weaker mechanism of transport (as seen in Chapter 3). Finally, the 
patch would have become very acidic because metal electrodes that hydrolyze water were 
used. This acidic pH could be related to the different tolerance to current by the four 
individuals. Thus this study was not performed in the best conditions for iontophoresis 
such as the use of reversible electrodes (such as Ag/AgCl) which do not acidify the pH.  
The second article refers to a case study (Sakata et al., 2007). Iontophoresis of 
dexamethasone was used to treat nail psoriasis. However the iontophoretic application had 
actually occurred on the skin. No information is provided about the outcome of the 
treatment. Finally none of these two reports show unequivocally the usefulness of 
iontophoresis as none of them included passive controls.   
There is very little known about the feasibility of applying iontophoresis in vivo. 
Transdermal iontophoresis is considered a minimally invasive and safe technique. Indeed 
several iontophoretic devices (Glucowatch®, LidoSite®, Ionsys®) have been approved by 
the regulatory agencies. However, the thickness and the structure of nail and skin are very 
different. First of all, the stratum corneum, or main barrier to skin permeation has an 
average thickness of 10-20 µm (Pailler-Mattei et al., 2007) while the nail thickness varied 
from 200 µm to more than 1 mm. Second, the contribution of the appendegeal (hair 
follicles and sweat glands) pathways to both electromigration and electroosmotic transport 
during transdermal iontophoresis (Cullander et al., 1992; Scott et al., 1992; Bath et al., 
2001) is not possible for the nail plate. Thus, one could expect the nails to offer a greater 
electrical resistance to the passage of current, and that the high voltages required for 
current application could damage the nail. Indeed, the previous data in this thesis and the 
literature have shown that high voltages (> 200 V) are usually observed in vitro when 
iontophoresis is started unless the nails are hydrated for relatively long times. These 
observations challenged the future of transungual iontophoresis as a drug delivery 
technique. Neither the voltages observed in vitro without extensive hydration (as those 
measured in previous chapters) are acceptable, nor are the extensive hydration times 
applied in other studies (6 and 24 h for Murthy et al. (2007) and Hao et al. (2008), 
respectively). However, James’ publication and preliminary experiments (unpublished) in 
our laboratory indicated that transungual iontophoresis is feasible in vivo after a short 
period of hydration. Therefore, one main objective of this chapter was to determine if 
iontophoresis is an acceptable procedure in vivo.  
The skin barrier integrity after iontophoresis has been investigated using impedance 
spectroscopy (Curdy et al., 2002), infrared spectroscopy (Brand et al., 1997) TEWL 
(TransEpidermal Water Loss), and laser doppler velocimetry (Thysman et al., 1995; Van 
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der Geest et al., 1996; Anigbogu et al., 2000). TEWL is the insensible loss of water from 
the body through the skin and it is considered a good marker of the skin barrier. The term 
TOWL or TransOnychial Water Loss simply indicates that the measurement takes place on 
the surface of the nail plate. In comparison to TEWL, TOWL has been very rarely reported 
(Spruit, 1971; Jemec et al., 1989; Kröner et al., 2001; Murdan et al., 2008). It is not clear 
yet if TOWL can be used as a marker for nail damage in the same way as TEWL is 
routinely applied. The skin has a crucial barrier function, most importantly to limit water 
loss from the body and the increased TEWL, consequence of barrier perturbation, acts as a 
“danger” signal to induce barrier repair (Fluhr et al., 2006). The thick nail plate structure 
also limits passage of water and it is expected that a damaged nail would be more 
permeable to water and show higher values of TOWL. However the nail function is not as 
strongly associated to water loss regulation as the skin is; and, for example, to the best of 
our knowledge, no studies have been done in which nails were damaged at different 
degree, and the recovery was monitored by TOWL.  
This work has investigated the in vivo nail application of iontophoresis in six healthy 
volunteers. The objectives were to 1) measure and compare the transungual sodium and 
chloride transport during passive and iontophoretic conditions, 2) investigate the effect of 
iontophoresis on TOWL as a possible marker of the nail barrier, and 3) decide on the 
feasibility of iontophoresis as a drug delivery technique.  
 
Materials and methods 
 
1. Materials 
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) free acid, magnesium 
chloride, potassium hydroxide 1.0 N in water, sodium hydroxide 50% (ion chromatography 
eluent grade), sodium chloride and methanesulfonic acid were obtained from Sigma 
Aldrich Co. (Gillingham, UK). All aqueous solutions were prepared using high purity 
deionised water (18.2 MΩ.cm, Barnstead Nanopure DiamondTM, Dubuque, IA, USA). 
Silver wire, silver chloride powder and platinum wire used to prepare the electrodes had a 
minimum purity of 99.99 % and were obtained from Sigma Aldrich Co. (Gillingham, UK).  
 
2. Volunteers 
Ethical approval was granted by the Salisbury Local IRB (UK). All volunteers gave their 
written informed consent prior to any experiment (See Appendix 4). 
A first study to collect TOWL values was performed on six healthy volunteers (A to F, 1 
male and 5 females) aged between 21 and 43 years old.  
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Six healthy volunteers (V1 to V6, 3 females and 3 males aged between 25 and 44 years 
old) participated in the transport/TOWL experiments. Six volunteers participated in three 
experiments (nail anodal iontophoresis, nail cathodal iontophoresis and passive) performed 
on the same nail in different days separated at least by 24 h. Five of the volunteers 
participated also in a skin-to-skin iontophoretic experiment. 
 
3. Methods 
Basal TOWL: 
Six volunteers participated in the first basal TOWL study (A to F). The TOWL was 
measured in six replicates on each fingernail of both hands. 
The TOWL measurements were performed using a condenser-chamber AquaFlux 
evaporimeter from Biox Systems Ltd (London, UK). A nail adapter and corresponding 
correction factor were kindly supplied by Biox Systems Ltd. The probe was placed on the 
nail; TOWL measurements started after 80 seconds of equilibration (Fig. 1). The final 
value was the mean of 15 measurements taken between 80-240 seconds of contact and with 
a CV target precision of 1%. The relative humidity and temperature of the room ranged 
between 26 and 44 % and between 20 and 26 ºC. 
 
Fig. 1: TOWL measurement. 
 
Nail iontophoresis: 
All nail-to-skin experiments were performed on different days separated at least by 24 h. 
After giving their informed consent, the volunteers were asked to indicate on which hand 
they would prefer the experiments to take place. Being right-handed, they all opted for 
their left hand which was subsequently used for all experiments. 
The thickness of the thumbnail was measured before the first experiment. The 
measurement took place on the free edge of the nail using a point micrometer (Point Anvil 
Micrometer, Mitutoyo, Andover, UK). Due to the shortness of certain nails, some 
measurements lacked precision and are given as a range. 
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Next, the baseline TOWL was measured, as described previously, in three replicates prior 
to experiment. 
Some preliminary work was done to overcome several challenges offered by nail 
iontophoresis. First of all, the nail electrode chamber had to adapt to the curved surface of 
the nail plate, and had to be fixed using an acceptable glue for human use. A home made 
high-grade polypropylene chamber was used for the thumbnail site to contain the buffer 
and the electrode. The chamber (~0.40 cm2 contact surface area and ~ 2.5 cm high) was 
fixed to the thumbnail using MD 7-4602 silicone kindly provided by Dow Corning Europe 
SA (Seneffe, Belgium). 
A dispersive pad (rectangular shape with round corners, 4.6 cm x 5.6 cm, ~25 cm2) from 
Iogel gelsponge electrodes’ kits (Balego & Associates, Inc., Saint Paul, MN, USA) was 
placed on the dorsal face of the hand to close the electrical circuit. In the nail anodal 
experiments (chloride extraction), a conditioned Ag/AgCl electrode (Green et al., 1991) 
was placed in the nail chamber and connected to the positive pole of a Phoresor II power 
supply (Iomed Inc., Salt Lake City, UT, USA); the cathodal skin dispersive pad was 
connected to the negative pole. In the nail cathodal experiment (sodium extraction), the 
Ag/AgCl electrode was placed in the nail chamber and connected to the negative pole of 
the Phoresor II whereas the anodal skin dispersive pad was connected to the positive pole 
(Fig. 2). 
 
 
Fig. 2: In vivo experimental set-up. The picture above shows a nail cathodal experiment (negative pole 
applied on the nail site, positive pole applied on the skin site). 
 
The nail chamber was filled with 1 mL of a pH 7.0 buffer (HEPES 5 mM added with 
MgCl2 5 mM) for (at least) three minutes to facilitate the nail hydration, before current 
application. The volunteers usually reported an uncomfortable “tingling effect” on the skin 
when current was applied directly after filling the nail chamber. After this short hydration 
Phoresor II 
Nail plastic chamber 
Skin dispersive pad 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 133 
time (usually 3 to 10 min) current was started and four 30 minute periods of a 0.2 mA 
direct constant current were applied.  
At the end of each iontophoretic period, the whole content of the nail chamber was 
sampled, filtered with 0.22 µm filters (Millipore, Sigma Aldrich Co., UK) and frozen at – 
20 ºC until analysis. The samples were analyzed for sodium (nail cathodal experiments) 
and for chloride (nail anodal experiments) as described below. The nail chamber was then 
filled again with 1 mL of fresh buffer and the following iontophoretic period started.  
The voltage of the nail-skin circuit was monitored during the whole experiment with a 
voltmeter as follows: the voltage was recorded every minute for the first 10 minutes of the 
first iontophoretic period, then every 5 minutes and finally 1 min before the end. For each 
subsequent iontophoretic period, the voltage was taken every 5 min and in addition, 1 min 
after the beginning and 1 min before the end. 
At the very end of each experiment, the electrode, dispersive pad and nail chamber were 
removed and the silicone was wiped off with isopropyl alcohol obtained from Sigma 
Aldrich Co (UK). 5 minutes after wiping with isopropyl alcohol, the TOWL was 
monitored during one hour (at 0, 5, 10, 15, 20, 30, 45 and 60 min).  
Despite MD 7-4602 silicone being very effective glue, leaks were observed at the fourth 
period of current application of nail cathodal iontophoresis for V5 and of nail anodal 
iontophoresis for V3. In the case of V4, the nail cathodal iontophoresis experiment was not 
possible probably due to the high electrical resistance presented by this thumbnail.  
The volunteers were asked to fill a form (see Appendices for forms) at the end of each 
iontophoretic experiment to score the discomfort experienced at the nail site, the skin site 
and overall by using a scale from 0 to 5 (5 being a very high discomfort). 
 
Passive experiments: 
A passive diffusion experiment was performed on each volunteer. Briefly, three repeated 
measurements of the TOWL were taken prior to the fixation of the plastic chamber with 
MD 7-4602 silicone to the left thumbnail which was subsequently filled with 1 mL buffer 
for 4 periods of 30 min. The sampling and the TOWL monitoring at the end of the 
experiment were performed in the same manner as during the nail iontophoretic 
experiment. Each sample obtained was filtered (0.22 µm), stored frozen and assayed for 
sodium and chloride ions as described below. 
 
Sodium and chloride analysis: 
Ion chromatography with suppressed conductivity detection (AS50 autosampler and 
thermal compartment, GP50 gradient pump, ED50 electrochemical detector, Chromeleon 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 134 
software, Dionex, Sunnyvale, CA) was used to measure the concentrations of sodium and 
chloride. For the quantification of sodium, the 25 mM methanesulfonic acid eluent was 
pumped under isocratic conditions (1 mL/min) through an IonPacTM CS12A column 
(Dionex, 250 x 4 mm) thermostated at 30ºC and a CSRS ULTRA II suppressor (Dionex, 4 
mm) set at a current of 80 mA. Concentration of Na+ was measured against calibration 
curves obtained from standard solutions ranging from 0.05 to 15 mM (at least five different 
concentrations) of its chloride salt in a pH 7.0 buffer (HEPES 5 mM added with 5 mM 
MgCl2). For the quantification of chloride, the 35 mM NaOH mobile phase was pumped 
through an IonPacTM AS16 column (Dionex, 250 x 4 mm) thermostated at 30ºC and the 
ASRS ULTRA II suppressor (Dionex, 4 mm) set a current of 90 mA. The calibration 
curves were obtained from at least five chloride solutions ranging from 0.05 to 15 mM 
prepared in a pH 7.0 buffer (HEPES 5 mM alone). For chloride and sodium analysis, the 
measurement error was below 5 %. 
 
Skin-to-skin iontophoretic experiment: 
To approximately estimate the contribution of the nail plate to the voltage in the nail-to-
skin previously described experiments, a skin-to-skin experiment was performed on 5 
volunteers (one volunteer was not available). A dispersive pad was cut into a 4 cm2 square, 
placed on the thumb as close as possible to the thumbnail and used as a cathode. A second 
dispersive pad (4.6 cm x 5.6 cm) was placed on the dorsal face of the hand as in the 
previous experiments and used as an anode (Fig. 3). A 0.2 mA current was passed during 
30 min and the voltage monitored as in the first iontophoretic period of the nail-to-skin 
experiments. 
 
 
Fig. 3: Skin-to-skin experimental set-up. 
 
Silicone content in sodium and chloride: 
Sodium and chloride ions are ubiquitous so their presence in the silicone adhesive was 
assessed in the following way: an amount of silicone equivalent to that used to fix the nail 
Phoresor II 
Skin dispersive pads 
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chamber in place (5 – 15 mg) was placed in 1 mL of deionised water and shaken for 2 
hours. The liquid in contact with the silicone was then passed through using 0.44 µm filters 
(Millipore, Sigma Aldrich Co., UK) and analysed for sodium and chloride by ion 
chromatography. A total 0.09 µmoles of chloride and 0.07 µmoles of sodium were 
extracted in this 2 hours extraction process. The contact between buffer and silicone during 
the in vivo experiments is much reduced compared to this extraction procedure, so it was 
considered that the silicone would release a negligible amount of ions to each 30 minutes 
sampling period (less than 0.02 µmoles of chloride and sodium ions).  
 
Fluxes and transport numbers: 
Chloride iontophoretic flux and transport number: 
The anodal chamber extracts chloride ions from inside or underneath the nail plate as it 
contains the positive electrode. However, the electrochemical reaction at the anode 
consumes chloride ions which react with the oxidized silver to precipitate at the electrode 
surface (Eq. 1).  
 
Ag(s) + Cl- → AgCl(s) + e- Eq. 1 
 
The theoretical amount of chloride consumed by the anode during each of the 30 minutes 
iontophoretic periods in the experiments (QE) can be calculated using Eq. 2. 
 
QE = I.t/F  Eq. 2 
 
where I is the intensity applied during the experiment in amperes (here, 0.2.10-3 A), t is the 
length of one experimental period in seconds (here, 30 min = 1800 s) and F is the Faraday 
constant which value was approximated to 96500 coulombs/mol. In these conditions, the 
theoretical amount of chloride ions consumed by the anode for each 30 min iontophoretic 
period was 3.73 µmol. 
The anodal buffer solution contained 5 mM HEPES and 5 mM MgCl2. Thus, to determine 
the chloride amount effectively driven across the nails by iontophoresis, Eq. 3 (Marro et 
al., 2001c) was used:  
 
QS = Q0 + QJ – QE  Eq. 3 
 
where, for each iontophoretic period, QS is the chloride amount in the sample, Q0 is the 
initial chloride amount in the buffer before experiment (typically between 8.7 and 10.7 
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mM), QE is the amount of chloride consumed electrochemically at the anode and QJ is the 
amount of chloride driven across the nail. 
QE is determined theoretically using Eq. 2 and QS and Q0 are measured by ion 
chromatography. QJ or amount of chloride reaching the anodal solution from inside or 
underneath the nail for each 30 min iontophoretic period was estimated using Eq. 3. Fluxes 
were directly deducted (multiplying by 2) and expressed in µmol/h. 
Chloride transport number was then calculated using Eq. 4:  
 
Ji = ti.I / Zi.F   Eq. 4   (Phipps et al., 1992) 
 
where Ji is the flux of the ion “i” in mol/sec, ti is the transport number of the ion “i”, I is the 
current intensity in coulombs/sec, Zi is the valence of the ion “i” and F is the Faraday 
constant. 
The transport number, ti, is the fraction of the total charge transported by a specific ion 
during iontophoresis and the sum of all transport numbers must be equal to 1. If 
iontophoresis is the only mechanism contributing to chloride transungual transport and the 
assumptions leading to Eq. 3 are valid on our experimental conditions, chloride transport 
number should vary from a minimum 0.3 to a maximum 1. These transport numbers 
translate into fluxes of 2.24 and 7.46 µmol/h respectively.  
 
Sodium iontophoretic flux and transport number 
Sodium ions were extracted during cathodal nail experiments as this positive ion is 
attracted to the negative electrode. At the cathode, the electrochemical reaction: 
 
AgCl(s) + e- → Ag(s) + Cl-(aq)  Eq. 5 
 
does not require sodium participation and the cathodal buffer does not contain any sodium 
ions. The buffer was prepared with HEPES free acid instead of the routinely used HEPES 
sodium salt and the pH was adjusted with KOH instead of NaOH. IC analysis indicated 
that the traces of sodium in the HEPES buffer were negligible as compared to sodium 
fluxes. Thus, sodium fluxes from inside or underneath the nail plate were directly 
estimated from the sodium content in the cathodal samples. The sodium transport number 
was then calculated using Eq. 4. 
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Passive fluxes: 
The amount of chloride and sodium ions extracted from inside or underneath the nail 
during passive experiments were calculated from the amount of ion in the receptor sample 
at the end of each 30 minutes period as measured by IC and by taking into account the 
background ion concentration present in the buffer. Fluxes were directly deducted as 
described for iontophoretic experiments. 
 
Relative TOWL:  
The relative TOWL was used to monitor the return to baseline values after a passive or an 
iontophoretic experiment and was calculated using the TOWL measured at a given post-
treatment time normalized by the mean baseline TOWL measured for the respective 
volunteer before the treatment (iontophoresis or passive) was started. It follows that a 
relative TOWL of 1 indicates that the TOWL has returned to the baseline values. 
 
4. Data analysis and statistics: 
All the results are expressed as mean ± SD unless otherwise stated. Linear, non linear 
regressions and statistics were performed using Graph Pad Prism V5.00 (Graph Pad 
Software Inc., San Diego, CA). Statistical differences were assessed with a one way 
ANOVA followed by a Tukey post-test and a two way ANOVA as described in the text. 
The level of statistical significance was fixed at p < 0.05.  
An empirical relation (one-phase exponential decay, Graph Pad Prism V5.00) between 
baseline TOWL and the thumbnail thickness was investigated (Eq. 6) by non linear 
regression analysis: 
 
Baseline TOWL = (Y0 – plateau) . e(-K.thickness) + plateau  Eq. 6 
 
where Y0 is the TOWL value when the thickness is equal to 0, the plateau is the TOWL 
value when the nail thickness becomes infinite and K is a constant; all determined by the 
Graph Pad Prism software. “Baseline TOWL” is the average of the three TOWL 
measurements taken before each experiment and “Thickness” is the nail thickness 
measured for each volunteer. A linear relationship between baseline TOWL and nail 
thickness was investigated as well (Eq. 7). 
 
Baseline TOWL = slope . Thickness + b Eq. 7 
 
where b is the intercept with the Y-axis (TOWL value corresponding to a null thickness). 
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Results and discussion 
This is the first time that passive and iontophoretic sodium and chloride transport across 
the nail have been measured and compared, demonstrating, in vivo, the potential of 
iontophoresis as an enhancing technique in the field of nail drug delivery. Also, we have 
investigated some key issues such as the voltages required for a practical application and 
started some preliminary safety evaluation of the technique via TOWL.  
 
Basal TOWL  
This first study was aimed to gather information about TOWL in order to plan the 
subsequent experiments (Fig. 4).  
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Fig. 4: Variation of TOWL in 6 volunteers and as a function of the finger and hand where the measurement 
took place. The last graph shows the average TOWL for the 6 volunteers. F1 indicates thumb, F2 forefinger, 
F3 middle finger, F4 ring finger and F5 little finger. 
 
In this study, all volunteers except D were right-handed. For each volunteer, a two way 
ANOVA revealed significant statistical difference between the hands: all volunteers except 
A had significantly higher TOWL values for the fingernails of the left hand. When 
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volunteers were considered individually, no fingernail systematically showed higher 
TOWL values than others (paired one way ANOVA followed by a Tukey post-test 
performed for each hand). 
On the graph presenting the average of the 6 volunteers, a two way ANOVA showed a 
statistical difference between the TOWL of the two hands. The mean TOWL for all the 
fingernails of the six volunteers was 38.0 ± 4.9 and 34.7 ± 6.3 g/(m2h) for the left and right 
hand respectively. For the average left hand, the TOWL of the thumb nail (F1) was 
significantly higher than the forefinger nail (F2) and for the right hand, the TOWL of the 
thumbnail (F1) was significantly lower than the ring finger nail (F4) and the little finger 
nail (F5) (paired one way ANOVA followed by a Tukey post-test performed for each 
hand). 
This study was undertaken as, at the time, there was not sufficient information on how 
TOWL varied inter and intra-individually. It was then decided that the thumb nail offered 
little differences to the other nails, but being bigger would be more suitable for the 
iontophoretic study. 
 
Iontophoretic fluxes of sodium and chloride ions and their transport number: 
The iontophoretic sodium and chloride fluxes measured for each volunteer are reported in 
Table 1 and the chloride fluxes are shown in Fig. 5. 
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Table 1: Chloride and sodium iontophoretic fluxes (µmol/h) for each volunteer and sampling interval. 
 
Period 
(min) 
Chloride 
flux 
Chloride 
Average flux 
Sodium 
flux 
Sodium 
Average flux 
30 1.5 3.45 
60 7.04 3.93 
90 2.86 4.21 
V1 
120 8.88* 
3.80 ± 2.89 
5.05 
4.16 ± 0.67 
30 51.47* 4.62 
60 7.03 4.56 
90 4.91 4.42 
V2 
120 5.37 
5.77 ± 1.11 
4.86 
4.61 ± 0.18 
30 120.65* 3.01 
60 9.05* 3.93 
90 8.21* 4.17 
V3 
120 3.15 
3.15 
3.87 
3.74 ± 0.51 
30 7.22 
60 35.56* 
90 7.82* 
V4 
120 24.82* 
7.22 ND 
30 6.53 2.38 
60 3.29 2.38 
90 3.51 2.76 
V5 
120 11.37* 
4.44 ± 1.81 
 
2.51 ± 0.22 
30 2.83 3.27 
60 4.77 3.61 
90 4.29 4.01 
V6 
120 6.03 
4.48 ± 1.32 
3.75 
3.66 ± 0.31 
* values which were not included in the average chloride flux because they corresponded to a transport 
number > 1. 
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Fig. 5: Apparent iontophoretic chloride extraction fluxes across the nail plate for each volunteer and sampling 
period. The dotted and continuous lines indicate the flux corresponding to a transport number equal to 0.5 
and 1, respectively. The Y axis had to be segmented for V2, V3 and V4 in order to facilitate the visualization. 
 
As discussed in Materials and methods, a chloride flux of 7.46 µmol/h indicates a chloride 
transport number equal to 1. This is an abnormal value, as one would expect sodium ions 
to carry some charge as well. There were several chloride fluxes even higher, suggesting 
chloride transport numbers higher than 1. These anomalous values indicate that the 
assumptions made in the calculation (see Materials and Methods) were not valid. An 
examination of Eq. 3 suggests two possible sources of error. First of all, the value of QE or 
the chloride consumed at the electrode is calculated theoretically, that is, assuming that 
oxidation of silver as described in Eq. 1 is the only process occurring at the anode. 
However, endogenous substances released from the nail into the electrode chamber could 
also be oxidized at the anode without chloride consumption. In this case, the theoretical 
value of QE is an overestimation of the amount of chloride consumed and, accordingly, of 
chloride flux. A second source of error could originate from the analytical methods. The 
buffer at the electrode contains some chloride (~10 mM or 10 µmoles in 1 mL), the amount 
of chloride arriving from beneath the nail is 3.73 µmol/h (~1.87 µmol/30 min) assuming a 
0.5 transport number. It follows that reading this small amounts against a given chloride 
background may carry some error as the amount of chloride for each period corresponds to 
~19 % of the amount in the buffer. An apparent transport number for chloride has been 
calculated after elimination of the fluxes corresponding to transport numbers higher than 1; 
thus the fluxes 3.8 ± 2.9, 5.8 ± 1.1, 3.1, 7.2, 4.4 ± 1.8 and 4.5 ± 1.3 µmol/h for V1, V2, V3, 
V4, V5 and V6 respectively were used (Fig. 6). However, these fluxes are subjected to the 
same errors discussed above and cannot be considered as valid measures. 
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Fig. 6: Apparent chloride transport number for each volunteer. 
 
The apparent transport numbers obtained for each volunteer were as follow: 0.51 ± 0.39 for 
V1, 0.77 ± 0.15 for V2, 0.42 for V3, 0.97 for V4, 0.59 ± 0.24 for V5 and 0.60 ± 0.18 for 
V6. The average apparent chloride transport number for all the volunteers was 0.63 ± 0.24. 
The same difficulties in estimating chloride fluxes have been described by Nixon et al. 
(2007). An accurate measure of chloride transport numbers would require the use of a 
different type of electrodes. However, the use of inert electrodes, which do not require 
chloride for functioning, results in pH variations that alter nail permselectivity (as seen in 
chapter 3). Moreover, the introduction of buffers to avoid pH fluctuations also complicates 
measurements by introducing competing ions.  
On the other hand, the iontophoretic fluxes and transport number of sodium were easily 
measured and were obtained for each volunteer and period as shown in Fig. 7 and 8.  
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Fig. 7: Iontophoretic sodium fluxes of extraction across the nail plate for each volunteer and sampling period. 
The dotted line indicates the flux corresponding to a transport number equal to 0.5. 
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The average iontophoretic sodium fluxes for each volunteer was: 4.2 ± 0.7, 4.6 ± 0.2, 3.7 ± 
0.5, 2.5 ± 0.2, 3.7 ± 0.3 µmol/h for V1, V2, V3, V5 and V6 respectively. The average 
sodium flux was 3.8 ± 0.8 µmol/h. 
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Fig. 8: Average (±SD) sodium transport number for each volunteer. 
 
The transport numbers obtained for the different volunteers were 0.56 ± 0.09, 0.63 ± 0.02, 
0.50 ± 0.07, 0.34 ± 0.03 and 0.49 ± 0.04 for V1, V2, V3, V5 and V6 respectively. The 
average transport number for all the volunteers was 0.51 ± 0.11. 
As a difference with chloride, sodium fluxes are directly deduced from the concentration of 
sodium ions in the buffer because they do not participate in the electrode reactions. 
Further, there is no sodium ions in the buffer, which facilitates a precise quantification of 
the amount of sodium arrived from underneath the nail. Thus, the transport numbers for 
each volunteer were very consistent and had a small CV (3 to 16 %). 
As previously discussed, this is the first time (to the authors’ knowledge) that in vivo 
sodium iontophoretic transungual fluxes and transport numbers have been measured. Thus, 
the closest comparisons can be done with the reverse iontophoretic transdermal extraction 
of sodium by Sieg et al. (2004b) and Leboulanger et al. (2004b) in human volunteers. Sieg 
et al. (2004b) extracted sodium in Tris buffer (10 mM, pH 8.5) by applying a 0.6 mA 
current (0.3 mA/cm2) for 5 hours and obtained a mean (±SD) of 0.55 ± 0.04 for sodium 
transport number (12 volunteers). Leboulanger et al. (2004b) used a 10 mM histidine 
solution (pH 7.47) and applied a 0.8 mA current (~0.25 mA/cm2) for four periods of 30 
min; sodium transport number was 0.54 ± 0.04 (24 patients). Although our value presents a 
relatively high SD, our average value, 0.51, is fairly similar to those obtained by Sieg and 
Leboulanger (2004b). As this was an in vivo experiment, it is expected that other cations 
which were not quantified were extracted at the same time (e.g. potassium and calcium). 
This means that the total cation transport number is probably closer to 0.6 which is in 
favour of a net negative charge of the nail at physiological pH. 
 
The smallest sodium transport number was obtained with V5 whose nail plate was the 
thickest (800 µm) of all used in the study. Thus, a potential relationship between sodium 
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transport number and nail’s thickness was investigated. However, as Fig. 9 shows, no 
relation is observed when all the volunteers are considered.  
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Fig. 9: Sodium transport number and nail plate thickness determined for each volunteer. Sodium extraction 
took place either in the first experiment (open circles) or in the second experiment (closed square). 
Measurement of thickness was done before the first experiment. 
 
Passive diffusion: 
The chloride and sodium passive fluxes are shown in Table 2 and Fig. 10. 
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Fig. 10: Sodium and chloride passive fluxes for each volunteer and sampling period. Missing columns 
indicate fluxes below the limit of detection. 
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Table 2: Chloride and sodium passive fluxes (µmol/h) for each volunteer and sampling interval. 
 
Period 
(min) 
Chloride 
Passive flux 
Chloride 
Average flux 
Sodium 
Passive flux 
Sodium 
Average flux 
30 0.36 0.20 
60 1.40 0.16 
90 0.80 0.16 
V1 
120 0.40 
0.74 ± 0.48 
0.14 
0.16 ± 0.03 
30 0.46 0.16 
60 1.58 0.10 
90 1.02 0.12 
V2 
120 0.22 
0.82 ± 0.61 
0.16 
0.12 ± 0.03 
30 0 0.2 
60 0.16 0.16 
90 0 0.12 
V3 
120 0.24 
0.10 ± 0.12 
0.10 
0.14 ± 0.04 
30 0.82 0.68 
60 1.08 0.10 
90 0.22 0.08 
V4 
120 0 
0.53 ± 0.50 
0.12 
0.24 ± 0.29 
30 0.19 0.10 
60 0.53 0.06 
90 0 0.04 
V5 
120 4.01 
1.18 ± 1.90 
0.06 
0.06 ± 0.03 
30 0 0.12 
60 0.04 0.10 
90 0.34 0.08 
V6 
120 0 
0.09 ± 0.16 
0.08 
0.09 ± 0.02 
 
Passive fluxes of sodium were low and relatively constant (0.06 to 0.24 µmol/h) whereas 
chloride fluxes were highly variable (0.09 to 1.18 µmol/h). Average (±SD) passive fluxes 
were 0.58 ± 0.86 µmol/h and 0.14 ± 0.12 µmol/h for chloride and sodium respectively. The 
wide variation observed in the chloride fluxes could be explained by the chloride (10 mM) 
background in the buffer which probably interfered with the measurement of the very 
small change in chloride concentration due to the passive flux. 
Sodium passive fluxes were significantly higher in vivo than in vitro (Mann Whitney non 
parametric t-test). For example, the average sodium flux at pH. 7.0 in vitro was 0.06 ± 
0.01µmol/h. The reason for this small difference is not clear, but this could be due to the 
different experimental conditions (2 hours in vivo compared to 16 hours in vitro). For 
example, the nail plate and the nail tips could have a slightly different content in sodium. 
The content in potassium, calcium and sodium of finger and toe nail clippings has been 
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reported to be 357, 368 and 440 µg per g of nail substance, respectively (Vellar, 1970) 
which correspond to 9, 9 and 19 µmol per g of nail substance, respectively. The portion of 
the nail exposed to iontophoresis corresponds to a weight of ~10-20 mg. Therefore, it is 
expected that the content in sodium of this portion will be ~190-380 nmoles. On the one 
hand, the in vivo and in vitro sodium passive fluxes are 140 and 60 nmol/h, respectively. 
On the other hand, the in vivo sodium iontophoretic flux is 3800 nmol/h. This shows that 
the sodium ions extracted by iontophoresis were rapidly coming from underneath the nail 
plate.  
In any case, iontophoretic fluxes of the two ions were significantly higher than their 
respective passive fluxes (Mann Whitney non parametric t-test). Iontophoretic fluxes 
enhance chloride and sodium transungual transport by 8 and 27 fold, respectively, 
compared to passive. These results clearly demonstrate the ability of iontophoresis to 
enhance the in vivo transport of small charged molecules across the nail plate and thus, its 
potential for transungual drug delivery. 
 
TOWL- iontophoresis: 
The baseline TOWL was measured for each volunteer at the beginning of each experiment 
and is shown in Table 3 along with the information regarding the volunteer’s age, gender 
and the thumbnail thickness.  
 
Table 3: Baseline TOWL (Mean ± SD, n=3) measured for each volunteer and participation. 
Baseline TOWL (g/(m2h)) 
Volunteer Gender Age Nail thickness (µm) 
Nail anodal Nail cathodal Passive diffusion 
V1 Female 27 250-340 56.3 ± 1.4 (2)a 51.4 ± 2.3 (1)a 65.1 ± 1.8 (3) 
V2 Female 32 390-440 42.2 ± 1.3 (1)ab 48.8 ± 2.4 (2)b 52.6 ± 2.5 (3) 
V3 Female 44 300 47.3 ± 1.1 (1)a 51.0 ± 5.5 (2)a 63.6 ± 2.7 (3) 
V4 Male 26 450-500 38.9 ± 2.9 (2)ab 46.6 ± 2.5 (3)b 49.0 ± 1.3 (1) 
V5 Male 25 800 38.8 ± 3.0 (2) 37.5 ± 3.0 (1) 44.5 ± 3.4 (3) 
V6 Male 25 450 43.1 ± 1.1 (1)a 47.5 ± 1.0 (2)a 56.0 ± 4.0 (3) 
(1)
, 
(2)
 and (3) indicate in which order the experiments were performed for each volunteer. 
a
 baseline TOWL before iontophoretic experiments significantly different (p < 0.05) to their baseline TOWL 
before passive diffusion. 
b
 baseline TOWL significantly different (p < 0.05) for the two iontophoretic experiments. 
 
The baseline TOWL values (37.5 – 65.1 g/m2h) are consistent with those measured for the 
thumb nail of the left hand in the first study (32.0 – 48.5 g/m2h). 
Previous values reported in the literature are 18.5-30.7 (Spruit, 1971), 11.7-33.5 (Jemec et 
al., 1989), 12.9 (Krönauer et al., 2001) and 28-75 g/(m2h) (Murdan et al., 2008). Spruit 
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(1971) used a home-made capsule to measure the vapour loss whereas Jemec et al. (1989) 
and Krönauer et al. (2001) used open chamber evaporimeters. Our values are higher than 
Spruit, Jemec and Krönauer but are consistent with Murdan et al. (2008) who used the 
same type of closed-chamber evaporimeter. 
 
A curious observation was that the baseline TOWL for 5 of the 6 volunteers increased as 
the experiments took place (Table 2) as it is shown in Figure 11. 
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Fig. 11: Baseline TOWL for each volunteer and experiment.  
 
The difference in the baseline values between the first and the last experiments was + 13.7 
(+27%), + 10.4 (+25%), + 16.3 (+34%), - 2.4 (-5%), + 7 (+19%) and + 12.9 g/(m2h) 
(+30%)  for V1, V2, V3, V4, V5 and V6 respectively.  
It is difficult to decide on the causes behind these differences. It would be premature to 
conclude that iontophoresis had an effect on the nail plate because the passive experiment 
was usually the last one performed. It would have been necessary to have the passive 
treatment done first in some volunteers to discard a possible effect of temperature, 
humidity or season. Further, this would be in contradiction with the prompt return to 
baseline values observed after each iontophoretic treatment. In the case of transdermal 
iontophoresis, TEWL is elevated for a transient period (~1-2 hours) before it returns to 
baseline values (Van Der Geest et al., 1996; Brand et al., 1997; Fouchard et al., 1997; 
Anigbogu et al., 2000). The purpose of the passive experiment was to hydrate the nail with 
the same buffer used during iontophoresis so the effects on TOWL due to hydration and 
passage of current could be separated. Figure 12 shows that TOWL was elevated both after 
iontophoresis and passive treatments and returns relatively fast to baseline values. Because 
the baseline values measured for each volunteer are different, it is easier to compare their 
relative values. A relative TOWL of 1 indicates a TOWL close to the baseline value.  
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Fig. 12: TOWL (left panels) and relative TOWL (right panels) measured for each volunteer after passive and 
iontophoretic treatment. Filled circle, open circle and filled triangle represent nail anodal, nail cathodal and 
nail passive experiments respectively. 
 
The results indicate that TOWL was back to pre-experimental values one hour after 
iontophoresis. Further, the profiles observed after passive and iontophoretic treatments 
were very similar suggesting that the elevated TOWL was mostly caused by the increased 
nail hydration. Thus, it would seem that iontophoresis did not increase water permeability 
across the nail plate. While these results are encouraging, it must be noticed that TOWL 
has not been validated as a marker of nail damage, and that there could be other effects of 
the current in the nail structure which are not accompanied by an increment in water loss. 
Thus, a more exhaustive study is required before drawing any definitive conclusion on the 
safety of the technique.  
 
A possible relation between TOWL and thickness of the nail plate was also investigated. 
Fig. 13 shows the baseline TOWL measured for each volunteer and experiment as a 
function of thickness of the nail. 
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Fig. 13: Relationship between nail thickness and baseline TOWL for each volunteer and experiment. The 
experimental data was fitted to the curve by non linear (Eq. 6: TOWL = (Y0 – plateau) . e(-K.thickness) + plateau) 
and linear relationship (Eq. 7: TOWL = slope . thickness + b). The dotted and continuous lines indicate the 
linear and non-linear regression prediction curves, respectively. All linear regressions were significant and r2 
was 0.55, 0.53 and 0.63 whereas, for non linear regressions, r2 was 0.55, 0.64 and 0.79 for the 1st, 2nd and 3rd 
experiment, respectively.  
 
Eq. 6 was used because it assumes, a fairly high value of TOWL for a nail of null thickness 
and second, a plateau for the TOWL, i.e. a threshold value of TOWL when the thickness 
increases (which can tend to 0). Linear regressions were calculated to compare both fitting 
methods (Eq. 7). The results of the non-linear and linear regressions are given in Table 4. 
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Table 4: Equation data for the non-linear and linear relationships between nail thickness and baseline TOWL. 
The results are expressed as estimate ± SE of the regressions. Exp. stands for experiment. 
 TOWL = (Y0 – plateau) . e(-K.thickness) + plateau TOWL = slope . thickness + b 
 Y0a Plateaub K Slope ba 
X-
interceptc 
(µm) 
1st exp. 58.9  ± 12.0 22.1 ± 55.5 0.001 ± 0.003 - 0.022 ± 0.005 55.1 ± 2.4 2505 
2nd exp. 113.8 ± 57.1 37.0 ± 4.6 0.005 ±  0.003 - 0.030 ± 0.007 60.8 ± 3.4 1999 
3rd exp. 175.9 ± 78.9 43.3 ± 3.6 0.006 ± 0.002 - 0.039 ± 0.007 72.6 ± 3.6 1858 
a
 TOWL for null thickness  b TOWL for infinite thickness  c thickness for null TOWL 
 
For the first experiment, both fitting models presented similar r2 (0.55) whereas for the two 
subsequent experiments the non-linear model fitted better the data (linear: r2 = 0.53 and 
0.63 for 2nd and 3rd experiment, respectively. Non-linear: r2 = 0.64 and 0.79 for 2nd and 3rd 
experiment, respectively).  
The inverse linear regressions suggest that a null TOWL can be achieved for nails 
presenting a thickness ranging from 1.8 to 2.5 mm whereas the non-linear curves suggest 
that a TOWL can not be null for any thickness and would rather tend to a plateau ranging 
between 22.1 to 43.3 g/m2h.  
Y0 in the non linear relationship and b in the linear relationship represent the same 
parameter: the TOWL value for a null thickness of the nails. In both relationships, this 
value increases with the experiments. The meaning of this increase is not clear and it is 
hoped that future experiments will help to understand it. 
Jemec et al. (1989) and Murdan et al. (2008) also studied the relationship between nail 
thickness and TOWL. The former did not find any dependence whereas, like in this study, 
the latter found one. Murdan et al. (2008) found an inverse linear relationship between the 
two variables for two individuals (mean ± SD for each fingernail of each volunteer) and 
found a Pearson correlation of -0.83 and -0.92 for the first and second individual. The 
relationship was stronger when each individual was considered separately than when the 
data from the two individuals were pooled together (Pearson correlation became -0.42). 
Our study pools the thumb nail thickness and TOWL of six individuals (mean ± SD for the 
left thumb nail of each volunteer) and, in these conditions, the linear regressions offer a 
stronger relationship than Murdan’s findings. This could be related to the fact that we only 
used thumbnails whereas Murdan et al. (2008) pooled all the fingernails together. 
However, the non-linear model that we used showed that the relationship became stronger 
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with the chronological order of the experiments; that was less apparent with the linear 
model. It is not clear which model’s assumptions are the closest to reality but it is likely 
that other factors like Murdan et al. (2008) suggested (i.e., nail composition) interfere in 
the relationship between TOWL and nail thickness.  
 
Feasibility of iontophoresis: 
The important voltages observed at the beginning of iontophoresis application in vitro were 
worrying. In fact, they were high enough to question the feasibility of transungual 
iontophoresis as a drug delivery technique. Deciding on this feasibility was an important 
objective of this in vivo study. The power supply, Phoresor II, used in this chapter is 
approved for medical applications and offers the level of safety required for in vivo studies. 
The Kepco power supply used in the in vitro studies is connected to the mains and is 
capable of maintaining very high voltages whereas the Phoresor II is battery (9V) operated 
and is able to apply a maximum voltage of 80 V. If for any reason the maximum voltage is 
reached, the device stops passing the current and provides an error message.  
The voltage measured during the nail-to-skin and the skin-to-skin experiments for each 
volunteer are shown in Fig. 14.  
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Fig. 14: Voltage measured during nail-to-skin and skin-to-skin iontophoresis. Filled circles, open circles and 
crosses indicate nail anodal, nail cathodal and skin-to-skin experiments, respectively. A dotted line separates 
each period of current application. 
 
No difference in the voltage versus application time profile was apparent between nail 
anodal and cathodal experiments; usually the voltages declined in both cases becoming 
quite similar at the end of the experiments. For 2 male volunteers (V4 and V5), 
experiments started at voltage superior to 60 V whereas for V1, V2, V3 and V6 the voltage 
started around 50 V and dropped fast. It is known that the dorsal nail is less hydrated than 
the nail bed (Gunt et al., 2007b) and it probably contributes to a higher electrical 
resistance. As current is passed the nail hydration and ionic content is increased, which 
decreases the electrical resistance. The importance of hydration was clearly observed; 
hydrating the nail with the buffer for ~ 3-10 min usually helped the application of the 
current, diminished the voltage at the beginning of the experiment and the patients 
“tingling” feelings. However, the nail cathodal experiment was not possible for V4 even 
after a 30 minutes hydration time. The voltage reached 80 V after a few minutes of current 
application which caused the Phoresor to automatically stop the current passage. A 
possible explanation would be a very high resistance of the nail plate for this volunteer; 
nevertheless the same volunteer had previously participated in an anodal experiment 
carried out without complications. It must be noticed that the voltages here measured 
correspond to the complete electrical circuit; and while the assumption that the nail is a 
significant contributor to the resistance of the other circuit is correct, any other faulty 
component of the circuit could have caused the problem. Further investigation on the nail 
behaviour during current application is necessary to confirm these observations in a higher 
number of volunteers and also to understand what causes the in vivo voltages to be lower 
than in vitro.  
The skin-to-skin experiments performed roughly estimate the nail contribution to the total 
voltage. The circuit used was similar to a nail cathodal experiment, but the cathode was 
placed on the skin of the thumb very close to the thumbnail, the anode was placed on the 
dorsal face of the hand as usual (Fig. 3). The voltages of the skin-to-skin circuits were 
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clearly lower than those observed in the first 30 minutes of the nail-to-skin experiments, 
indicating a variable but sometimes high contribution of the nail to the resistance of the 
total circuit. The nail-to-skin voltages slowly decrease with time, reaching for all the 
volunteers, with the exception of V6, values similar to the skin-to-skin experiments. This 
happened during the third (V2 and V3) or the fourth (V1 and V4) period of current 
application and suggests that the resistance of the nail decreases greatly with the time of 
the application of the current.  
 
In any case, the results indicate that iontophoresis is feasible. Further, as shown by Table 5, 
the discomfort experienced by the volunteers during the iontophoretic experiments was 
lower if not comparable to that reported during skin iontophoresis. 
 
Table 5: Discomfort experienced during nail iontophoresis as reported by the participants. The discomfort 
was ranked on a 0 to 5 scale where 5 represented a very high discomfort. 
Discomfort score 
Site Experiment 
V1 V2 V3 V4 V5 V6 
Nail anodal 1 0 1 0 0 2 
Skin site 
Nail cathodal 3 0 1 ND 0 2 
Nail anodal 1 0 0 3 0 0 
Nail 
Nail cathodal 2 0 0 ND 0 0 
Nail anodal 1 1 1 2 0 0 
General 
Nail cathodal 2 1 1 ND 0 1 
ND: Not determined. 
 
The discomfort score was typically between 0 and 2, showing that the volunteers tolerated 
well nail iontophoresis. Two volunteers (V1 and V6) reported verbally a higher “tingling” 
sensation at the skin site during the nail cathodal experiment and indeed, it has been also 
reported for transdermal iontophoresis that volunteers usually expressed a greater 
discomfort at the anodal than at the cathodal site (Ledger, 1992; Brand et al., 1997; 
Leboulanger et al., 2004b; Sieg et al., 2004b). However non parametric t-tests performed 
between anodal and cathodal discomfort and between the skin and nail discomfort did not 
reveal any statistical differences. 
 
Finally, a possible relationship between voltages and nail’s thickness was investigated 
(Fig. 15). This investigation did not reveal any relationship between the two parameters 
during nail cathodal experiment but a linear relationship presenting a r2 equal to 0.76 was 
found during nail anodal experiment. 
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Fig. 15: Voltage measured for each volunteer and type of experiment as a function the nail thickness. Open 
circles and closed squares indicate whether the experiment was the first (open circle) or the second (closed 
square) for the participant.  
 
Conclusions of chapter 5 
In summary, we have measured sodium and chloride fluxes across the nail during passive 
and iontophoretic transport. Iontophoresis clearly enhanced sodium and chloride fluxes 
demonstrating that iontophoresis efficiently improves ionic transport across the nail. 
Sodium transport numbers could be measured and were similar to those measured during 
transdermal iontophoresis.  
Transungual iontophoresis was feasible and well tolerated by volunteers. A transient 
elevation in TOWL after iontophoresis was probably due to the increased hydration of the 
nail plate. Baseline TOWL values were typically recovered 1-2 hours post-treatment 
suggesting that iontophoresis had not altered irreversibly the permeability of water across 
the nail plate. These encouraging results indicate that transungual iontophoresis merits 
further investigations with regard to future applications in drug delivery. 
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GENERAL DISCUSSION AND PERSPECTIVES  
 
The aims of this thesis were to investigate iontophoresis as a possible enhancing method 
for transungual delivery. As little information existed on the feasibility and outcomes of 
ungual iontophoresis, basic studies were designed to investigate: 1) the in vitro extent of 
ionic fluorescent markers penetration and to visualize the routes used to penetrate the nail, 
2) the in vitro permselective properties of the nail plate 3) the relative enhancement of nail 
penetration induced by iontophoresis as compare to passive diffusion and 4) the feasibility 
of an in vivo application of iontophoresis. 
 
General discussion 
 
We developed a new method using confocal microscopy which gave information on the 
depth and pathways of penetration of two fluorescent markers under passive and 
iontophoretic conditions: SF, a hydrophilic di-anion, and NBC, a lipophilic cation. 
Both compounds use mainly the transcellular pathway (with a possible contribution of the 
paracellular pathway) during passive diffusion and iontophoresis. Given this is the first 
study of this kind and that it only investigated two compounds, it is not possible to draw 
conclusions about these being the pathways followed by most drugs. However, knowing 
the pathways of transport is a step towards a rational optimization of nail transport and this 
will be useful information on which future research can be based. Surprisingly, increasing 
the current intensity did not result in a proportional deeper penetration of the markers. 
Indeed, the iontophoretic delivery of ionised compound is governed by Faraday’s law (Eq. 
1). 
 
1.Eq
zF
tIJ
d
d
d
⋅
⋅
=  
 
This equation, as mentioned previously, shows the proportionality of the flux with the 
intensity of the current. It seemed clear from these results that other factors were causing 
these anomalous observations. Unfortunately, additional experiments performed, such as 
the binding study, did not provide explanation for these results. Previous works have 
demonstrated that salicylic acid, terbinafine, mannitol and urea (although only in the anode 
to cathode direction for mannitol and urea) transungual fluxes to be directly determine by 
the current applied (Murthy et al., 2007b; Hao et al., 2008a; Nair et al., 2008). Again, it 
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will be necessary to perform additional studies to establish if iontophoresis will be an 
efficient method to control drug delivery across the nail or not. 
Due to the molecular weight of the markers used (353.85 and 376. 28 Da for NBC and SF, 
respectively), it seemed logical to think that their transport was not only the fact of 
electromigration but was also due to electroosmosis. We have used a cationic and a di-
anionic compound, and assuming that nails are negatively charged at physiological pH, one 
could expect the cationic compound to be transported more efficiently than the di-anionic 
one. It was not the case. However, as mentioned in Chapter 2, the solution of NBC had a 
pH of 3 whereas SF solution had a pH of 8. A pH of 3 could have reversed the nail charged 
to be positive, and in this case, NBC would have been delivered against the 
electroosmostic flow, the same as SF. It follows that the iontophoretic transport of the two 
markers was not facilitated. Therefore, the contribution of electroosmotic and 
electrorepulsive forces needed to be investigated. 
Murthy et al. (2007a) and Hao et al. (2008a and b) both showed that the nail membrane 
presents a net negative charge at physiological pH. Therefore, it was expected that the 
results of our electroosmotic study support this finding. However, even if the results tend 
to show that the electroosmotic flux is in the anode to cathode direction at physiological 
pH, the variability of the mannitol fluxes measured in the different nails prevented to draw 
any clear conclusion. There is no clear reason for this variability which seems to be 
maximal at physiological pH and in the anode to cathode direction. This could be related to 
a difference in the nail swelling at different pH. However, no information is available 
about this subject. Another hypothesis could be related to the incorporation of 
drugs/elements into the nail plate during nail formation. Indeed, nails have been used in 
forensic investigations because drugs are incorporated in the nail in formation (Palmeri et 
al., 2000). Therefore, nail composition could vary between individuals and even in the 
same individual according to diet, drug treatment or the chemicals handled during work, 
house work or spare time activities. This variability in nail composition could thus be 
responsible for the inter- and intra-nail variability observed in the electroosmotic flux. 
Further, that would mean that for a same person, the nail composition may vary greatly 
with time and thus, even if the same experiment was performed on the tip coming from a 
same finger, results might differ and show variability. These unexpected results raised 
questions about the feasibility of a transungual iontophoretic application for big, polar, 
uncharged compounds (most of the criteria presented by antifungals) and made the study 
of the electrorepulsive force even more essential to characterize the nail behaviour. 
The iontophoresis of sodium and lithium ions revealed little variability and provided a 
clear evidence of a nail cation permselectivity at physiological pH. Moreover, nails 
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demonstrated behaviours similar to skin in term of evolution of transport numbers with the 
molar fraction and in term of a threshold in the total cation transport number. Considering 
the high variability in the mannitol fluxes and the weak penetration of SF and NBC, it is 
possible to hypothesize that the molecular size of these permeants may be too close to the 
mesh size of the nail. To a certain extent, this hypothesis could be supported by Khengar et 
al. (2007): these authors studied the passive mannitol transport after pre-treating the nail 
tips with penetration enhancers and they obtained extremely variable mannitol fluxes after 
each enhancer pre-treatment. It is possible that the nails did not react in the same manner to 
the pre-treatment and thus did not swell to the same extent resulting in different mesh size 
modifying drug penetration.  
One could argue as well that this variability in the fluxes may demonstrate that the 
chemical enhancers and iontophoresis have an irreversible effect on the nail membrane. 
Indeed, Khengar et al. (2007) and Malhotra et al. (2002) noticed that when a chemical 
enhancer was efficient, this was associated with an irreversible change in the nail surface 
and properties. However, passive diffusion fluxes of sodium and lithium did not vary much 
during in vitro experiments whereas the same nails were used across three different pHs 
and were exposed three times to iontophoresis. If the passive fluxes had varied a lot, this 
would have demonstrated an irreversible effect of the current. As the in vitro cations fluxes 
were very encouraging, it was decided that the feasibility of an in vivo application should 
be explored.  
The in vivo experiments showed that, indeed, it was possible to apply iontophoresis to 
human volunteers. The current application did not result in high voltages and was well 
accepted by the volunteers. This was demonstrated by evaluating the discomfort that 
volunteers experienced during the experiments. Due to the experimental setting, the 
transport number obtained for chloride ions was not exploitable but the transport number 
obtained for sodium ions was in favour of a negative charge hold by the nail in vivo at 
physiological pH. Interestingly, whereas during in vitro experiments, sodium fluxes were 
not stable even at the end of 8 hours of iontophoresis, in vivo, sodium fluxes seemed stable 
after 30 min/1 hour of current application. This finding might be related to a structural or 
hydration difference between the nail plate in vivo and the nail clippings in vitro. In vitro 
iontophoresis of terbinafine (Nair et al., 2008) has shown to lead to steady-state fluxes after 
only 15 min of current application whereas salicylic acid delivery needed ~8 hours to reach 
steady-state (Murthy et al., 2007b); and mannitol and tetraethylammonium (Hao et al., 
2008a) needed less than 9 hours and ~15 hours, respectively. The reasons for these very 
different lag times are not clear. Although Hao et al. (2008a) specifically used mannitol 
and tetraethylammonium for their similar effective hydration radius, the two molecules 
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demonstrated very different lag time. Moreover, terbinafine, despite its MW (almost 300 
Da), reached steady-state in less than 15 min whereas sodium (23 Da), in this thesis, 
needed more than 8 hours. Nair’s results are surprising but, to date, not enough information 
are available to discuss this particular point. 
On the whole the in vivo study supports the practical use of iontophoresis as a drug 
delivery technique if justified by the enhancement provided for a given drug. 
 
Perspectives 
 
During confocal microscopy experiments, SF and NBC were used. As discussed 
previously, both compounds present a relatively high MW and therefore, it could be 
hypothesised that different results may be obtained if using fluorescent markers presenting 
a lower MW. However, the molecular weight of fluorescent markers is unlikely to be 
below mannitol’s molecular weight (182 Da) and thus, it might be easier to study the 
penetration of radioactive compounds of different MW and to estimate their penetration by 
counting the radioactivity in the successive layers of the nail. For this, a method to cut 
small slices of nail of constant thickness still needs to be developed. Nails are difficult to 
slice in a regular fashion due to their rigidity/elasticity properties. While methods such as 
the successive drilling (Hui et al., 2002) or slicing of nail layers by microtomes (Wegener 
et al., 1990) have been tried, there is not yet a technique available that can be considered 
equivalent to “tape stripping” in the skin.  
Whole human nails or clippings of sufficient size for experiments are difficult to obtain. 
Some authors like Mertin et al. performed some of their studies on hooves and on human 
nail to determine if hooves could be a suitable model. However, due to their different 
structure, the hoof does not seem to behave exactly like the human nail and, therefore, it 
could be interesting to perform a study similar to what have been done in this thesis in 
order to measure the penetration depth and visualize the pathways of fluorescent markers. 
This could allow the identification of the different structural elements involved in nail and 
hoof permeability. 
During the binding study, SF clearly diffused deeper in the nail at the end of the first week 
compared to its penetration at 24 hours. SF could be applied in iontophoretic pulse therapy 
for 3 or 4 hours (once, twice or three times a week. The regimen will probably depend on 
further studies) and its penetration followed by confocal microscopy after 2 or 3 weeks. 
The results of this study might give useful information and allow the design of a 
therapeutic procedure during which the nail plate could be loaded with the drug during 
short iontophoretic sessions applied by health personnel and using the subsequent diffusion 
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phenomenon previously observed to drive the drug sequentially deeper into the nail plate 
between the sessions. 
The nail hydration has been said to be of great importance during passive diffusion study. 
It seems important to investigate this parameter by varying the hydration times and/or 
hydration medium used to soak the nails before experiments. This could allow the 
determination of how and if this factor contributes to iontophoretic transport. 
The ionic strength in the donor chamber has been said to have a great influence over 
electroosmosis (Santi et al., 1996) and therefore reducing the amount of NaCl in the donor 
chamber containing the mannitol from 154 mM to smaller values may increase the fluxes 
and make more obvious the differences between anodal, cathodal and passive delivery. 
As it has been previously highlighted, TOWL has not been validated yet as a tool to 
monitor the effects of iontophoresis on the nail. Therefore, this technique could be 
validated by monitoring the evolution of the TOWL with time on nails damaged at 
different degree. Damages could be caused by a chemical agent or by tape-stripping, for 
example.  
Other methods such as SEM or AFM could be explored to monitor the effects of 
iontophoresis. SEM and AFM have been used to assess the effect of chemical enhancers on 
the nail surface (Repka et al., 2002) and could allow the visualization of the in vitro effects 
of iontophoresis.  
The characterization of the in vivo nail permselectivity properties will be complete only by 
studying electroosmosis. This study may be performed by attempting to extract glucose 
through the nail. However, this study might be difficult if the mannitol fluxes measured in 
vitro are predictive of reverse iontophoretic glucose fluxes. 
In this thesis, iontophoresis did not show an interesting enhancing potential for compounds 
presenting MW around or above 200 Da whereas a recent article (Nair et al., 2008) showed 
that terbinafine (291 Da) could be efficiently delivered and detected in the receptor 
solutions after only 15 minutes of iontophoresis. This finding is extremely surprising and 
some light needs to be put on the role of the MW upon transungual iontophoretic delivery. 
This could be done by measuring the transport number of ionic compounds of increasing 
MW. Indeed, as controversy and doubts remained about a MW cut-off existence, nails are 
usually treated as a black box and most authors perform experiments with drugs because of 
their systemic potency and not according to their suitability for nail delivery. Obviously, it 
would be of little use to administrate a drug only because it penetrates well in the nail but, 
if a very potent drug hardly penetrates the nail, a drug of less potency with a good 
penetration profile would be a better option. The determination of the relationship between 
MW and transport number could be a useful tool to predict how efficiently a molecule will 
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be delivered by iontophoresis and then, it could be used to screen potential drug 
candidates. 
The association of chemical enhancers and iontophoresis has been recently investigated by 
Hao et al. (2008b). The authors (Hao et al., 2008b) found that thioglycolic acid was able to 
increase the transport number of tetraethylammonium but had no effect on electroosmosis. 
Although this finding certainly needs to be confirmed by further investigations, this could 
lead to an enhancement of the already enhanced delivery due to iontophoresis and 
therefore, maximize the possibility to treat effectively and quickly certain nail diseases. 
The future of iontophoresis for nail application is not known but device to apply efficiently 
iontophoresis to several finger or toe nails could simplify treatments. Indeed, nail diseases 
usually affect several fingers or toes and thus topical treatments are individually 
administrated to each finger or toe. For iontophoresis, a device could be designed in the 
form of a glove or of a sock with little gel pads at each finger/toe extremity connected to 
electrodes; the skin electrodes could be placed on the dorsal face of the hand/foot and the 
treatment gel pads could be filled injecting the drug solution. The whole device could be 
simply pulled on the hand/foot, tighten to the limb with adequate elastics or bands and the 
iontophoretic device could be fixed along the wrist or the ankle. This could allow the 
simultaneous treatment of all the diseased area and each device could be adapted to 
individual. 
Finally, this work has used nail plates from healthy volunteers only; one could expect the 
structure and properties of the diseased nails to be very different, so it would be very 
interesting to validate our findings by experimenting on diseased nail. 
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CONCLUSIONS 
 
We developed a new technique to follow the in vitro penetration of fluorescent markers 
into human nails using confocal microscopy. Iontophoresis of SF and NBC was performed 
during 18 hours and showed that the current intensity had no influence on the markers 
penetration depth. Under no conditions the markers went deeper than 12 % of the whole 
nail thickness and the layer exposed to the fluorescent marker was not a discriminating 
factor. During passive diffusion and iontophoresis, both markers mainly followed the 
transcellular pathway. 
The in vitro experiment investigating the contribution of electroosmosis gave results 
stained with significant variability. However, results were in favour of a negative charge of 
the nail at physiological pH. 
Iontophoresis enhanced only moderately the delivery of the fluorescent markers and 
mannitol compared to passive diffusion whereas a clear enhancement was noticeable for 
lithium and sodium ions. 
The in vitro study of cation electromigration revealed similarities between skin and nail 
iontophoresis and a cation permselectivity of the nail at pH 7.0. Unlike electroosmosis, the 
fluxes measured showed little variability. 
The iontophoretic extraction of chloride and sodium ions was successful and ionic fluxes 
were measured in vivo for the first time. The participants did not experience any major 
discomfort during the experiments and, as a general rule, the current application as well as 
the resulting voltage were well accepted by the participants. 
 
On the whole, it has been proven that transungual iontophoresis enhanced in vitro and in 
vivo fluxes of small ions compared to passive diffusion. The feasibility of in vivo 
iontophoresis was established and showed that further investigations were necessary to 
fully demonstrate the ability of this technique to enhance transungual drug delivery. 
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Appendix 1: Confocal microscopy images 
 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 182 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 183 
 
 
 
 
 
 
 
 
 
 
 
 
NBC.Passive 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 184 
 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 185 
TRANSVERSAL MEASUREMENTS 
 
 
 
 
Fig. 1: Transversal measurements on NBC.Passive images. Panel A: images from nail 4RF2. Panel B: images 
from nail 12LF5. Images taken at objective x10. 
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Fig. 1 (continued): Transversal measurements on NBC.Passive images. Panel C: images from nail 14RF4. 
Images taken at objective x10. 
 
DORSAL MEASUREMENTS 
 
Fig. 2: Dorsal measurements on NBC.Passive 3-D reconstructions. Panel A: images from nail 4RF2. Images 
taken at objective x10. 
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Fig. 2(continued): Dorsal measurements on NBC.Passive 3-D reconstructions. Panel B: images from nail 
12LF5. Panel C: images from nail 14RF4. Images taken at objective x10. 
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Fig. 3: Dorsal measurements on NBC.Passive z-stack. Panels A: images from nail 4RF2. Panel B: images 
from nail 12LF5. Images taken at objective x10. 
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Fig. 3 (continued): Dorsal measurements on NBC.Passive z-stack. Panels B: images from nail 12LF5. Images 
taken at objective x10. 
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Fig. 3 (continued): Dorsal measurements on NBC.Passive z-stack. Panel B: images from nail 12LF5. Panels 
C: images from nail 14RF4. Images taken at objective x10. 
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Fig. 3: Dorsal measurements on NBC.Passive z-stack. Panel A: images from nail 4RF2. Panel B: images 
from nail 12LF5. Panel C: images from nail 14RF4. Images taken at objective x10. 
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Fig. 4: NBC pathway during NBC.Passive. Panel A: images from nail 4RF2. Panel B: images from nail 
12LF5. Panel C: images from nail 14RF4. Images taken at objective x20. 
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NBC.0.1 
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TRANSVERSAL MEASUREMENTS 
 
 
  
Fig. 1: Transversal measurements on NBC.0.1 images. Panel A: images from nail 2LF5. Panel B: images 
from nail 12RF1. Images taken at objective x10. 
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Fig. 1 (Continued): Transversal measurements on NBC.0.1 images. Panel C: images from nail 7LF4. Images 
taken at objective x10. 
 
DORSAL MEASUREMENTS 
 
 
Fig. 2: Dorsal measurements on NBC.0.1 3-D reconstructions. Panel A: images from nail 2LF5. Images 
taken at objective x10. 
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Fig. 2: Dorsal measurements on NBC.0.1 3-D reconstructions. Panel B: images from nail 12RF1. Panel C: 
images from nail 7LF4. Images taken at objective x10. 
 
 
Fig. 3 Dorsal measurements on NBC.0.1 z-stack. Panel A: images from nail 2LF5. Images taken at objective 
x10. 
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Fig. 3 (continued) Dorsal measurements on NBC.0.1 z-stack. Panels A: images from nail 2LF5. Images taken 
at objective x10. 
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Fig. 3 (continued) Dorsal measurements on NBC.0.1 z-stack. Panels B: images from nail 12RF1. Images 
taken at objective x10. 
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Fig. 3 (continued) Dorsal measurements on NBC.0.1 z-stack. Panels B: images from nail 12RF1. Images 
taken at objective x10. 
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Fig. 3 (continued) Dorsal measurements on NBC.0.1 z-stack. Panels C: images from nail 7LF4. Images taken 
at objective x10. 
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Fig. 3 (continued) Dorsal measurements on NBC.0.1 z-stack. Panel C: images from nail 7LF4. Images taken 
at objective x10. 
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NBC.0.4 
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TRANSVERSAL MEASUREMENTS 
 
 
 
Fig. 1: Transversal measurements on NBC.0.4 images. Panel A: images from nail 4LF4. Panel B: images 
from nail 12LF3. Images taken at objective x10. 
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Fig. 1 (continued): Transversal measurements on NBC.0.4 images. Panel C: images from nail 13LF3. Images 
taken at objective x10. 
 
 
Fig. 2: Dorsal measurements on NBC.0.4 3-D reconstructions. Panel A: images from nail 4LF4. Images 
taken at objective x10. 
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Fig. 2 (continued): Dorsal measurements on NBC.0.4 3-D reconstructions. Panel B: images from nail 12LF3. 
Panel C: images from nail 13LF3. Images taken at objective x10. 
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Fig. 3: Dorsal measurements on NBC.0.4 z-stack. Panel A: images from nail 4LF4. Images taken at objective 
x10. 
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Fig. 3 (continued): Dorsal measurements on NBC.0.4 z-stack. Panels A: images from nail 4LF4. Panels B: 
images from nail 12LF3. Images taken at objective x10. 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 210 
 
 
 
 
Fig. 3 (continued): Dorsal measurements on NBC.0.4 z-stack. Panels B: images from nail 12LF3. Images 
taken at objective x10. 
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Fig. 3 (continued): Dorsal measurements on NBC.0.4 z-stack. Panels C: images from nail 13LF3. Images 
taken at objective x10. 
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Fig. 3: Dorsal measurements on NBC.0.4 z-stack. Panel C: images from nail 13LF3. Images taken at 
objective x10. 
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Fig. 4: NBC pathway during NBC.0.4. Panels A: images from nail 4LF4. Images taken at objective x20 
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Fig. 4 (continued): NBC pathway during NBC.0.4. Panel A: images from nail 4LF4. Panels B: images from 
nail 12LF3. Images taken at objective x20 
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Fig. 4 (continued): NBC pathway during NBC.0.4. Panel B: images from nail 12LF3. Panels C: images from 
nail 13LF3. Images taken at objective x20. 
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Fig. 4 (continued): NBC pathway during NBC.0.4. Panel B: images from nail 12LF3. Panels C: images from 
nail 13LF3. Images taken at objective x20. 
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Fig. 1: Transversal measurements on SF.Passive images. Panel A: images from nail 2LF5. Panel B: images 
from nail 4R. Images taken at objective x10. 
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Fig. 1 (continued): Transversal measurements on SF.Passive images. Panel C: images from nail 12LF2. 
Images taken at objective x10. 
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Fig. 2: Dorsal measurements on SF.Passive 3-D reconstructions. Panel A: images from nail 2LF5. Images 
taken at objective x10. 
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Fig. 2 (continued): Dorsal measurements on SF.Passive 3-D reconstructions. Panel B: images from nail 4R. 
Panel C: images from nail 12LF2. Images taken at objective x10. 
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Fig. 3: Dorsal measurements on SF.Passive z-stack. Panel A: images from nail 2LF5. Images taken at 
objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.Passive z-stack. Panel B: images from nail 4R. Panel C: 
images from nail 12LF2. Images taken at objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.Passive z-stack. Panel C: images from nail 12LF2. Images 
taken at objective x10. 
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Fig. 1: Transversal measurements on SF.0.1 images. Panel A: images from nail 2LF4. Panel B: images from 
nail 12LF1. Images taken at objective x10. 
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Fig. 1: Transversal measurements on SF.0.1 images. Panel C: images from nail 4LF5. Panel D: images from 
nail 7LF4. Images taken at objective x10. 
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Fig. 2: Dorsal measurements on SF.0.1 3-D reconstructions. Panel A: images from nail 2LF4. Panel B: 
images from nail 12LF1. Images taken at objective x10. 
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Fig. 2: Dorsal measurements on SF.0.1 3-D reconstructions. Panel C: images from nail 4LF5. Panel D: 
images from nail 7LF4. Images taken at objective x10. 
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Fig. 3: Dorsal measurements on SF.0.1 z-stack. Panel A: images from nail 2LF4. Images taken at objective 
x10. 
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Fig. 3 (continued): Dorsal measurements on SF.0.1 z-stack. Panel A: images from nail 2LF4. Panel B: images 
from nail 12LF1. Images taken at objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.0.1 z-stack. Panel B: images from nail 12LF1. Images taken 
at objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.0.1 z-stack. Panel C: images from nail 4LF5. Images taken at 
objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.0.1 z-stack. Panel C: images from nail 4LF5. Panel D: images 
from nail 7LF4. Images taken at objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.0.1 z-stack. Panel C: images from nail 4LF5. Images taken at 
objective x10. 
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Fig. 4 (continued): SF pathway during SF.0.1. Panel A: images from nail 2LF4. Panel B: images from nail 
12LF1.  Images taken at objective x20. 
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Fig. 4(continued): SF pathway during SF.0.1. Panel B: images from nail 12LF1. Panel C: images from nail 
4LF5. Images taken at objective x20. 
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Fig. 4(continued): SF pathway during SF.0.1. Panel C: images from nail 4LF5. Images taken at objective 
x20. 
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Fig. 4(continued): SF pathway during SF.0.1. Panel D: images from nail 7LF4 Images taken at objective x20. 
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Fig. 1: Transversal measurements on SF.0.4 images. Panel A: images from nail 12RF5. Panel B: images from 
nail 2LF4. Images taken at objective x10. 
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Fig. 1(continued): Transversal measurements on SF.0.4 images. Panel C: images from nail 4LF5. Images 
taken at objective x10. 
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Fig. 2: Dorsal measurements on SF.0.4 3-D reconstructions. Panel A: images from nail 12RF5. Images taken 
at objective x10. 
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Fig. 2 (continued): Dorsal measurements on SF.0.4 3-D reconstructions. Panel B: images from nail 2LF4. 
Panel C: images from nail 4LF5. Images taken at objective x10. 
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Fig. 3: Dorsal measurements on SF.0.4 z-stack. Panel A: images from nail 12LF5. Images taken at objective 
x10. 
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Fig. 3 (continued): Dorsal measurements on SF.0.4 z-stack. Panel A: images from nail 12LF5. Panel B: 
images from nail 2LF4. Images taken at objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.0.4 z-stack. Panel B: images from nail 2LF4. Images taken at 
objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.0.4 z-stack. Panel B: images from nail 2LF4. Panel C: images 
from nail 4LF5. Images taken at objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.0.4 z-stack. Panel C: images from nail 4LF5. Images taken at 
objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.0.4 z-stack. Panel C: images from nail 4LF5. Images taken at 
objective x10. 
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Fig. 1: Transversal measurements on SF.V.Passive images. Panel A: images from nail 1RF5. Panel B: images 
from nail 2RF5. Images taken at objective x10. 
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Fig. 1(Continued): Transversal measurements on SF.V.Passive images. Panel C: images from nail 12RF4. 
Images taken at objective x10. 
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Fig. 2: Dorsal measurements on SF.V.Passive 3-D reconstructions. Panel A: images from nail 1RF5. Images 
taken at objective x10. 
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Fig. 2: Dorsal measurements on SF.V.Passive 3-D reconstructions. Panel B: images from nail 2RF5. Panel C: 
images from nail 12RF4. Images taken at objective x10. 
 
 
Fig. 3: Dorsal measurements on SF.V.Passive z-stack. Panel A: images from nail 1RF5. Images taken at 
objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.V.Passive z-stack. Panel A: images from nail 1RF5. Images 
taken at objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.V.Passive z-stack. Panel B: images from nail 2RF5. Images 
taken at objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.V.Passive z-stack. Panel B: images from nail 2RF5. Panel C: 
images from nail 12RF4. Images taken at objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.V.Passive z-stack. Panel C: images from nail 12RF4. Images 
taken at objective x10. 
 
 
Fig. 4: SF pathway during SF.V.Passive. Images taken at objective x20. 
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Fig. 1: Transversal measurements on SF.V.0.1 images. Panel A: images from nail 12RF3. Images taken at 
objective x10. 
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Fig. 1(continued): Transversal measurements on SF.V.0.1 images. Panel B: images from nail 2LF3. Panel C: 
images from nail 7LF5. Images taken at objective x10. 
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Fig. 1(continued): Transversal measurements on SF.V.0.1 images. Panel D: images from nail 13RF4. Images 
taken at objective x10. 
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Fig. 2: Dorsal measurements on SF.V.0.1 3-D reconstructions. Panel A: images from nail 12RF3. Images 
taken at objective x10. 
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Fig. 2 (continued): Dorsal measurements on SF.V.0.1 3-D reconstructions. Panel B: images from nail 2LF3. 
Panel C: images from nail 7LF5. Images taken at objective x10. 
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Fig. 2 (continued): Dorsal measurements on SF.V.0.1 3-D reconstructions. Panel D: images from nail 13RF4. 
Images taken at objective x10. 
 
 
 
 
Fig. 3: Dorsal measurements on SF.V.0.1 z-stack. Panel A: images from nail 12RF3. Images taken at 
objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.V.0.1 z-stack. Panel A: images from nail 12RF3. Panel B: 
images from nail 2LF3. Images taken at objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.V.0.1 z-stack. Panel B: images from nail 2LF3. Images taken 
at objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.V.0.1 z-stack. Panel C: images from nail 7LF5. Images taken 
at objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.V.0.1 z-stack. Panel C: images from nail 7LF5. Panel D: 
images from nail 13RF4. Images taken at objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.V.0.1 z-stack. Panel D: images from nail 13RF4. Images 
taken at objective x10. 
 
 
Fig. 4: SF pathway during SF.V.0.1. Panel A: images from nail 12RF3.  Images taken at objective x20. 
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Fig. 4 (continued): SF pathway during SF.V.0.1. Panel A: images from nail 12RF3.  Images taken at 
objective x20. 
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Fig. 4 (continued): SF pathway during SF.V.0.1. Panel B: images from nail 2LF3. Images taken at objective 
x20. 
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Fig. 4 (continued): SF pathway during SF.V.0.1. Panel B: images from nail 2LF3. Panel C: images from nail 
7LF5. Images taken at objective x20. 
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Fig. 4 (continued): SF pathway during SF.V.0.1. Panel C: images from nail 7LF5. Images taken at objective 
x20. 
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Fig. 4 (continued): SF pathway during SF.V.0.1. Panel C: images from nail 7LF5. Panel D: images from nail 
13RF4. Images taken at objective x20. 
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Fig. 4 (continued): SF pathway during SF.V.0.1. Panel D: images from nail 13RF4. Images taken at objective 
x20. 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 279 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SF.I.0.1 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 280 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 281 
TRANSVERSAL MEASUREMENTS 
 
 
 
Fig. 1: Transversal measurements on SF.I.0.1 images. Panel A: images from nail 12LF1. Panel B: images 
from nail 8LF4. Images taken at objective x10. 
 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 282 
 
Fig. 1(continued): Transversal measurements on SF.I.0.1 images. Panel C: images from nail 4LF4. Images 
taken at objective x10. 
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Fig. 2: Dorsal measurements on SF.I.0.1 3-D reconstructions. Panel A: images from nail 12LF1. Images 
taken at objective x10. 
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Fig. 2 (continued): Dorsal measurements on SF.I.0.1 3-D reconstructions. Panel B: images from nail 8LF4. 
Panel C: images from nail 4LF4. Images taken at objective x10. 
 
 
Fig. 3: Dorsal measurements on SF.I.0.1 z-stack. Panel A: images from nail 12LF1. Images taken at objective 
x10. 
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Fig. 3 (continued): Dorsal measurements on SF.I.0.1 z-stack. Panel A: images from nail 12LF1. Images taken 
at objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.I.0.1 z-stack. Panel A: images from nail 12LF1. Panel B: 
images from nail 8LF4. Images taken at objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.I.0.1 z-stack. Panel B: images from nail 8LF4. Images taken 
at objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.I.0.1 z-stack. Panel C: images from nail 4LF4. Images taken 
at objective x10. 
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Fig. 3 (continued): Dorsal measurements on SF.I.0.1 z-stack. Panel C: images from nail 4LF4. Images taken 
at objective x10. 
 
 
 
 
Fig. 4: SF pathway during SF.I.0.1. Panel A: images from nail 12LF1. Images taken at objective x20. 
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Fig. 4 (continued): SF pathway during SF.I.0.1. Panel A: images from nail 12LF1. Images taken at objective 
x20. 
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Fig. 4 (continued): SF pathway during SF.I.0.1. Panel B: images from nail 8LF4. Images taken at objective 
x20. 
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Fig. 4 (continued): SF pathway during SF.I.0.1. Panel B: images from nail 8LF4. Panel C: images from nail 
4LF4. Images taken at objective x20. 
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Fig. 4 (continued): SF pathway during SF.I.0.1. Panel C: images from nail 4LF4. Images taken at objective 
x20. 
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SF Binding Study 
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Fig. 1: SF binding study. Pieces D1, E1 and F1 at 24 hours. 
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Fig. 2: SF binding study. Pieces D2, E2 and F2 at one week. 
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Fig. 3: SF binding study. Pieces D3, E3 and F3 at two week. 
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Appendix 2: Mannitol recovered in the nails 
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Set I 
 
Mannitol content at pH 4.0: 
 
 4LF3 12LF3 13LF3 
 
Exposed 
area 
Non 
exposed 
area 
Exposed 
area 
Non 
exposed 
area 
Exposed 
area 
Non 
exposed 
area 
Mannitol 
content 
(nmol/mg) 
1.53 0.58 3.64 0.57 1.69 0.51 
 
Mannitol content at pH 5.0: 
 
 2LF5 7LF1 13LF4 
 
Exposed 
area 
Non 
exposed 
area 
Exposed 
area 
Non 
exposed 
area 
Exposed 
area 
Non 
exposed 
area 
Mannitol 
content 
(nmol/mg) 
4.29 0.67 2.66 0.37 1.95 0.44 
 
Mannitol content at pH 7.4: 
 
 2LF5 7LF5 9RF5 
 
Exposed 
area 
Non 
exposed 
area 
Exposed 
area 
Non 
exposed 
area 
Exposed 
area 
Non 
exposed 
area 
Mannitol 
content 
(nmol/mg) 
1.62 0.62 1.29 0.30 1.25 0.28 
 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
 301 
Set II 
 
 2LF3 4RF3 7LF3 
 
Exposed 
area 
Non 
exposed 
area 
Exposed 
area 
Non 
exposed 
area 
Exposed 
area 
Non 
exposed 
area 
Mannitol 
content 
(nmol/mg) 
1.21 0.20 1.00 0.41 0.65 0.16 
 
Set III 
 
 2RF5 4LF5 13LF5 
 
Exposed 
area 
Non 
exposed 
area 
Exposed 
area 
Non 
exposed 
area 
Exposed 
area 
Non 
exposed 
area 
Mannitol 
content 
(nmol/mg) 
0.81 0.28 1.64 0.28 1.55 0.23 
 
Set IV 
 
 2RF4 4RF4 12RF4 
 
Exposed 
area 
Non 
exposed 
area 
Exposed 
area 
Non 
exposed 
area 
Exposed 
area 
Non 
exposed 
area 
Mannitol 
content 
(nmol/mg) 
1.23 0.34 0.72 0.14 0.85 0.17 
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Appendix 3: Ethical forms for nail collection 
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Department of Pharmacy & Pharmacology    Begoña Delgado-Charro, PhD 
Claverton Down       Tel. +44.1225.383969; fax +44.1225.386114 
Bath, BA2 7AY       Email:  B.Delgado-Charro@bath.ac.uk 
 
 
Participant information sheet 
 
Collection of finger nails by nail clipping. 
 
You are being invited to take part in a research study. 
Before you decide on your participation, it is important for you to understand why the 
research is being done and what it will involve. Please take time to read the following 
information carefully and discuss it with others if you wish. 
Please, contact us if there is anything that is not clear or if you would like more 
information. 
Take as much time as you want to decide whether or not you wish to take part in this study. 
 
Thank you for reading this information sheet. 
 
Purpose of the study: 
Fungal infections of the nail are a common disease. Unfortunately, they are quite difficult 
to treat: local treatments have low efficiency because drugs penetrate poorly into the nail. 
The alternative is oral treatments (taken by mouth) but this exposes the whole body to the 
medicine which results in frequent adverse effects. 
Our research team is looking into new ways of applying drugs to the nail. Specifically, we 
are investigating nail iontophoresis. This technique consists on the application of small 
electrical currents to the nail in order to improve drug penetration. Iontophoresis is 
currently used to increase the passage of drugs through the skin, and we think that it could 
also be used for delivering drugs to the nail.  
 
This study wants to answer the following questions:  
1. Does the application of small electrical currents (iontophoresis) improve the 
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penetration of antifungal drugs (such as terbinafine, griseofulvin or amorolfine) into the 
nail as compared with the standard topical treatments available? 
And if the answer is yes: 
2. Which are the most appropriate drugs; formulations and treatment conditions that 
should be used to treat nail fungal infections with this technique? 
 
For doing these experiments we need human nails. Hooves from animal are different in 
their structure and composition to human nails, so we may get the wrong answers to the 
questions above if we use them. 
This is the reason for performing this fingernail collection. We require healthy volunteers 
to donate their fingernails tips (8-10 mm length) to our research, so we can use the nails to 
do experiments that study antifungal drugs penetration. 
Participants must be healthy and their nails should not present any disease, brittleness, 
infection or decolouration. This is important because diseased and healthy nails may 
behave differently.  
The chief investigator teaches Pharmacy to undergraduate students. To avoid conflicts of 
interests, the undergraduate pharmacy students at the University of Bath are also excluded 
from this study. 
 
Your participation in the research: 
It is up to you to decide whether or not to take part in this study. If you agree to participate 
the following will happen: 
1. You will be given a copy of this information sheet to keep for your records. 
2. There will be some time (from 1 day minimum to 2-3 months) during which 
you will let your fingernails grow. Note that you can choose how many (1 to 
10) nails, in which hand, and which nails you prefer to let grow.  During all this 
time, you can change your mind about your participation; you are still free to 
withdraw at any time and without giving a reason. 
3. Once the free edge of the nails has reached the right length, and if you still want 
to donate them to our research, you will contact the research team. You will be 
asked to come to our laboratories (9W 4.04 and 9W 4.06) at the University of 
Bath and you will be given a consent form to sign. After you have given your 
informed consent, a researcher will cut the free edge of your fingernails with a 
standard manicure scissors. 
4. Your nail clippings will be made anonymous and identified with a code: Subject 
1/nail 1, Subject 1/nail 2 and so on. The researcher will record the date of the
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donation, your name, age and gender, the finger and hand where each nail was 
harvested from and the use of nail cosmetics (if relevant).  All this information will 
be kept separately from the nails so it will not be possible to identify the donor of 
each sample. The researcher will kept this information securely. 
5. Once, the nail collection is done, you will be allowed to leave the laboratories 
and your participation will be considered as finished. The total donation act will 
take a maximum time of 30 minutes. To acknowledge you for your time and 
contribution, we will pay you £3 per nail donated.  
6. You may if you wish, participate more than once into the study. 
 
Lifestyle modifications: 
We would expect you to avoid the use of nail cosmetics (specially nail lacquers) while 
your nails are growing. Some people may find unpractical or unpleasant to have long nails. 
You may decide to stop your participation at any moment, or just grow the nails you think 
more convenient. 
 
What will happen to my nails? 
Your nail clippings will be used to investigate if the application of low electrical currents is 
likely to provide a better treatment of fungal infections. For this, we will study the 
penetration of different compounds (fluorescent markers and antifungal drugs) into the 
nail.  
Your nail clippings will NOT be used for DNA analysis or any other test concerning your 
genetic inheritance.  
At the end of the experiments the nail will be disposed of according to the regulations of 
the University of Bath concerning the use of human tissues. 
 
Can I get my nails back? 
If you agree to donate your nails to us, they will be considered as a gift and you will NOT 
retain any rights on them. For example, you can NOT claim them back. However, we will 
only use them for the research described in this form. 
 
Side effects : 
There are not side effects or risks expected from your participation into this study, other 
than those associated with nail clipping. Some people may find unpractical or unpleasant to 
have long nails. You may feel inconvenient to have very short nails just after the nail 
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clipping. 
 
Possible benefits of taking part:  
There is no direct benefit for you as a result of your participation. This is a preliminary 
study which will hopefully help us to develop more effective ways to treat nail fungal 
infections. 
 
If something goes wrong: 
The University of Bath has site specific insurance to cover research on healthy volunteers. 
Please note that this insurance does NOT cover any harm that you could cause with your 
nails to yourself, others or any items during the growing period. 
 
Confidentiality: 
All personal information collected during the course of this research will be kept strictly 
confidential. When the results are made public, these will not include any names, initials, 
or any type of information which could result in your identification.  
 
Results of the study:  
The results of this study will be published in scientific journals and/or presented during 
conferences, and/or internal reports. You will be allowed to have a copy of published 
articles upon request. 
 
Organisation and funding of the research: 
This research is funded by the Department of Pharmacy and Pharmacology. The protocol 
has been reviewed by the Bath Local Research Ethics Committee. 
 
Contact for further information: 
We will be more than happy to answer to all the questions you could have about this 
research and your participation. Please contact: 
  
Ms Julie Dutet: jd251@bath.ac.uk   Phone: 01225 38 ext.4317 or 
4313 
 Dr Begoña Delgado-Charro: prsbd@bath.ac.uk Phone: 01225 383969 
 
You will be given a copy of this information sheet and a signed consent form to keep. 
Thank you for considering taking part in this study.
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Department of Pharmacy & Pharmacology    Begoña Delgado-Charro, PhD 
Claverton Down       Tel. +44.1225.383969; fax +44.1225.386114 
Bath, BA2 7AY       Email:  B.Delgado-Charro@bath.ac.uk 
 
 
 
Centre: University of Bath. Department of Pharmacy and Pharmacology.  
 Skin & nail research group 
 
Participant Identification Number for this study: 
 
 
CONSENT FORM 
 
 
Title :    Collection of finger nails for iontophoretic in vitro study. 
 
 
Researcher: Ms. Julie Dutet 
Principal Investigator: Dr. M. Begoña Delgado-Charro 
 
 
 Please initial 
box 
1. I confirm that I have read and that I understand the information sheet 
dated 07/07/2006 (version 2) for the above study and have had the 
opportunity to ask questions. 
 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical 
care or legal rights being affected. 
 
3. I understand that the donation of my fingernails is a gift. If I donate 
my nails to this study I will not retain any rights on them.  
 
 
4. I agree to take part in the above study.   
 
 
Name of Participant:   Date:    Signature: 
 
 
 
 
 
Researcher:     Date:    Signature: 
 
 
 
 
1 copy for participant, 1 copy for researcher 
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Department of Pharmacy & Pharmacology    Begoña Delgado-Charro, PhD 
Claverton Down       Tel. +44.1225.383969; fax +44.1225.386114 
Bath, BA2 7AY       Email:  B.Delgado-Charro@bath.ac.uk 
 
 
Questionnaire 
 
Date : 
 
1. Name : ………………………………….. 
 
2. Subject code : …………………………… 
 
3. Gender of the participant : ......................... 
 
4. Age of the participant : .............................. 
 
5. The donation concerns (circle nail code): 
 
 
R.F.1  R.F.2  R.F.3  R.F.4  R.F.5 
 
 
L.F.1  L.F.2  L.F.3  L.F.4  L.F.5 
 
 
6. Please, tell us if you used any nail cosmetics during the time you let your nails grow.  
..................................................................................................................................................
..................................................................................................................................................
..................................................................................................................................................
..................................................................................................................................................
..................................................................................................................................................
..................................................................................................................................................
.................................................................................................................................................. 
 
7. Let us know if you had any previous nails infections or problems (brittleness, fungal 
infection, psoriasis, decolouration, etc). 
..................................................................................................................................................
.................................................................................................................................................. 
..................................................................................................................................................
..................................................................................................................................................
..................................................................................................................................................
..................................................................................................................................................
.................................................................................................................................................. 
..................................................................................................................................................
.................................................................................................................................................. 
 
Thank you for your participation ! 
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Appendix 4: Ethical forms for in vivo experiments 
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Department of Pharmacy & Pharmacology    Begoña Delgado-Charro, PhD 
Claverton Down       Tel. +44.1225.383969; fax +44.1225.386114 
Bath, BA2 7AY       Email:  B.Delgado-Charro@bath.ac.uk 
 
 
Participant information sheet 
 
Application of iontophoresis to finger nails 
 
You are being invited to take part in a research study. 
Before you decide on your participation, it is important for you to understand why the 
research is being done and what it will involve. Please take time to read the following 
information carefully and discuss it with others if you wish. 
Please, contact us if there is anything that is not clear or if you would like more 
information. 
Take as much time as you want to decide whether or not you wish to take part in this study. 
 
Thank you for reading this information sheet. 
 
Purpose of the study: 
Fungal infections of the nail are a common disease. Unfortunately, they are quite difficult 
to treat: local treatments have low efficiency because drugs penetrate poorly into the nail. 
The alternative is oral treatments (taken by mouth) but this exposes the whole body to the 
medicine which results in frequent adverse effects. 
Our research team is looking into new ways of applying drugs to the nail. Specifically, we 
are investigating nail iontophoresis. This technique consists on the application of small 
electrical currents to the nail in order to improve drug penetration. Iontophoresis is 
currently used to increase the passage of drugs through the skin, and we think that it could 
also be used for delivering drugs to the nail.  
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Before this technique can be developed, we need to understand how the nail behaves under 
the passage of a small electrical current (0.1-0.4 mA). This study wants to answer the 
following questions: 
 
3. How are physiological molecules (such as glucose, chloride or sodium) transported 
through the nail? This will tell us about the electrical properties of the nail and help 
in identifying the best drugs and iontophoretic conditions that could be used in 
future studies. 
4. How does the nail behave under the application of a small electrical current? We 
will compare the properties of the nail before and after iontophoresis. We will also 
ask you to describe your feelings during current application. This will help us in 
identifying the iontophoretic conditions which provide the least discomfort to 
future participants. 
5. Which type of formulation (solutions, gels, creams) is better adapted for nail 
iontophoresis? 
 
For this, we require healthy volunteers (a maximum of 100 participants) which will 
participate at different stages of the research project. The participation of each volunteer 
will take a maximum of 4-5 hours. Participants must be healthy and their nails should not 
present any disease, brittleness or decolouration. This is important because diseased and 
healthy nails may behave differently.  
 
We will NOT apply any drugs to your nail or skin.  
 
Your participation in the research: 
It is up to you to decide whether or not to take part in this study. If you do decide to take 
part: 
7. You will be given a copy of this information sheet to keep for your records, and  
8. You will be asked to sign a consent form.  
9. If you change your mind about it, you are still free to withdraw at any time and 
without giving a reason. 
 
What is going to happen to you during the study: 
You will be involved in this research for a maximum of 4-5 hours.   
You will participate in one experiment which will take place at our research laboratories at 
the University of Bath (9.W 4.04 - 4.06). 
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1. We will choose either the left or right hand as the testing site. The nail of the thumb 
will be used as the nail iontophoresis site. A nearby skin site will be used as the 
skin iontophoresis site. This is required to close the electrical circuit. (Figure 1) 
 
Figure 1: Example of device for iontophoresis to the nail 
 
2. The initial values of the transepidermal water loss (TEWL) and the colour of both 
the skin and nail sites will be measured. These are completely non-invasive 
procedures standard in dermatological and cosmetic studies. (Figure 2) 
 
Figure 2: Device used to determine the TEWL 
 
3. A plastic or glass cylinder will be attached to the nail and to the skin sites. This will 
be use to hold a formulation consisting of aqueous solutions of physiological 
buffers or simply sodium chloride (salt). In some experiments, a gel formulation 
will be used. A gel formulation will also contain excipients (such as polymers) 
approved for topical medicines. These formulations will NOT contain any drug. 
4. Iontophoresis will be applied using two silver/silver chloride electrodes which are 
the electrodes used in all the approved iontophoretic devices for skin applications. 
These electrodes will be placed inside the formulation, taking special care to avoid  
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any direct contact between the nail and/or the skin, and the electrode. In some 
experiments, a commercial Ag/AgCl electrode will be used for the skin site. 
5. Current will be applied using the Phoresor Auto device which has the CE mark and 
is routinely used for iontophoretic skin applications. This device automatically 
stops passing current if the electrical circuit is faulty. The intensity of current will 
be fixed to a value comprised betwen 0.1 and 0.4 milliamperes (which is a very 
small current). In all cases, the area of the nail will be considered so the density of 
current does not exceed the limit of 0.5 milliamperes/square centimeter, which is 
considered the maximum value of current density well tolerated by the skin. 
6. Four iontophoretic periods of 30 minutes each will be done. At the end of each 
iontophoretic period, the formulation will be removed and reserved for analysis. 
The plastic cylinder will be refilled with fresh formulation. Between two current 
periods, you will be allowed to have a comfort break. 
7. During current application, you must remain seated. You will be able to perform 
some quiet activities like reading. The experiments will take place in a research 
laboratory, thus, accordingly to safety rules you will not be able to drink, eat or 
smoke during this time. 
8. After 4 periods of 30 minutes (total 2 hours current) the iontophoresis will be 
stopped. The formulation will be taken for analysis and the plastic holder and 
commercial electrode removed.  
9. Finally, the colour and TEWL values of the nail and skin application sites after 
current will be measured. We will do these measurements at the following times: 
just after iontophoresis, and 15, 30, 45, and 60 minutes after iontophoresis. In 
between these measurements, and in case of need, you will be allowed to have a 
comfort break out of the laboratory (eat, drink, etc). 
10.  At the end of the experiment, you will be asked to fill a questionnaire about the 
degree of feelings, sensations and/or discomfort you felt at the application sites 
during the experiment. 
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Lifestyle modifications: 
We would expect you to avoid the use of nail cosmetics (creams, nail lacquers, for 
example) prior to the experiment. 
 
Procedure which is being tested during the experiment: 
Iontophoresis is a technique currently used to pass drugs across the skin. Some 
iontophoretic devices have been recently been marketed. There are not devices available 
for nail iontophoresis because this is a new idea. 
The iontophoresis device Phoresor Auto is marketed and has a CE mark for skin 
applications.  
 
Side effects of iontophoresis: 
Iontophoresis is considered to be a safe technique. It can provoke light feelings of tingling 
or heat sensation when applied to skin. Some redness (erythema) is observed that usually 
resolves in several days. Several iontophoretic devices are approved in the market for 
delivering drugs to the skin. 
There is not information on the effects of iontophoresis on the nail, but one would expect 
them to be similar to those observed with the skin. 
If you experience unpleasant feelings or discomfort during the experiment, you should 
communicate it to the researcher who will stop the experiment at once at your request. 
 
Possible benefits of taking part:  
There is no direct benefit for you as a result of your participation. This is a preliminary 
study which will hopefully help us to develop more effective ways to treat nail fungal 
infections. 
 
If something goes wrong: 
The University of Bath has site specific insurance to cover research on healthy volunteers. 
 
Aknowledgement: 
To thank you for your participation and time we will pay you 15 pounds at the end of the 
experiment. You will receive this complete amount even if the experiment is stopped 
before completion, for example if you experienced strong discomfort during current 
application. 
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Confidentiality of taking part in this study: 
All personal information collected during the course of this research will be kept strictly 
confidential. When the results are made public, these will not include any names, initials, 
or any type of information which could result in your identification. 
The researcher may ask you for permission to take a picture of the experiment. If you 
agree, the photography will only include the treated skin or nail sites.  
 
Results of the study:  
The results of this study will be published in scientific journals and/or presented during 
conferences, and/or internal reports. You will be allowed to have a copy of published 
articles upon request. 
 
Organisation and funding of the research: 
This research is funded by the Department of Pharmacy and Pharmacology.  
The protocol has been reviewed by the Salisbury and South Wiltshire Research Ethics 
Committee. 
 
Contact for further information: 
We will be more than happy to answer to all the questions you could have about this 
research and your participation.  
Please contact: 
  
Ms Julie Dutet: jd251@bath.ac.uk  Phone: 01225 38 ext.4317 or 4313 
 Dr Begoña Delgado-Charro: prsbd@bath.ac.uk Phone: 01225 383969 
 
You will be given a copy of this information sheet and a signed consent form to keep. 
 
Thank you for taking part in this study. 
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Department of Pharmacy & Pharmacology    Begoña Delgado-Charro, PhD 
Claverton Down       Tel. +44.1225.383969; fax +44.1225.386114 
Bath, BA2 7AY       Email:  B.Delgado-Charro@bath.ac.uk 
 
 
 
Centre: University of Bath. Department of Pharmacy and Pharmacology.  
 Skin & nail research group 
 
Participant Identification Number for this study: 
 
 
CONSENT FORM 
 
 
Title :    Application of iontophoresis to finger nails. 
 
 
Researcher: Ms. Julie Dutet 
Principal Investigator: Dr. M. Begoña Delgado-Charro 
 
 
 Please 
initial box 
1. I confirm that I have read and that I understand the information sheet 
dated 01/03/2006 (version 2) for the above study and have had the 
opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, whithout my medical 
care or legal rights being affected. 
 
 
3. I allow the researcher to take photographs of the application sites during 
the experiment.  
 
 
4. I agree to take part in the above study.  
 
 
Name of Participant:   Date:    Signature: 
 
 
 
 
 
Researcher:     Date:    Signature: 
 
 
 
 
1 copy for participant, 1 copy for researcher 
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Department of Pharmacy & Pharmacology    Begoña Delgado-Charro, PhD 
Claverton Down       Tel. +44.1225.383969; fax +44.1225.386114 
Bath, BA2 7AY       Email:  B.Delgado-Charro@bath.ac.uk 
 
Experiment Code:  
Application sites: 
Skin formulation: 
Nail formulation: 
Polarity of nail site: 
Intensity of current applied: 
 
Questionnaire 
 
 
Express your degree of sensations and discomfort using the scale from 0 to 5. Please 
indicate 0 if you didn’t feel any discomfort, 5 if you felt a very strong discomfort. 
 
 
1. Discomfort at the skin site:  0 1 2 3 4 5 
 
 
 
2. Discomfort at the nail site:  0 1 2 3 4 5 
 
 
 
3. General discomfort:   0 1 2 3 4 5 
 
 
 
4. Please, describe your sensations and discomfort if you had any.  
..................................................................................................................................................
..................................................................................................................................................
..................................................................................................................................................
..................................................................................................................................................
..................................................................................................................................................
..................................................................................................................................................
.................................................................................................................................................. 
 
5. Let us know if you have any comments about the experiment. 
..................................................................................................................................................
.................................................................................................................................................. 
..................................................................................................................................................
..................................................................................................................................................
..................................................................................................................................................
..................................................................................................................................................
.................................................................................................................................................. 
Thank you for your participation ! 
 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
  324 
 
PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com
